<SEC-DOCUMENT>0001104659-24-121025.txt : 20241120
<SEC-HEADER>0001104659-24-121025.hdr.sgml : 20241120
<ACCEPTANCE-DATETIME>20241120161536
ACCESSION NUMBER:		0001104659-24-121025
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20241120
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241120
DATE AS OF CHANGE:		20241120

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GILEAD SCIENCES, INC.
		CENTRAL INDEX KEY:			0000882095
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				943047598
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19731
		FILM NUMBER:		241480589

	BUSINESS ADDRESS:	
		STREET 1:		333 LAKESIDE DR
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		6505743000

	MAIL ADDRESS:	
		STREET 1:		333 LAKESIDE DR
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GILEAD SCIENCES INC
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2426602d4_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:GILD="http://gilead.com/20241120">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_039_GILD_gilead.com_20241120 -->
<!-- Field: Set; Name: xdx; ID: xdx_04B_20241120_20241120 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0000882095 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-11-20" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-11-20" id="Fact000004" name="dei:EntityCentralIndexKey">0000882095</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="gild-20241120.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-11-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000882095</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-20</xbrli:startDate>
        <xbrli:endDate>2024-11-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 18pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 7.5pt; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 7.55pt; text-align: center"><b>SECURITIES AND EXCHANGE
COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 2.6pt; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: bold 18pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 7.5pt; text-align: center"><b>FORM <span id="xdx_907_edei--DocumentType_c20241120__20241120_zp6dZQZ3kpCi"><ix:nonNumeric contextRef="AsOf2024-11-20" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 7.5pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 176.1pt 0pt 176.35pt; text-align: center; text-indent: -0.05pt"><b>Pursuant
to Section 13 or 15(d) of<br/>
 The Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 7.5pt; text-align: center">DATE OF REPORT (DATE OF EARLIEST
EVENT REPORTED): <b><span id="xdx_90C_edei--DocumentPeriodEndDate_c20241120__20241120_zcFHXsQg5d48"><ix:nonNumeric contextRef="AsOf2024-11-20" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">November 20, 2024</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 18pt Times New Roman, Times, Serif; margin: 0pt 7.45pt; text-align: center"><b><span id="xdx_907_edei--EntityRegistrantName_c20241120__20241120_z9mDlG152r08"><ix:nonNumeric contextRef="AsOf2024-11-20" id="Fact000011" name="dei:EntityRegistrantName">GILEAD SCIENCES, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt 0pt 7.6pt; text-align: center">(Exact name of registrant
as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20241120__20241120_zw3lm68Sa292"><ix:nonNumeric contextRef="AsOf2024-11-20" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 34%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90A_edei--EntityFileNumber_c20241120__20241120_znRThHAA8GDc"><ix:nonNumeric contextRef="AsOf2024-11-20" id="Fact000013" name="dei:EntityFileNumber">0-19731</ix:nonNumeric></span></b></span></td>
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90A_edei--EntityTaxIdentificationNumber_c20241120__20241120_zirygGmW1i16"><ix:nonNumeric contextRef="AsOf2024-11-20" id="Fact000014" name="dei:EntityTaxIdentificationNumber">94-3047598</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or Other Jurisdiction of&#8239;Incorporation)</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission File No.)</span></td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS Employer&#8239;Identification No.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90E_edei--EntityAddressAddressLine1_c20241120__20241120_zDTYPMm1mh2c"><ix:nonNumeric contextRef="AsOf2024-11-20" id="Fact000015" name="dei:EntityAddressAddressLine1">333 Lakeside Drive</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressCityOrTown_c20241120__20241120_zYnYC4UflGIc"><ix:nonNumeric contextRef="AsOf2024-11-20" id="Fact000016" name="dei:EntityAddressCityOrTown">Foster City</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressStateOrProvince_c20241120__20241120_z3BI96TtXrxi"><ix:nonNumeric contextRef="AsOf2024-11-20" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Address of Principal Executive Offices)</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt; text-align: center"><b>&#160;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt; text-align: center"><b><span id="xdx_90A_edei--EntityAddressPostalZipCode_c20241120__20241120_zxJQdbWyjYI5"><ix:nonNumeric contextRef="AsOf2024-11-20" id="Fact000018" name="dei:EntityAddressPostalZipCode">94404</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt; text-align: center">(Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt; text-align: center"><b>(<span id="xdx_90A_edei--CityAreaCode_c20241120__20241120_zghkDV6xhvT8"><ix:nonNumeric contextRef="AsOf2024-11-20" id="Fact000019" name="dei:CityAreaCode">650</ix:nonNumeric></span>)</b> <b><span id="xdx_90A_edei--LocalPhoneNumber_c20241120__20241120_zWrPtK3vPJjh"><ix:nonNumeric contextRef="AsOf2024-11-20" id="Fact000020" name="dei:LocalPhoneNumber">574-3000</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s Telephone Number, Including
Area Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 7.45pt; text-align: center"><b>Not Applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.75pt 0pt 5.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_906_edei--WrittenCommunications_c20241120__20241120_zzaGiSuUPlCj"><ix:nonNumeric contextRef="AsOf2024-11-20" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span> &#8239;&#8239;&#8239;&#8239;&#8239;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_903_edei--SolicitingMaterial_c20241120__20241120_z11kjSABjYbc"><ix:nonNumeric contextRef="AsOf2024-11-20" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span> &#8239;&#8239;&#8239;&#8239;&#8239;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_909_edei--PreCommencementTenderOffer_c20241120__20241120_zVqLLJ78s8Kc"><ix:nonNumeric contextRef="AsOf2024-11-20" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span> &#8239;&#8239;&#8239;&#8239;&#8239;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_903_edei--PreCommencementIssuerTenderOffer_c20241120__20241120_zdHG8VJ7tBw6"><ix:nonNumeric contextRef="AsOf2024-11-20" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span> &#8239;&#8239;&#8239;&#8239;&#8239;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Securities registered pursuant to Section 12(b) of
the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 32%; font-size: 10pt; text-align: center">Title of each class</td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%; font-size: 10pt; text-align: center">Trading Symbol(s)</td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Name of each exchange on which registered</p></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: center"><b><span id="xdx_90E_edei--Security12bTitle_c20241120__20241120_zuvi8bHZt6u"><ix:nonNumeric contextRef="AsOf2024-11-20" id="Fact000025" name="dei:Security12bTitle">Common Stock, par value $0.001 per share</ix:nonNumeric></span></b></td>
    <td>&#160;</td>
    <td style="font-size: 10pt; text-align: center"><b><span id="xdx_903_edei--TradingSymbol_c20241120__20241120_z8Q8hYt3FvLg"><ix:nonNumeric contextRef="AsOf2024-11-20" id="Fact000026" name="dei:TradingSymbol">GILD</ix:nonNumeric></span></b></td>
    <td>&#160;</td>
    <td style="font-size: 10pt; text-align: center"><b><span id="xdx_90B_edei--SecurityExchangeName_c20241120__20241120_zUenqESJqFVi"><ix:nonNumeric contextRef="AsOf2024-11-20" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">The Nasdaq Global Select Market</ix:nonNumeric></span></b></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">Emerging
growth company <span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_906_edei--EntityEmergingGrowthCompany_c20241120__20241120_zTtlRdrMrSA6"><ix:nonNumeric contextRef="AsOf2024-11-20" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings"><span style="font-family: Wingdings">&#168;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.5pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.5pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-top: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item 1.01. Entry into a Material Definitive Agreement.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt">Supplemental Indenture</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On November 20, 2024, Gilead Sciences, Inc. (the
&#8220;Company&#8221;) and Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National Association,
as trustee (the &#8220;Trustee&#8221; and, together with the Company, the &#8220;Parties&#8221;), entered into a Tenth Supplemental Indenture
(the &#8220;Tenth Supplemental Indenture&#8221;) to the Indenture between the Parties, dated as of March 30, 2011 (the &#8220;Base Indenture&#8221;).
The Tenth Supplemental Indenture relates to the Company&#8217;s issuance of (a) $750,000,000 aggregate principal amount of the Company&#8217;s
4.80% Senior Notes due 2029 (the &#8220;2029 Notes&#8221;), (b) $1,000,000,000 aggregate principal amount of the Company&#8217;s 5.10%
Senior Notes due 2035 (the &#8220;2035 Notes&#8221;), (c) $1,000,000,000 aggregate principal amount of the Company&#8217;s 5.50% Senior
Notes due 2054 (the &#8220;2054 Notes&#8221;) and (d) $750,000,000 aggregate principal amount of the Company&#8217;s 5.60% Senior Notes
due 2064 (the &#8220;2064 Notes&#8221; and, together with the 2029 Notes, the 2035 Notes and the 2054 Notes, the &#8220;Notes&#8221;).
The Notes were sold in a public offering pursuant to the Company&#8217;s Registration Statement on Form S-3 (File No. 333-273745).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The 2029 Notes will pay interest semi-annually
at a rate of 4.80% per annum until November 15, 2029. The 2035 Notes will pay interest semi-annually at a rate of 5.10% per annum until
June 15, 2035. The 2054 Notes will pay interest semi-annually at a rate of 5.50% per annum until November 15, 2054. The 2064 Notes will
pay interest semi-annually at a rate of 5.60% per annum until November 15, 2064.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company intends to use the net proceeds from
the sale of the Notes for general corporate purposes, which may include the repayment of indebtedness.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Base Indenture and the Tenth Supplemental
Indenture contain certain restrictions, including a limitation that restricts the Company&#8217;s ability and ability of certain of its
subsidiaries to create or incur secured indebtedness, enter into sale and leaseback transactions and consolidate, merge or transfer all
or substantially all of the Company&#8217;s assets and the assets of its subsidiaries, and also requires the Company to offer to repurchase
the Notes upon certain change of control events.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company may redeem some or all of the Notes
at any time and from time to time at the applicable redemption prices described in the form of such notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">For a complete description of the terms and conditions
of the Base Indenture, please refer to the Base Indenture, filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K, filed
with the Commission on April 1, 2011 and incorporated herein by reference. For a complete description of the terms and conditions of the
Tenth Supplemental Indenture and the Notes, please refer to the Tenth Supplemental Indenture and the forms of each series of Notes, each
of which is incorporated herein by reference and attached to this Current Report on Form 8-K as Exhibits 4.2, 4.3, 4.4, 4.5 and 4.6, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item 2.03. Creation of a Direct Financial Obligation or an Obligation
under an Off-Balance Sheet Arrangement of a Registrant.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The information set forth in Item 1.01 is incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item 8.01. Other Information.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt">Underwriting Agreement</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">On November 13, 2024, the Company entered into
an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Barclays Capital Inc. and BofA Securities, Inc., as representatives
of the several underwriters listed in Schedule 1 thereto, relating to the issuance and sale by the Company of the Notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The description of the Underwriting Agreement
contained herein is qualified in its entirety by reference to the Underwriting Agreement, which is filed as Exhibit 1.1 to this Current
Report on Form 8-K and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></span></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-weight: normal">The above-mentioned
offering was made pursuant to the Company's effective shelf registration statement on Form S-3 (File No. 333-273745). Opinion of counsel
for the Company is filed as Exhibit 5.1 to this Current Report on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item 9.01. Financial Statements and Exhibits.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt">(d) Exhibits</p>

<p style="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; width: 10%">
    <p style="border-bottom: Black 0.5pt solid; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Exhibit<br/>

Number </p></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 89%">
    <p style="border-bottom: Black 0.5pt solid; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Description</p></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2426602d4_ex1-1.htm" style="-sec-extract: exhibit">&#8206;1.1&#8206;</a></td>
    <td>&#160;</td>
    <td><a href="tm2426602d4_ex1-1.htm" style="-sec-extract: exhibit">Underwriting Agreement, dated November 13, 2024, among the Company and Barclays Capital Inc. and BofA Securities, Inc., as representatives of the several underwriters listed in Schedule 1 thereto.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="https://www.sec.gov/Archives/edgar/data/882095/000119312511086814/dex41.htm" style="-sec-extract: exhibit">4.1</a></td>
    <td>&#160;</td>
    <td><a href="https://www.sec.gov/Archives/edgar/data/882095/000119312511086814/dex41.htm" style="-sec-extract: exhibit">Indenture, dated as of March 30, 2011, between the Company and Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National Association, as Trustee (incorporated by reference from Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K, filed with the Commission on April 1, 2011).</a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2426602d4_ex4-2.htm" style="-sec-extract: exhibit">&#8206;4.2&#8206;</a></td>
    <td>&#160;</td>
    <td><a href="tm2426602d4_ex4-2.htm" style="-sec-extract: exhibit">&#8206;Tenth Supplemental Indenture, dated as of November 20, 2024, between the Company and Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National Association, as Trustee</a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2426602d4_ex4-2.htm" style="-sec-extract: exhibit">&#8206;4.3&#8206;</a></td>
    <td>&#160;</td>
    <td><a href="tm2426602d4_ex4-2.htm" style="-sec-extract: exhibit">&#8206;Form of 2029 Note (included in Exhibit 4.2 above)</a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2426602d4_ex4-2.htm" style="-sec-extract: exhibit">&#8206;4.4</a></td>
    <td>&#160;</td>
    <td><a href="tm2426602d4_ex4-2.htm" style="-sec-extract: exhibit">Form of 2035 Note (included in Exhibit 4.2 above)</a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2426602d4_ex4-2.htm" style="-sec-extract: exhibit">&#8206;4.5</a></td>
    <td>&#160;</td>
    <td><a href="tm2426602d4_ex4-2.htm" style="-sec-extract: exhibit">Form of 2054 Note (included in Exhibit 4.2 above)</a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2426602d4_ex4-2.htm" style="-sec-extract: exhibit">&#8206;4.6</a></td>
    <td>&#160;</td>
    <td><a href="tm2426602d4_ex4-2.htm" style="-sec-extract: exhibit">Form of 2064 Note (included in Exhibit 4.2 above)</a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2426602d4_ex5-1.htm" style="-sec-extract: exhibit">&#8206;5.1&#8206;</a></td>
    <td>&#160;</td>
    <td><a href="tm2426602d4_ex5-1.htm" style="-sec-extract: exhibit">Opinion of Davis Polk &amp; Wardwell LLP regarding the validity of the Notes</a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><a href="tm2426602d4_ex5-1.htm" style="-sec-extract: exhibit">&#8206;23.1&#8206;</a></td>
    <td>&#160;</td>
    <td><a href="tm2426602d4_ex5-1.htm" style="-sec-extract: exhibit">Consent of Davis Polk &amp; Wardwell LLP (included as part of Exhibit 5.1)</a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center">104</td>
    <td>&#160;</td>
    <td>Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.&#8206;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3">GILEAD SCIENCES, INC.</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>By:</td>
    <td colspan="2" style="border-bottom: Black 1pt solid">/s/ Andrew D. Dickinson</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 5%">Name:</td>
    <td style="width: 42%; padding-right: 5.75pt; padding-left: 5.75pt">Andrew D. Dickinson</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Title:</td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">Chief Financial Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: November 20, 2024</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2OVKXQvCtpCKyCInodckplnRHZjezT+ovW5VoGBiGe8+9QkzEhta6QobLssjhhHVTKYdQ4A0ZzRW9I9vuUvC3wLu2jpVxw/sDM/IMemY+lfLqhcHaaotlClESxkkoZxDLdJbAYi+CXs/I3HSJxmlVgTIlHJka1ugUv8eEk+rIUP0eqs7IVpNJIZ5Go/wBGcUSDtSqF/HDQp5nIpgME4gN07PxrlXn0PQkrCqsfZ0d6f8GXwR1Sog= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tm2426602d4_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-weight: bold; text-align: right; margin: 0">Exhibit 1.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B><I>Execution Version</I></B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">GILEAD SCIENCES, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Underwriting Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 4.5in">November 13, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Barclays Capital Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BofA Securities, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">as Representatives of the several Underwriters</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">listed in Schedule 1 hereof</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">c/o Barclays Capital Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">745 Seventh Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">c/o BofA Securities, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">One Bryant Park</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Gilead Sciences, Inc., a Delaware
corporation (the &ldquo;<B><I>Company</I></B>&rdquo;), proposes to issue and sell to the several Underwriters listed in <U>Schedule 1</U>
hereto (the &ldquo;<B><I>Underwriters</I></B>&rdquo;), for whom Barclays Capital Inc. (&ldquo;<B><I>Barclays</I></B>&rdquo;) and BofA
Securities, Inc. (&ldquo;<B><I>BofA</I></B>&rdquo;) are acting as representatives (the &ldquo;<B><I>Representatives</I></B>&rdquo;), $750,000,000
principal amount of its 4.80% Senior Notes due 2029 (the &ldquo;<B><I>2029 Notes</I></B>&rdquo;), $1,000,000,000 principal amount of its
5.10% Senior Notes due 2035 (the &ldquo;<B><I>2035 Notes</I></B>&rdquo;), $1,000,000,000 principal amount of its 5.50% Senior Notes due
2054 (the &ldquo;<B><I>2054 Notes</I></B>&rdquo;) and $750,000,000 principal amount of its 5.60% Senior Notes due 2064 (the &ldquo;<B><I>2064
Notes</I></B>&rdquo; and, together with the 2029 Notes, the 2035 Notes and the 2054 Notes, the &ldquo;<B><I>Securities</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities will be issued
pursuant to an Indenture dated as of March 30, 2011 (the &ldquo;<B><I>Base Indenture</I></B>&rdquo;) between the Company and Computershare
Trust Company, N.A., as successor to Wells Fargo Bank, National Association, as trustee (the &ldquo;<B><I>Trustee</I></B>&rdquo;), as
supplemented by a supplemental indenture to be dated as of November 20, 2024 (together with the Base Indenture, the &ldquo;<B><I>Indenture</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby confirms
its agreement with the several Underwriters concerning the purchase and sale of the Securities, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration
Statement</U>. The Company has prepared and filed with the Securities and Exchange Commission (the &ldquo;<B><I>Commission</I></B>&rdquo;)
under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the &ldquo;<B><I>Securities
Act</I></B>&rdquo;), a registration statement on Form S-3 (File No. 333-273745), including a prospectus, relating to the Securities. Such
registration statement, including the information, if any, deemed pursuant to Rule 430A, 430B or 430C under the Securities Act to be part
of the registration statement at the time of its effectiveness (&ldquo;<B><I>Rule 430 Information</I></B>&rdquo;), is referred to herein
as the &ldquo;<B><I>Registration Statement</I></B>&rdquo;; and as used herein, the term &ldquo;<B><I>Preliminary Prospectus</I></B>&rdquo;
means each prospectus included in such registration statement (and any amendments thereto) before it became effective, any prospectus
filed with the Commission pursuant to Rule 424(a) under the Securities Act and the prospectus included in the Registration Statement at
the time of its effectiveness that omits Rule 430 Information, and the term &ldquo;<B><I>Prospectus</I></B>&rdquo; means the prospectus
in the form first used (or made available upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection with
confirmation of sales of the Securities. If the Company has filed an abbreviated registration statement pursuant to Rule 462(b) under
the Securities Act (the &ldquo;<B><I>Rule 462 Registration Statement</I></B>&rdquo;), then any reference herein to the term &ldquo;Registration
Statement&rdquo; shall be deemed to include such Rule 462 Registration Statement. Any reference in this Agreement to the Registration
Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference
therein pursuant to Item 12 of Form S-3 under the Securities Act, as of the effective date of the Registration Statement or the date of
such Preliminary Prospectus or the Prospectus, as the case may be and any reference to &ldquo;amend&rdquo;, &ldquo;amendment&rdquo; or
 &ldquo;supplement&rdquo; with respect to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer
to and include any documents filed after such date under the Securities Exchange Act of 1934, as amended, and the rules and regulations
of the Commission thereunder (collectively, the &ldquo;<B><I>Exchange Act</I></B>&rdquo;) that are deemed to be incorporated by reference
therein. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Registration Statement and the
Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At or prior to 5:00 P.M.,
New York City time, on the date hereof (the &ldquo;<B><I>Time of Sale</I></B>&rdquo;), the Company had prepared the following information
(collectively, the &ldquo;<B><I>Time of Sale Information</I></B>&rdquo;): a Preliminary Prospectus dated November 13, 2024, and each &ldquo;free-writing
prospectus&rdquo; (as defined pursuant to Rule 405 under the Securities Act) listed on <U>Annex A</U> hereto as constituting part of the
Time of Sale Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase
of the Securities by the Underwriters</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company agrees to issue and sell the Securities to the several Underwriters as provided in this Agreement, and each Underwriter, on the
basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees, severally
and not jointly, to purchase from the Company the respective principal amount of Securities set forth opposite such Underwriter&rsquo;s
name in <U>Schedule 1</U> hereto at a price equal to 99.638% of the aggregate principal amount of the 2029 Notes, 99.149% of the aggregate
principal amount of the 2035 Notes, 98.834% of the aggregate principal amount of the 2054 Notes and 98.415% of the aggregate principal
amount of the 2064 Notes, in each case, plus accrued interest, if any, from November 20, 2024 to the Closing Date (as defined below).
The Company will not be obligated to deliver any of the Securities except upon payment for all the Securities to be purchased as provided
herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company understands that the Underwriters intend to make a public offering of the Securities as soon after the effectiveness of this Agreement
as in the judgment of the Representatives is advisable, and initially to offer the Securities on the terms set forth in the Prospectus.
The Company acknowledges and agrees that the Underwriters may offer and sell Securities to or through any affiliate of an Underwriter
and that any such affiliate may offer and sell Securities purchased by it to or through any Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment
for and delivery of the Securities will be made at the offices of Latham &amp; Watkins LLP, 1271 Avenue of the Americas, New York, NY
10020 at 10:00 A.M., New York City time, on November 20, 2024, or at such other time or place on the same or such other date, not later
than the fifth business day thereafter, as the Representatives and the Company may agree upon in writing. The time and date of such payment
for the Securities is referred to herein as the &ldquo;<B><I>Closing Date</I></B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment
for the Securities shall be made by wire transfer in immediately available funds to the account(s) specified by the Company to the Representatives
against delivery to the nominee of The Depository Trust Company, for the respective accounts of the several Underwriters of one or more
global notes representing the Securities (collectively, the &ldquo;<B><I>Global Note</I></B>&rdquo;), with any transfer or other similar
taxes payable in connection with the sale of such Securities duly paid by the Company. The Global Note will be made available for inspection
by the Representatives at the offices of Latham &amp; Watkins LLP set forth above not later than 1:00 P.M., New York City time, on the
business day prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company acknowledges and agrees that the Underwriters are acting solely in the capacity of an arm&rsquo;s-length contractual counterparty
to the Company with respect to the offering of Securities contemplated hereby (including in connection with determining the terms of the
offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company or any other person. Additionally, neither the
Representatives nor any other Underwriter is advising the Company or any other person as to any legal, tax, investment, accounting or
regulatory matters in any jurisdiction. The Company shall consult with its own advisors concerning such matters and shall be responsible
for making its own independent investigation and appraisal of the transactions contemplated hereby, and the Underwriters shall have no
responsibility or liability to the Company with respect thereto. Any review by the Underwriters of the Company, the transactions contemplated
hereby or other matters relating to such transactions will be performed solely for the benefit of the Underwriters and shall not be on
behalf of the Company. The Company agrees that it will not claim that the Underwriters, or any of them, has rendered advisory services
of any nature or respect, or owes a fiduciary or similar duty to the Company, in connection with such transaction or the process leading
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations
and Warranties of the Company</U>. The Company represents and warrants to each Underwriter that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preliminary
Prospectus. </I>No order preventing or suspending the use of any Preliminary Prospectus has been issued by the Commission, and each Preliminary
Prospectus, at the time of filing thereof, complied in all material respects with the Securities Act and did not contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation
and warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter
furnished to the Company in writing by such Underwriter through the Representatives expressly for use in any Preliminary Prospectus, it
being understood and agreed that the only such information furnished by any Underwriter consists of the information described as such
in Section 7(b) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Time
of Sale Information</I>. The Time of Sale Information, at the Time of Sale, did not contain any untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading; <U>provided</U> that the Company makes no representation and warranty with respect to any statements or omissions
made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter
through the Representatives expressly for use in such Time of Sale Information, it being understood and agreed that the only such information
furnished by any Underwriter consists of the information described as such in Section 7(b) hereof. No statement of material fact included
in the Prospectus has been omitted from the Time of Sale Information and no statement of material fact included in the Time of Sale Information
that is required to be included in the Prospectus has been omitted therefrom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Issuer
Free Writing Prospectus. </I>The Company (including its agents and representatives, other than the Underwriters in their capacity as such)
has not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any
 &ldquo;written communication&rdquo; (as defined in Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation
of an offer to buy the Securities (each such communication by the Company or its agents and representatives (other than a communication
referred to in clauses (i), (ii), (iii) and (iv) below) an &ldquo;<B><I>Issuer Free Writing Prospectus</I></B>&rdquo;) other than (i)
any document not constituting a prospectus pursuant to Section 2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act,
(ii) the Preliminary Prospectus, (iii) the Prospectus, (iv) the Registration Statement, (v) the documents listed on Annex A hereto, including
the term sheets substantially in the form of Annex B hereto, each of which constitute part of the Time of Sale Information and (vi) any
electronic road show and any other written communications approved in writing in advance by the Representatives. Each such Issuer Free
Writing Prospectus complied in all material respects with the Securities Act, has been or will be (within the time period specified in
Rule 433) filed in accordance with the Securities Act (to the extent required thereby) and, when taken together with the Preliminary Prospectus
filed prior to the first use of such Issuer Free Writing Prospectus, did not, and at the Closing Date will not, contain any untrue statement
of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; <U>provided</U> that the Company makes no representation and warranty with respect to any
statements or omissions made in each such Issuer Free Writing Prospectus in reliance upon and in conformity with information relating
to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in any Issuer
Free Writing Prospectus, it being understood and agreed that the only such information furnished by any Underwriter consists of the information
described as such in Section 7(b) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Registration
Statement and Prospectus. </I>The Registration Statement is an &ldquo;automatic shelf registration statement&rdquo; as defined under Rule
405 of the Securities Act that has been filed with the Commission not earlier than three years prior to the date hereof; and no notice
of objection of the Commission to the use of such registration statement or any post-effective amendment thereto pursuant to Rule 401(g)(2)
under the Securities Act has been received by the Company. No order suspending the effectiveness of the Registration Statement has been
issued by the Commission and no proceeding for that purpose or pursuant to Section 8A of the Securities Act against the Company or related
to the offering of the Securities has been initiated or threatened by the Commission; as of the applicable effective date of the Registration
Statement and any amendment thereto, the Registration Statement complied and will comply in all material respects with the Securities
Act and the Trust Indenture Act of 1939, as amended, and the rules and regulations of the Commission thereunder (collectively, the &ldquo;<B><I>Trust
Indenture Act</I></B>&rdquo;), and did not and will not contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary in order to make the statements therein not misleading; and as of the date of the Prospectus
and any amendment or supplement thereto and as of the Closing Date, the Prospectus will not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light
of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation and warranty
with respect to (i) that part of the Registration Statement that constitutes the Statement of Eligibility and Qualification (Form T-1)
of the Trustee under the Trust Indenture Act or (ii) any statements or omissions made in reliance upon and in conformity with information
relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in the
Registration Statement and the Prospectus and any amendment or supplement thereto, it being understood and agreed that the only such information
furnished by any Underwriter consists of the information described as such in Section 7(b) hereof.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Incorporated
Documents. </I>The documents incorporated by reference in the Registration Statement, the Prospectus and the Time of Sale Information,
when they became effective or were filed with the Commission, as the case may be, conformed in all material respects with the requirements
of the Exchange Act and none of such documents contained any untrue statement of a material fact or omitted to state a material fact required
to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading;
and any further documents so filed and incorporated by reference in the Registration Statement, the Prospectus or the Time of Sale Information,
when such documents become effective or are filed with the Commission, as the case may be, will conform in all material respects with
the requirements of the Securities Act or the Exchange Act, as applicable, and will not contain any untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Financial
Statements. </I>The financial statements and the related notes thereto of the Company and its consolidated subsidiaries included or incorporated
by reference in the Registration Statement, the Time of Sale Information and the Prospectus comply in all material respects with the applicable
requirements of the Securities Act and the Exchange Act, as applicable, and present fairly, in all material respects, the financial position
of the Company and its consolidated subsidiaries, as of the dates indicated and the results of their operations and the changes in their
cash flows for the periods specified; such financial statements have been prepared in conformity with U.S. generally accepted accounting
principles (&ldquo;<B><I>GAAP</I></B>&rdquo;) applied on a consistent basis throughout the periods covered thereby. The interactive data
in eXtensible Business Reporting Language of the Company and its consolidated subsidiaries incorporated by reference in the Registration
Statement, the Time of Sale Information and the Prospectus fairly presents the information called for in all material respects and has
been prepared in accordance with the Commission&rsquo;s rules and guidelines applicable thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Material Adverse Change. </I>Since the date of the most recent financial statements of the Company included or incorporated by reference
in the Registration Statement, the Time of Sale Information and the Prospectus, except as otherwise stated therein (i) there has been
no material adverse change in the business, financial condition, prospects or in the earnings of the Company and its subsidiaries considered
as one enterprise, (ii) there have been no transactions entered into by the Company or any of its subsidiaries, other than those in the
ordinary course of business, which are material with respect to the Company and its subsidiaries considered as one enterprise and (iii)
there has been no dividend or distribution of any kind declared, paid or made by the Company on any class of its capital stock not described
in the Registration Statement, the Time of Sale Information and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Organization
and Good Standing. </I>Each of the Company, Kite Pharma, Inc., a Delaware corporation (&ldquo;<B><I>Kite</I></B>&rdquo;), Gilead Sciences
Ireland UC, an unlimited company organized under the laws of the Republic of Ireland (&ldquo;<B><I>Gilead Ireland</I></B>&rdquo;) and
Immunomedics, Inc., a Delaware corporation (&ldquo;<B><I>Immunomedics</I></B>&rdquo; and, together with Kite and Gilead Ireland, the &ldquo;<B><I>Significant
Subsidiaries</I></B>&rdquo;), has been duly incorporated and is validly existing and in good standing under the laws of the jurisdiction
in which it is incorporated, chartered or organized, with the corporate or company power and authority to own or lease, as the case may
be, and to operate its properties and conduct its business as described in the Registration Statement, the Time of Sale Information and
the Prospectus and is duly qualified to do business as a foreign corporation or organization and is in good standing under the laws of
each jurisdiction which requires such qualification, except, in each case, where the failure so to qualify or to be in good standing would
not have a Material Adverse Effect (as defined below). The Significant Subsidiaries are the only significant subsidiaries (as defined
in Rule 1-02 of Regulation S-X under the Exchange Act) of the Company. As used herein, &ldquo;<B><I>Material Adverse Effect</I></B>&rdquo;
means a material adverse effect on the business or financial condition of the Company and its subsidiaries, considered as one enterprise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Capitalization.
</I>The capitalization of the Company as of September 30, 2024,&nbsp;is as set forth in the Time of Sale Information and the Prospectus
in the column entitled &ldquo;Actual&rdquo; under the caption &ldquo;Capitalization.&rdquo; The outstanding shares of capital stock of
the Company have been duly and validly authorized and issued and are fully paid and nonassessable; none of the outstanding shares of capital
stock of the Company was issued in violation of the preemptive or similar rights of any security holder of the Company. Except as described
in the Registration Statement, the Time of Sale Information and the Prospectus, there are no outstanding rights (including, without limitation,
pre-emptive rights), warrants or options to acquire, or instruments convertible into or exchangeable for, any shares of capital stock
or other equity interest in the Company or any of its subsidiaries, or any contract, commitment, agreement, understanding or arrangement
of any kind relating to the issuance of any capital stock or other equity interest, as applicable, of the Company or any such subsidiary,
any such convertible or exchangeable securities or any such rights, warrants or options; the capital stock of the Company conforms in
all material respects to the description thereof contained in the Registration Statement, the Time of Sale Information and the Prospectus.
There are no persons with registration rights or other similar rights to have any securities included in any registration statement filed
pursuant to a registration agreement or in any offering made pursuant to such registration statement. All the issued and outstanding shares
of capital stock or other equity interest, as applicable, of each Significant Subsidiary have been duly and validly authorized and issued
and are fully paid and nonassessable, and, except as may be otherwise set forth in the Registration Statement, the Time of Sale Information
and the Prospectus, all outstanding shares of capital stock or other equity interest, as applicable, of the Significant Subsidiaries are
owned by the Company either directly or through a wholly-owned subsidiary free and clear of any security interest, mortgage, pledge, lien,
encumbrance, claim or equity; none of the outstanding shares of capital stock or other equity interest, as applicable, of any Significant
Subsidiary was issued in violation of the preemptive or similar rights of any securityholder of any Significant Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The
Indenture</I>. The Indenture has been duly authorized by the Company and upon effectiveness of the Registration Statement was or will
have been duly qualified under the Trust Indenture Act, and when duly executed and delivered by the Company and, assuming the due authorization,
execution and delivery of the Indenture by the Trustee, will be a valid and binding agreement of the Company enforceable against the Company
in accordance with its terms, except (i) to the extent that a waiver of rights under any usury laws may be unenforceable and as the enforceability
thereof may be limited by bankruptcy, insolvency, fraudulent conveyance, moratorium or other similar laws now or hereafter in effect relating
to or affecting the enforcement of creditors&rsquo; rights and remedies generally and (ii) as rights of acceleration and the availability
of equitable remedies may be limited by equitable principles of general applicability, whether or not enforcement is sought at law or
in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Underwriting
Agreement. </I>This Agreement has been duly authorized, executed and delivered by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>The
Securities. </I>The Securities have been duly authorized by the Company, and, at the Closing Date, will have been duly executed by the
Company and, when authenticated, issued and delivered in the manner provided for in the Indenture and delivered against payment of the
purchase price as provided in this Agreement, will be the valid and binding obligations of the Company, enforceable against the Company
in accordance with their terms, except (i) to the extent that a waiver of rights under any usury laws may be unenforceable and as the
enforceability thereof may be limited by bankruptcy, insolvency, fraudulent conveyance, moratorium or other similar laws now or hereafter
in effect relating to or affecting the enforcement of creditors&rsquo; rights and remedies generally and (ii) as rights of acceleration
and the availability of equitable remedies may be limited by equitable principles of general applicability, whether or not enforcement
is sought at law or in equity. At the Closing Date, the Securities will be in the form contemplated by, and will be entitled to the benefits
of, the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Descriptions
of the Transaction Documents. </I>The Securities and the Indenture will conform in all material respects to the respective statements
relating thereto contained in the Registration Statement, the Time of Sale Information and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)<I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Violation and No Conflicts. </I>The Company is not in violation of its Restated Certificate of Incorporation, as amended as of the date
of this Agreement (the &ldquo;<B><I>Certificate of Incorporation</I></B>&rdquo;), or its Amended and Restated Bylaws, as amended as of
the date of this Agreement (the &ldquo;<B><I>Bylaws</I></B>&rdquo;). No Significant Subsidiary is in violation of its certificate of incorporation,
by-laws or equivalent, each as amended as of the date of this Agreement. Neither the Company nor any Significant Subsidiary is in default
in the performance or observance of any obligation, agreement, covenant or condition contained in any contract, indenture, mortgage, deed
of trust, loan or credit agreement, note, lease or other agreement or instrument to which the Company or any of its subsidiaries is a
party or by which it or any of them may be bound, or to which any of the property or assets of the Company or any of its subsidiaries
is subject, except for such defaults that would not result in a Material Adverse Effect. The execution, delivery and performance by the
Company of its obligations under this Agreement, the Indenture and the Securities will not contravene any provision of (i) the Certificate
of Incorporation or the Bylaws,&nbsp;(ii)&nbsp;any agreement or other instrument binding upon the Company or its business or assets that
is material to the financial condition of the Company and its subsidiaries, considered as one enterprise,&nbsp;(iii)&nbsp;applicable law&nbsp;or&nbsp;(iv)&nbsp;any
judgment, order, decree of any governmental body, agency or court having jurisdiction over the Company or its business or assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Consents Required. </I>No consent, approval, authorization or order of or qualification with any governmental body or agency is required
for the performance by the Company of its obligations under this Agreement, the Indenture or in connection with the offering, issuance
and sale of the Securities, except (A) such as have been already obtained or will have been obtained prior to the Closing Date and (B)
as may be required under the Securities Act or the Trust Indenture Act, in each case with respect to transactions contemplated by the
Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Legal
Proceedings. </I>Except as described in the Registration Statement, the Time of Sale Information and the Prospectus, there is no action,
suit, proceeding, inquiry or investigation before or brought by any court or governmental agency or body, domestic or foreign, now pending,
or, to the knowledge of the Company, threatened, against or affecting the Company or any of its subsidiaries which might reasonably be
expected to result in a Material Adverse Effect or which might reasonably be expected to materially and adversely affect the properties
or assets of the Company or any of its subsidiaries or the consummation of the transactions contemplated by this Agreement or the performance
by the Company of its obligations hereunder. The aggregate of all pending legal or governmental proceedings to which the Company or any
of its subsidiaries is a party or of which any of their respective property or assets is the subject which are not described in the Registration
Statement, the Time of Sale Information and the Prospectus, including ordinary routine litigation incidental to the business, could not
reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Independent
Accountants. </I>Ernst&nbsp;&amp;&nbsp;Young,&nbsp;LLP, independent registered public accounting firm, which has audited certain consolidated
financial statements of the Company and its consolidated subsidiaries to be incorporated by reference in the Prospectus, are independent
registered public accountants with respect to the Company and its subsidiaries within the applicable rules and regulations adopted by
the Commission and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Title
to Intellectual Property. </I>The Company and the Significant Subsidiaries own or possess, or can acquire on reasonable terms, adequate
patents, patent rights, licenses, inventions, copyrights, know-how (including trade secrets and other unpatented and/or unpatentable proprietary
or confidential information, systems or procedures), trademarks, service marks and trade names (collectively, the &ldquo;<B><I>Intellectual
Property</I></B>&rdquo;) which in each case are material to the financial condition of the Company and its subsidiaries considered as
one enterprise and, except as described in the Registration Statement, the Time of Sale Information and the Prospectus, neither the Company
nor any Significant Subsidiary has received any notice of any infringement of or conflict with asserted rights of others with respect
to any Intellectual Property, which infringement or conflict, individually or in the aggregate, could reasonably be expected to result
in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Investment
Company Act. </I>The Company is not and, after giving effect to the offering and sale of the Securities and the application of the proceeds
thereof as described in the Registration Statement, the Time of Sale Information and the Prospectus, will not be an &ldquo;investment
company&rdquo; or an entity &ldquo;controlled&rdquo; by an &ldquo;investment company&rdquo; as such terms are defined in the Investment
Company Act of 1940, as amended, and the rules and regulations of the Commission thereunder (collectively, the &ldquo;<B><I>Investment
Company Act</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Taxes.
</I>The Company and its subsidiaries have paid all federal, state, local and foreign taxes and filed all tax returns required to be paid
or filed through the date hereof, except for such failures to pay or to file as would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect; and except as otherwise disclosed in the Registration Statement, the Time of Sale Information
and the Prospectus, there is no tax deficiency that has been, or could reasonably be expected to be, asserted against the Company or any
of its subsidiaries or any of their respective properties or assets, except for such tax deficiencies as would not, individually or in
the aggregate, have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Licenses
and Permits. </I>The Company has all necessary consents, authorizations, approvals, orders, certificates and permits of and from (collectively,
the &ldquo;<B><I>Governmental Permits</I></B>&rdquo;), and has made all declarations and filings with, all federal, state, local and other
governmental authorities, all self-regulatory organizations and all courts and other tribunals, to own, lease, license and use its properties
and assets and to conduct its business in the manner described in the Registration Statement, the Time of Sale Information and the Prospectus,
except to the extent that the failure to obtain or file would not have a Material Adverse Effect; and the Company has not received any
notice of proceedings relating to the revocation or modification of any such Governmental Permits which, individually or in the aggregate,
could reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Compliance
With Environmental Laws. </I>Except as described in the Registration Statement, the Time of Sale Information and the Prospectus and except
as would not, individually or in the aggregate, result in a Material Adverse Effect, (i) neither the Company nor any of its subsidiaries
is in violation of any federal, state, local or foreign statute, law, rule, regulation, ordinance, code, policy or rule of common law
or any judicial or administrative interpretation thereof, including any judicial or administrative order, consent, decree or judgment,
relating to pollution or protection of human health, the environment (including, without limitation, ambient air, surface water, groundwater,
land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations relating to the release or threatened
release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products (collectively,
the &ldquo;<B><I>Hazardous Materials</I></B>&rdquo;) or to the manufacture, processing, distribution, use, treatment, storage, disposal,
transport or handling of Hazardous Materials (collectively, the &ldquo;<B><I>Environmental Laws</I></B>&rdquo;), (ii) the Company and
its subsidiaries have all permits, authorizations and approvals required under any applicable Environmental Laws and are each in compliance
with their requirements, (iii) there are no pending or threatened administrative, regulatory or judicial actions, suits, demands, demand
letters, claims, liens, notices of noncompliance or violation, investigations or proceedings relating to any Environmental Law against
the Company or any of its subsidiaries and (iv) there are no events or circumstances that might reasonably be expected to form the basis
of an order for clean-up or remediation, or an action, suit or proceeding by any private party or governmental body or agency, against
or affecting the Company or any of its subsidiaries relating to Hazardous Materials or any Environmental Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(w)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Hazardous
Substances</I>. Neither the Company nor any of its subsidiaries is in violation of any federal or state law or regulation relating to
occupational safety and health or to the storage, handling and transportation of hazardous or toxic materials; the Company and each of
its subsidiaries have received all permits, licenses or other approvals required of them under applicable federal and state occupational
safety and health laws and Environmental Laws and regulations to conduct their respective businesses, and the Company and each of its
subsidiaries is in compliance with all terms and conditions of any such permit, license or approval, except for any such violation of
law or regulation, failure to receive required permits, licenses or other approvals or failure to comply with the terms and conditions
of such permits, licenses or approvals that would not, singly or in the aggregate, result in a Material Adverse Effect, except as described
in or contemplated by the Registration Statement, the Time of Sale Information and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Compliance
With ERISA. </I>(i) Each employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974,
as amended (&ldquo;<B><I>ERISA</I></B>&rdquo;), for which the Company or any member of its &ldquo;Controlled Group&rdquo; (defined as
any trade or business which is a member of a controlled group of corporations within the meaning of Section 414 of the Internal Revenue
Code of 1986, as amended (the &ldquo;<B><I>Code</I></B>&rdquo;)) would have any liability (each, a &ldquo;<B><I>Plan</I></B>&rdquo;) has
been maintained in material compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations,
including but not limited to ERISA and the Code; (ii) no prohibited transaction, within the meaning of Section 406 of ERISA or Section
4975 of the Code, has occurred with respect to any Plan excluding transactions effected pursuant to a statutory or administrative exemption
and excluding transactions that, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect;
(iii) for each Plan that is subject to the funding rules of Section 412 of the Code or Section 302 of ERISA, no &ldquo;accumulated funding
deficiency&rdquo; as defined in Section 412 of the Code, whether or not waived, has occurred or is reasonably expected to occur; (iv)
the fair market value of the assets of each Plan exceeds the present value of all benefits accrued under such Plan (determined based on
those assumptions used to fund such Plan) except to the extent that any such accumulated funding deficiency could not reasonably be expected
to result in a Material Adverse Effect with respect to the Company; (v) no &ldquo;reportable event&rdquo; (within the meaning of Section
4043(c) of ERISA) has occurred or is reasonably expected to occur that, individually or in the aggregate, could reasonably be expected
to result in a Material Adverse Effect; and (vi) neither the Company nor any member of its Controlled Group has incurred, nor reasonably
expects to incur, any material liability under Title IV of ERISA (other than contributions to the Plan or premiums to the PBGC, in the
ordinary course and without default) in respect of a Plan (including a &ldquo;multiemployer plan&rdquo;, within the meaning of Section
4001(a)(3) of ERISA).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(y)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Disclosure
Controls</I>. The Company maintains an effective system of &ldquo;disclosure controls and procedures&rdquo; (as defined in Rule 13a-15(e)
of the Exchange Act) that is designed to ensure that information required to be disclosed by the Company in reports that it files or submits
under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission&rsquo;s rules
and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company&rsquo;s
management as appropriate to allow timely decisions regarding required disclosure. The Company has carried out evaluations of the effectiveness
of its disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(z)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Accounting
Controls. </I>The Company and its subsidiaries, taken as a whole, maintain a system of internal accounting controls sufficient to provide
reasonable assurances that&nbsp;(A) transactions are executed in accordance with management&rsquo;s general or specific authorization;
(B)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain
accountability for assets;&nbsp;(C) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization;
(D) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken
with respect to any differences; and (E) the interactive data in eXtensible Business Reporting Language incorporated by reference in the
Registration Statement, the Time of Sale Information and the Prospectus fairly presents the information called for in all material respects
and is prepared in accordance with the Commission&rsquo;s rules and guidelines applicable thereto. Except as disclosed in the Registration
Statement, the Time of Sale Information and the Prospectus, there are no material weaknesses in the Company&rsquo;s internal controls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(aa)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Insurance.
</I>The Company and each of its subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks
and in such amounts as are reasonable and consistent with sound business practice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(bb)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Compliance
with Money Laundering Laws</I>. The operations of the Company and its subsidiaries are and have been conducted at all times in compliance
with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, the money laundering statutes of all jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations
or guidelines, issued, administered or enforced by any governmental agency (collectively, the &ldquo;<B><I>Money Laundering Laws</I></B>&rdquo;)
and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(cc)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Compliance
with Sanctions. </I>None of the Company, any of its subsidiaries or, to the knowledge of the Company, any director, officer, agent, employee
or affiliate of the Company or any of its subsidiaries is currently the subject or target of any sanctions administered or enforced by
the government of the United States, including, without limitation, the U.S. Department of the Treasury&rsquo;s Office of Foreign Assets
Control, the United Nations Security Council, the European Union, His Majesty&rsquo;s Treasury, or other relevant sanctions authority
(collectively, &ldquo;<B><I>Sanctions</I></B>&rdquo;), nor is the Company located, organized or resident in a country or territory that
is the subject of Sanctions; and the Company will not directly or indirectly use the proceeds of the offering of the Securities hereunder,
or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity, for
the purpose of financing the activities of any person currently subject to any Sanctions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(dd)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Restrictions on Subsidiaries</I>. No Significant Subsidiary is currently prohibited, directly or indirectly, under any agreement or other
instrument to which it is a party or is subject, from paying any dividends to the Company, from making any other distribution on such
subsidiary&rsquo;s capital stock or other equity interest, as applicable, from repaying to the Company any loans or advances to such subsidiary
from the Company or from transferring any of such subsidiary&rsquo;s properties or assets to the Company or any other subsidiary of the
Company, except as may be described in or contemplated by the Registration Statement, the Time of Sale Information and the Prospectus
and except as would not result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ee)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Registration Rights</I>. No person has the right to require the Company or any of its subsidiaries to register any securities for sale
under the Securities Act by reason of the filing of the Registration Statement with the Commission or the issuance and sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ff) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Stabilization. </I>The Company has not taken, directly or indirectly, any action designed to or that could reasonably be expected to cause
or result in any stabilization or manipulation of the price of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(gg)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Status
Under the Securities Act</I>. The Company is not an ineligible issuer and is a well-known seasoned issuer, in each case as defined under
the Securities Act, in each case at the times specified in the Securities Act in connection with the offering of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(hh)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Cybersecurity</I>.
(A) To the Company&rsquo;s knowledge, there has been no security breach or incident, unauthorized access or disclosure, or other compromise
of or relating to the Company or its subsidiaries&rsquo; information technology and computer systems, networks, hardware, software, data
and databases (including, as applicable, the data and information of their respective customers, employees, suppliers, vendors and any
third party data maintained, processed or stored by the Company and its subsidiaries, and any such data processed or stored by third parties
on behalf of the Company and its subsidiaries), equipment or technology (collectively, &ldquo;<B><I>IT Systems and Data</I></B>&rdquo;),
except in each case as would not reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect; and (B)
the Company and its subsidiaries have implemented appropriate controls, policies, procedures, and technological safeguards to maintain
and protect the integrity, continuous operation, redundancy and security of their IT Systems and Data reasonably consistent in all material
respects with industry standards and practices and applicable regulatory standards. The Company and its subsidiaries are presently in
material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or
governmental or regulatory authority relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems
and Data from unauthorized use, access, misappropriation or modification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Further
Agreements of the Company</U>. The Company covenants and agrees with each Underwriter that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Required
Filings. </I>The Company will file the final Prospectus with the Commission within the time periods specified by Rule 424(b) and Rule
430A, 430B or 430C under the Securities Act, will file any Issuer Free Writing Prospectus (including the term sheets in the form of <U>Annex
B</U> hereto) to the extent required by Rule 433 under the Securities Act and will file promptly all reports and any definitive proxy
or information statements required to be filed by the Company with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the
Exchange Act subsequent to the date of the Prospectus and for so long as the delivery of a prospectus is required in connection with the
offering or sale of the Securities; and the Company will furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to
the extent not previously delivered) to the Underwriters in New York City prior to 10:00 A.M., New York City time, on the second business
day succeeding the date of this Agreement in such quantities as the Representatives may reasonably request. The Company will pay the registration
fees for this offering within the time period required by Rule 456(b)(1)(i) under the Securities Act (without giving effect to the proviso
therein) and in any event prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Delivery
of Copies. </I>The Company will deliver, without charge, (i) to the Representatives, two signed copies of the Registration Statement as
originally filed and each amendment thereto, in each case including all exhibits and consents filed therewith; and (ii) to each Underwriter
(A) a conformed copy of the Registration Statement as originally filed and each amendment thereto (without any exhibits) and (B) during
the Prospectus Delivery Period (as defined below), as many copies of the Prospectus (including all amendments and supplements thereto
and documents incorporated by reference therein) and each Issuer Free Writing Prospectus as the Representatives may reasonably request.
As used herein, the term &ldquo;<B><I>Prospectus Delivery Period</I></B>&rdquo; means such period of time after the first date of the
public offering of the Securities as in the opinion of counsel for the Underwriters a prospectus relating to the Securities is required
by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Securities
by any Underwriter or dealer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Amendments
or Supplements; Issuer Free Writing Prospectuses. </I>Before making, preparing, using, authorizing, approving, referring to or filing
any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement or the Prospectus, whether
before or after the time that the Registration Statement becomes effective the Company will furnish to the Representatives and counsel
for the Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for review and will not make, prepare,
use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus or file any such proposed amendment or supplement to
which the Representatives reasonably object.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Notice
to the Representatives. </I>The Company will advise the Representatives promptly, and confirm such advice in writing, (i) when the Registration
Statement has become effective; (ii) when any amendment to the Registration Statement has been filed or becomes effective; (iii) when
any supplement to the Prospectus or any amendment to the Prospectus or any Issuer Free Writing Prospectus has been filed; (iv) of any
request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus or the receipt
of any comments from the Commission relating to the Registration Statement or any other request by the Commission for any additional information;
(v) of the issuance by the Commission of any order suspending the effectiveness of the Registration Statement or preventing or suspending
the use of any Preliminary Prospectus or the Prospectus or the initiation or threatening of any proceeding for that purpose or pursuant
to Section 8A of the Securities Act; (vi) of the occurrence of any event within the Prospectus Delivery Period as a result of which the
Prospectus, the Time of Sale Information or any Issuer Free Writing Prospectus as then amended or supplemented would include any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances existing when the Prospectus, the Time of Sale Information or any such Issuer Free Writing
Prospectus is delivered to a purchaser, not misleading; (vii) of the receipt by the Company of any notice of objection of the Commission
to the use of the Registration Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act;
and (viii) of the receipt by the Company of any notice with respect to any suspension of the qualification of the Securities for offer
and sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and the Company will use its reasonable
best efforts to prevent the issuance of any such order suspending the effectiveness of the Registration Statement, preventing or suspending
the use of any Preliminary Prospectus or the Prospectus or suspending any such qualification of the Securities and, if any such order
is issued, will use its reasonable best efforts to obtain as soon as possible the withdrawal thereof.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Time
of Sale Information. </I>If at any time prior to the Closing Date (i) any event shall occur or condition shall exist as a result of which
the Time of Sale Information as then amended or supplemented would include any untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading
or (ii) it is necessary to amend or supplement the Time of Sale Information to comply with law, the Company will promptly notify the Underwriters
thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission (to the extent required) and furnish to the
Underwriters and to such dealers as the Representatives may designate, such amendments or supplements to the Time of Sale Information
as may be necessary so that the statements in the Time of Sale Information as so amended or supplemented will not, in the light of the
circumstances, be misleading or so that the Time of Sale Information will comply with law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Ongoing
Compliance</I>. If during the Prospectus Delivery Period (i) any event shall occur or condition shall exist as a result of which the Prospectus
as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact required to be
stated therein or necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus is
delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement the Prospectus to comply with law, the Company
will promptly notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission and
furnish to the Underwriters and to such dealers as the Representatives may designate, such amendments or supplements to the Prospectus
as may be necessary so that the statements in the Prospectus as so amended or supplemented will not, in the light of the circumstances
existing when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus will comply with law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Blue
Sky Compliance. </I>The Company will qualify the Securities for offer and sale under the securities or Blue Sky laws of such jurisdictions
as the Representatives shall reasonably request and will continue such qualifications in effect so long as required for distribution of
the Securities; <U>provided</U> that the Company shall not be required to (i) qualify as a foreign corporation or other entity or as a
dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii) file any general consent to
service of process in any such jurisdiction or (iii) subject itself to taxation in any such jurisdiction if it is not otherwise so subject.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Earning
Statement. </I>The Company will make generally available to its security holders and the Representatives as soon as practicable an earning
statement that satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder covering
a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the &ldquo;effective date&rdquo;
(as defined in Rule 158) of the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Clear
Market. </I>During the period from the date hereof through and including the business day following the Closing Date, the Company will
not, without the prior written consent of the Representatives, directly or indirectly, offer, sell, contract to sell or otherwise dispose
of any debt securities issued or guaranteed by the Company and having a tenor of more than one year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Use
of Proceeds. </I>The Company will apply the net proceeds from the sale of the Securities as described in the Registration Statement, the
Time of Sale Information and the Prospectus under the heading &ldquo;Use of Proceeds&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Stabilization. </I>The Company will not take, directly or indirectly, any action designed to or that could reasonably be expected to cause
or result in any stabilization or manipulation of the price of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Record
Retention</I>. The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each Issuer Free Writing
Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain
Agreements of the Underwriters</U>. Each Underwriter hereby represents and agrees that it has not used, authorized use of, referred to,
or participated in the planning of use of, and will not use, authorize use of, refer to, or participate in the planning for use of, any
 &ldquo;free writing prospectus&rdquo;, as defined in Rule 405 under the Securities Act (which term includes use of any written information
furnished to the Commission by the Company and not incorporated by reference into the Registration Statement and any press release issued
by the Company) other than (i) a free writing prospectus that, solely as a result of use by such Underwriter, would not trigger an obligation
to file such free writing prospectus with the Commission pursuant to Rule 433, (ii) any Issuer Free Writing Prospectus listed on <U>Annex
A</U> or prepared pursuant to Section 3(c) or Section 4(c) above (including any electronic road show), or (iii) any free writing prospectus
prepared by such Underwriter and approved by the Company in advance in writing. Notwithstanding the foregoing, the Underwriters may use
the term sheets substantially in the form of <U>Annex B</U> hereto without the consent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions
of Underwriters&rsquo; Obligations</U>. The obligation of each Underwriter to purchase Securities on the Closing Date as provided herein
is subject to the performance by the Company of its covenants and other obligations hereunder and to the following additional conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Registration
Compliance; No Stop Order. </I>No order suspending the effectiveness of the Registration Statement shall be in effect, and no proceeding
for such purpose, pursuant to Rule 401(g)(2) or pursuant to Section 8A under the Securities Act shall be pending before or threatened
by the Commission; the Prospectus and each Issuer Free Writing Prospectus shall have been timely filed with the Commission under the Securities
Act (in the case of an Issuer Free Writing Prospectus, to the extent required by Rule 433 under the Securities Act) and in accordance
with Section 4(a) hereof; and all requests by the Commission for additional information shall have been complied with to the reasonable
satisfaction of the Representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Representations
and Warranties. </I>The representations and warranties of the Company contained herein shall be true and correct on the date hereof and
on and as of the Closing Date; and the statements of the Company and its officers made in any certificates delivered pursuant to this
Agreement shall be true and correct on and as of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Downgrade. </I>Subsequent to the earlier of (A) the Time of Sale and (B) the execution and delivery of this Agreement, (i) no downgrading
shall have occurred in the rating accorded the Securities or any other debt securities or preferred stock of or guaranteed by the Company
or any of its subsidiaries by any &ldquo;nationally recognized statistical rating organization&rdquo;, as such term is defined by the
Commission for purposes of Section 3(a)(62) under the Exchange Act and (ii) no such organization shall have publicly announced that it
has under surveillance or review, or has changed its outlook with respect to, its rating of the Securities or of any other debt securities
or preferred stock of or guaranteed by the Company or any of its subsidiaries (other than an announcement with positive implications of
a possible upgrading).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Material Adverse Change. </I>No event or condition of a type described in Section 3(g) hereof shall have occurred or shall exist, which
event or condition is not described in the Time of Sale Information (excluding any amendment or supplement thereto) and the Prospectus
(excluding any amendment or supplement thereto) and the effect of which in the judgment of the Representatives makes it impracticable
or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement,
the Time of Sale Information and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Officer&rsquo;s
Certificate. </I>The Representatives shall have received on and as of the Closing Date a certificate of the chief financial officer of
the Company or another senior executive officer of the Company who is satisfactory to the Representatives (i) confirming that such officer
has carefully reviewed the Registration Statement, the Time of Sale Information and the Prospectus and, to the best knowledge of such
officer, the representations set forth in Sections 3(a) and 3(b) hereof are true and correct, (ii) confirming that the other representations
and warranties of the Company in this Agreement are true and correct and that the Company has complied with all agreements and satisfied
all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date and (iii) to the effect set forth in
paragraphs (a), (c) and (d) above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Comfort
Letters. </I>On the date of this Agreement and on the Closing Date, Ernst &amp; Young LLP shall have furnished to the Representatives
and the board of directors of the Company, at the request of the Company, letters, dated the respective dates of delivery thereof and
addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, containing statements and information
of the type customarily included in accountants&rsquo; &ldquo;comfort letters&rdquo; to underwriters with respect to the financial statements
and certain financial information contained or incorporated by reference in the Registration Statement, the Time of Sale Information and
the Prospectus; <U>provided</U>, that the letter delivered on the Closing Date shall use a &ldquo;cut-off&rdquo; date no more than three
business days prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Opinion
and 10b-5 Statement of Counsel for the Company. </I>Davis Polk &amp; Wardwell LLP, counsel for the Company, shall have furnished to the
Representatives, at the request of the Company, their written opinion and 10b-5 statement, dated the Closing Date and addressed to the
Underwriters, in form and substance reasonably satisfactory to the Representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Opinion
of General Counsel for the Company. </I>The General Counsel of the Company shall have furnished to the Representatives, at the request
of the Company, her written opinion, dated the Closing Date and addressed to the Underwriters, in form and substance reasonably satisfactory
to the Representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Opinion
and 10b-5 Statement of Counsel for the Underwriters. </I>The Representatives shall have received on and as of the Closing Date an opinion
and 10b-5 statement of Latham &amp; Watkins LLP, counsel for the Underwriters, with respect to such matters as the Representatives may
reasonably request, and such counsel shall have received such documents and information as they may reasonably request to enable them
to pass upon such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No
Legal Impediment to Issuance. </I>No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted
or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date, prevent the issuance
or sale of the Securities; and no injunction or order of any federal, state or foreign court shall have been issued that would, as of
the Closing Date, prevent the issuance or sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Good
Standing</I>. The Representatives shall have received on and as of the Closing Date satisfactory evidence of the good standing of the
Company and each Significant Subsidiary and the Company&rsquo;s good standing as a foreign corporation in California, in each case in
writing or any standard form of telecommunication from the appropriate governmental authorities of such jurisdictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All opinions, letters, certificates
and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they
are in form and substance reasonably satisfactory to counsel for the Underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the several obligations
of the Underwriters to purchase the Securities hereunder are subject to the delivery to the Underwriters on the Closing Date, if any,
of such other documents as the Underwriters may reasonably request with respect to:&nbsp;(1) the good standing of the Company;&nbsp;and
(2)&nbsp;the due authorization, execution, authentication and issuance of the Securities to be sold on the Closing Date and&nbsp;matters
related thereto, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification
and Contribution</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Indemnification
of the Underwriters. </I>The Company agrees to indemnify and hold harmless each Underwriter, its affiliates, directors and officers and
each person, if any, who controls such Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act, from and against any and all losses, claims, damages and liabilities (including, without limitation, reasonable legal fees and other
expenses incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), joint
or several, that arise out of, or are based upon, (i) any untrue statement or alleged untrue statement of a material fact contained in
the Registration Statement or caused by any omission or alleged omission to state therein a material fact required to be stated therein
or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, or (ii)
any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto),
any Issuer Free Writing Prospectus or any Time of Sale Information, or caused by any omission or alleged omission to state therein a material
fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, in each
case except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or
alleged untrue statement or omission made in reliance upon and in conformity with any information relating to any Underwriter furnished
to the Company in writing by such Underwriter through the Representatives expressly for use therein, it being understood and agreed that
the only such information furnished by any Underwriter consists of the information described as such in subsection (b) below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Indemnification
of the Company. </I>Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, its directors, its
officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act to the same extent as the indemnity set forth in paragraph (a) above, but only with respect
to any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue
statement or omission made in reliance upon and in conformity with any information relating to such Underwriter furnished to the Company
in writing by such Underwriter through the Representatives expressly for use in the Registration Statement, the Prospectus (or any amendment
or supplement thereto), any Issuer Free Writing Prospectus or any Time of Sale Information, it being understood and agreed upon that the
only such information furnished by any Underwriter consists of the information contained in the eighth paragraph of the Preliminary Prospectus
and the Prospectus under the heading &ldquo;Underwriting.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Notice
and Procedures. </I>If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand shall be
brought or asserted against any person in respect of which indemnification may be sought pursuant to either paragraph (a) or (b) above,
such person (the &ldquo;<B><I>Indemnified Person</I></B>&rdquo;) shall promptly notify the person against whom such indemnification may
be sought (the &ldquo;<B><I>Indemnifying Person</I></B>&rdquo;) in writing; <U>provided</U> that the failure to notify the Indemnifying
Person shall not relieve it from any liability that it may have under paragraph (a) or (b) above except to the extent that it has been
materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and <U>provided</U>, <U>further</U>,
that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise
than under paragraph (a) or (b) above. If any such proceeding shall be brought or asserted against an Indemnified Person and it shall
have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified
Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent the Indemnified
Person in such proceeding and shall pay the fees and expenses of such counsel related to such proceeding, as incurred. In any such proceeding,
any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense
of such Indemnified Person unless (i) the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii)
the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii)
the Indemnified Person shall have reasonably concluded that there may be legal defenses available to it that are different from or in
addition to those available to the Indemnifying Person; or (iv) the named parties in any such proceeding (including any impleaded parties)
include both the Indemnifying Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate
due to actual or potential differing interest between them. It is understood and agreed that the Indemnifying Person shall not, in connection
with any proceeding or related proceeding in the same jurisdiction, be liable for the fees and expenses of more than one separate firm
(in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be paid or reimbursed as they
are incurred. Any such separate firm for any Underwriter, its affiliates, directors and officers and any control persons of such Underwriter
shall be designated in writing by the Representatives and any such separate firm for the Company, its directors, its officers who signed
the Registration Statement and any control persons of the Company shall be designated in writing by the Company. The Indemnifying Person
shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if
there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any
loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an Indemnified Person
shall have requested that an Indemnifying Person reimburse the Indemnified Person for fees and expenses of counsel as contemplated by
this paragraph, the Indemnifying Person shall be liable for any settlement of any proceeding effected without its written consent if (i)
such settlement is entered into more than 30 days after receipt by the Indemnifying Person of such request, and (ii) the Indemnifying
Person shall not have reimbursed the Indemnified Person in accordance with such request prior to the date of such settlement. No Indemnifying
Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in
respect of which any Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified
Person, unless such settlement (x) includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory
to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y) does not include any statement
as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Contribution.
</I>If the indemnification provided for in paragraphs (a) and (b) above is unavailable to an Indemnified Person or insufficient in respect
of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying
such Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result of such losses,
claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Company, on the
one hand, and the Underwriters, on the other, from the offering of the Securities or (ii) if the allocation provided by clause (i) is
not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause
(i) but also the relative fault of the Company, on the one hand, and the Underwriters, on the other, in connection with the statements
or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The
relative benefits received by the Company, on the one hand, and the Underwriters, on the other, shall be deemed to be in the same respective
proportions as the net proceeds (before deducting expenses) received by the Company from the sale of the Securities and the total underwriting
discounts and commissions received by the Underwriters in connection therewith, in each case as set forth in the table on the cover the
prospectus, bear to the aggregate offering price of the Securities. The relative fault of the Company, on the one hand, and the Underwriters,
on the other, shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact
or the omission or alleged omission to state a material fact relates to information supplied by the Company or by the Underwriters and
the parties&rsquo; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Limitation
on Liability. </I>The Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to this Section
7 were determined by <U>pro rata</U> allocation (even if the Underwriters were treated as one entity for such purpose) or by any other
method of allocation that does not take account of the equitable considerations referred to in paragraph (d) above. The amount paid or
payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d) above shall be
deemed to include, subject to the limitations set forth above, any reasonable legal or other expenses incurred by such Indemnified Person
in connection with any such action or claim. Notwithstanding the provisions of this Section 7, in no event shall an Underwriter be required
to contribute any amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter
with respect to the offering of the Securities exceeds the amount of any damages that such Underwriter has otherwise been required to
pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such
fraudulent misrepresentation. The Underwriters&rsquo; obligations to contribute pursuant to this Section 7 are several in proportion to
their respective purchase obligations hereunder and not joint.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Non-Exclusive
Remedies. </I>The remedies provided for in this Section 7 are not exclusive and shall not limit any rights or remedies which may otherwise
be available to any Indemnified Person at law or in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Effectiveness
of Agreement</U>. This Agreement shall become effective upon the execution and delivery hereof by the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Termination</U>.
This Agreement may be terminated in the absolute discretion of the Representatives, by notice to the Company, if after the execution and
delivery of this Agreement and prior to the Closing Date (i) trading generally shall have been suspended or materially limited on or by
any of the New York Stock Exchange or the Nasdaq Global Select Market; (ii) trading of any securities issued or guaranteed by the Company
shall have been suspended on any exchange or in any over-the-counter market; (iii) a general moratorium on commercial banking activities
shall have been declared by federal or New York State authorities; or (iv) there shall have occurred any outbreak or escalation of hostilities
or any change in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the
Representatives, is material and adverse and makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the
Securities on the terms and in the manner contemplated by this Agreement, the Time of Sale Information and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.&#8239;&#8239;&#8239;&#8239;&#8239;<U>Defaulting
Underwriter</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If,
on the Closing Date, any Underwriter defaults on its obligation to purchase the Securities that it has agreed to purchase hereunder, the
non-defaulting Underwriters may in their discretion arrange for the purchase of such Securities by other persons satisfactory to the Company
on the terms contained in this Agreement. If, within 36 hours after any such default by any Underwriter, the non-defaulting Underwriters
do not arrange for the purchase of such Securities, then the Company shall be entitled to a further period of 36 hours within which to
procure other persons satisfactory to the non-defaulting Underwriters to purchase such Securities on such terms. If other persons become
obligated or agree to purchase the Securities of a defaulting Underwriter, either the non-defaulting Underwriters or the Company may postpone
the Closing Date for up to five full business days in order to effect any changes that in the opinion of counsel for the Company or counsel
for the Underwriters may be necessary in the Registration Statement and the Prospectus or in any other document or arrangement, and the
Company agrees to promptly prepare any amendment or supplement to the Registration Statement and the Prospectus that effects any such
changes. As used in this Agreement, the term &ldquo;Underwriter&rdquo; includes, for all purposes of this Agreement unless the context
otherwise requires, any person not listed in Schedule 1 hereto that, pursuant to this Section 10, purchases Securities that a defaulting
Underwriter agreed but failed to purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If,
after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the non-defaulting
Underwriters and the Company as provided in paragraph (a) above, the aggregate principal amount of such Securities that remains unpurchased
does not exceed one-eleventh of the aggregate principal amount of all the Securities, then the Company shall have the right to require
each non-defaulting Underwriter to purchase the principal amount of Securities that such Underwriter agreed to purchase hereunder plus
such Underwriter&rsquo;s <U>pro rata</U> share (based on the principal amount of Securities that such Underwriter agreed to purchase hereunder)
of the Securities of such defaulting Underwriter or Underwriters for which such arrangements have not been made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If,
after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the non-defaulting
Underwriters and the Company as provided in paragraph (a) above, the aggregate principal amount of such Securities that remains unpurchased
exceeds one-eleventh of the aggregate principal amount of all the Securities, or if the Company shall not exercise the right described
in paragraph (b) above, then this Agreement shall terminate without liability on the part of the non-defaulting Underwriters. Any termination
of this Agreement pursuant to this Section 10 shall be without liability on the part of the Company, except that the Company will continue
to be liable for the payment of expenses as set forth in Section 11 hereof and except that the provisions of Section 7 hereof shall not
terminate and shall remain in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nothing
contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company or any non-defaulting Underwriter
for damages caused by its default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.6in 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment
of Expenses</U><I>. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whether
or not the transactions contemplated by this Agreement are consummated or this Agreement is terminated, the Company will pay or cause
to be paid all costs and expenses incident to the performance of its obligations hereunder, including without limitation, (i) the costs
incident to the authorization, issuance, sale, preparation and delivery of the Securities and any taxes payable in that connection; (ii)
the costs incident to the preparation, printing and filing under the Securities Act of the Registration Statement, the Preliminary Prospectus,
any Issuer Free Writing Prospectus, any Time of Sale Information and the Prospectus (including any exhibits, amendments and supplements
thereto) and the distribution thereof; (iii) the costs of reproducing and distributing each of the Transaction Documents; (iv) the fees
and expenses of the Company&rsquo;s counsel and independent accountants; (v) the fees and expenses incurred in connection with the registration
or qualification and determination of eligibility for investment of the Securities under the laws of such jurisdictions as the Representatives
may designate and the preparation, printing and distribution of a Blue Sky Memorandum (including the related fees and expenses of counsel
for the Underwriters); (vi) any fees charged by rating agencies for rating the Securities, if applicable; (vii) the fees and expenses
of the Trustee and any paying agent (including related reasonable fees and expenses of any counsel to such parties); (viii) all expenses
and application fees incurred in connection with any filing with, and clearance of the offering by, the Financial Industry Regulatory
Authority; and (ix) all expenses incurred by the Company in connection with any &ldquo;road show&rdquo; presentation to potential investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
(i) this Agreement is terminated pursuant to Section 9, (ii) the Company for any reason fails to tender the Securities for delivery to
the Underwriters or (iii) the Underwriters decline to purchase the Securities for any reason permitted under this Agreement, the Company
agrees to reimburse the Underwriters for all out-of-pocket costs and expenses (including the fees and expenses of their counsel) reasonably
incurred by the Underwriters in connection with this Agreement and the offering contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.&#8239;&#8239;&#8239;&#8239;&#8239;<U>Persons
Entitled to Benefit of Agreement</U>. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective
successors and the officers and directors and any controlling persons referred to in Section 7 hereof. Nothing in this Agreement is intended
or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or
any provision contained herein. No purchaser of Securities from any Underwriter shall be deemed to be a successor merely by reason of
such purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.&#8239;&#8239;&#8239;&#8239;&#8239;<U>Survival</U>.
The respective indemnities, rights of contribution, representations, warranties and agreements of the Company and the Underwriters contained
in this Agreement or made by or on behalf of the Company or the Underwriters pursuant to this Agreement or any certificate delivered pursuant
hereto shall survive the delivery of and payment for the Securities and shall remain in full force and effect, regardless of any termination
of this Agreement or any investigation made by or on behalf of the Company or the Underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">14.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-weight: normal"><U>Recognition
of the U.S. Special Resolution Regimes.</U> In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding
under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under
this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this
Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that any Underwriter
that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime,
Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent
than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the
United States or a state of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For the purposes of this Section 14:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&ldquo;<B>BHC Act
Affiliate</B>&rdquo; has the meaning assigned to the term &ldquo;affiliate&rdquo; in, and shall be interpreted in accordance with, 12
U.S.C. &sect; 1841(k);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Covered Entity</B>&rdquo;
means any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD STYLE="text-align: justify">a &ldquo;covered entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R.
 &sect;&nbsp;252.82(b);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(ii)</TD><TD STYLE="text-align: justify">a &ldquo;covered bank&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R.
 &sect;&nbsp;47.3(b); or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(iii)</TD><TD STYLE="text-align: justify">a &ldquo;covered FSI&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R.
 &sect;&nbsp;382.2(b);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;<B>Default Right</B>&rdquo; has
the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect; 252.81, 47.2 or 382.1, as applicable;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>U.S. Special Resolution
Regime</B>&rdquo; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of
the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Certain
Defined Terms</U>. For purposes of this Agreement, (a) except where otherwise expressly provided, the term &ldquo;<B><I>affiliate</I></B>&rdquo;
has the meaning set forth in Rule 405 under the Securities Act; (b) the term &ldquo;<B><I>business day</I></B>&rdquo; means any day other
than a day on which banks are permitted or required to be closed in New York City; and (c) the term &ldquo;<B><I>subsidiary</I></B>&rdquo;
has the meaning set forth in Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Authority
of the Representatives. </I>Any action by the Underwriters hereunder may be taken by Barclays or BofA on behalf of the Underwriters, and
any such action taken by Barclays or BofA shall be binding upon the Underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Notices.
</I>All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted
and confirmed by any standard form of telecommunication. Notices to the Underwriters shall be given to the Representatives c/o Barclays
Capital Inc., 745 Seventh Avenue, New York, New York 10019 (fax: (646) 834-8133); Attention: Syndicate Registration and BofA Securities,
Inc., 114 West 47th Street, NY8-114-07-01, New York, New York 10036 (fax: (212) 901-7881); Attention: High Grade Debt Capital Markets
Transaction Management/Legal; with a copy to Latham &amp; Watkins LLP, 1271 Avenue of the Americas, New York, New York 10020 (fax: (212)
751-4864); Attention: Greg Rodgers. Notices to the Company shall be given to it at 333 Lakeside Drive, Foster City, California 94404 (fax:
(650) 578-9264); Attention: Chief Financial Officer and General Counsel, with a copy to Davis Polk &amp; Wardwell LLP, 450 Lexington Avenue
(fax: (212) 702-5421); Attention: Richard D. Truesdell, Jr., Roshni Banker Cariello.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Governing
Law. </I>This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by and construed
in accordance with the laws of the State of New York. <FONT STYLE="text-transform: uppercase">The Company agrees that any suit or proceeding
arising in respect of this Agreement or the Underwriters&rsquo; engagement will be tried exclusively in the U.S. District Court for the
Southern District of New York or, if that court does not have subject matter jurisdiction, in any state court located in The City and
County of New&nbsp;York and the Company agrees to submit to the jurisdiction of, and to venue in, such courts</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">(</FONT>d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="text-transform: uppercase"><I>Waiver
of Trial by Jury</I>. The Company and each of the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable
law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated
hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Counterparts.
</I>This Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of telecommunication),
each of which shall be an original and all of which together shall constitute one and the same instrument. Counterparts may be delivered
via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions
Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart
so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Amendments
or Waivers. </I>No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom, shall
in any event be effective unless the same shall be in writing and signed by the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Headings.
</I>The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning or
interpretation of, this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Patriot
Act</I>. In accordance with the requirements of the U.S. Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)),
the Underwriters are required to obtain, verify and record information that identifies their respective clients, including the Company,
which information may include the name and address of their respective clients, as well as other information that will allow the Underwriters
to properly identify their respective clients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the foregoing is in accordance
with your understanding, please indicate your acceptance of this Agreement by signing in the space provided below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">GILEAD SCIENCES, INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Andrew D. Dickinson &nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 42%"><FONT STYLE="font-size: 10pt">Andrew D. Dickinson</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[<I>Signature Page to Underwriting
Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accepted as of the date set forth above:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">BARCLAYS CAPITAL INC.</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">BOFA SECURITIES, INC.</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">For themselves and on behalf of the several Underwriters listed
in Schedule 1 hereto.</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">BARCLAYS CAPITAL INC.</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-size: 10pt">By</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-size: 10pt">/s/ James Gutow</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Authorized Signatory</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">BOFA SECURITIES, INC.</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Douglas A. Muller</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Authorized Signatory</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[Signature Page &ndash; Underwriting Agreement]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Schedule 1&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Underwriters</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Principal<BR> Amount of<BR> 2029 Notes</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Principal<BR> Amount of<BR> 2035 Notes</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Principal<BR> Amount of<BR> 2054 Notes</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Principal<BR> Amount of<BR> 2064 Notes</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; font-size: 10pt; text-align: left; text-indent: -0.75in; padding-left: 0.75in">Barclays Capital Inc.</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">112,500,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">150,000,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">150,000,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">112,500,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.75in; padding-left: 0.75in">BofA Securities, Inc.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">112,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">150,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">150,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">112,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.8in; padding-left: 0.8in">Citigroup Global Markets Inc.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.8in; padding-left: 0.8in">Goldman Sachs &amp; Co. LLC</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.8in; padding-left: 0.8in">HSBC Securities (USA) Inc.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.8in; padding-left: 0.8in">J.P. Morgan Securities LLC</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.8in; padding-left: 0.8in">Mizuho Securities USA LLC</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.8in; padding-left: 0.8in">Morgan Stanley &amp; Co. LLC</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.8in; padding-left: 0.8in">RBC Capital Markets, LLC</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.8in; padding-left: 0.8in">SG Americas Securities, LLC</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.8in; padding-left: 0.8in">TD Securities (USA) LLC</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.8in; padding-left: 0.8in">U.S. Bancorp Investments, Inc.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.8in; padding-left: 0.8in">Wells Fargo Securities, LLC</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.8in; padding-left: 0.8in">Blaylock Van, LLC</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.8in; padding-left: 0.8in">Siebert Williams Shank &amp; Co., LLC</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">16,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.8in; padding-left: 0.8in">American Veterans Group, PBC</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.8in; padding-left: 0.8in">Independence Point Securities LLC</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.8in; padding-left: 0.8in">Loop Capital Markets LLC</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.8in; padding-left: 0.8in">Samuel A. Ramirez &amp; Company, Inc.</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,000,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,500,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -0.8in; padding-left: 0.8in">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; font-size: 10pt; text-align: left; padding-bottom: 2.5pt">Total&#9;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">750,000,000</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,000,000,000</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,000,000,000</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">750,000,000</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">28</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Annex A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>a. Time of Sale Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Term sheets containing the terms of the Securities,
substantially in the form of Annex B.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">Annex B</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PRICING TERM SHEETS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See attached</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Free Writing Prospectus</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed Pursuant to Rule 433</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration Statement No. 333-273745</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>November 13, 2024</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>GILEAD SCIENCES, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><IMG SRC="tm2426602d4_ex1-1img01.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>PRICING TERM SHEET</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">4.80% SENIOR NOTES DUE 2029<BR>
5.10% SENIOR NOTES DUE 2035</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">5.50% SENIOR NOTES DUE 2054</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">5.60% SENIOR NOTES DUE 2064</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 43%"><B>Issuer:</B><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 57%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gilead Sciences, Inc. (the &ldquo;Company&rdquo;)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top"><B>Title of Security:</B></TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4.80% Senior Notes due 2029 (the &ldquo;2029 Notes&rdquo;)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5.10% Senior Notes due 2035 (the &ldquo;2035 Notes&rdquo;)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5.50% Senior Notes due 2054 (the &ldquo;2054 Notes&rdquo;)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5.60% Senior Notes due 2064 (the &ldquo;2064 Notes&rdquo;)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top"><B>Principal Amount:</B></TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2029 Notes: $750,000,000</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2035 Notes: $1,000,000,000</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2054 Notes: $1,000,000,000</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2064 Notes: $750,000,000</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top"><B>Trade Date:</B></TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">November 13, 2024</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top"><B>Settlement&nbsp;Date:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">November 20, 2024 (T+5)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>It is expected that delivery of the notes will be made against
payment therefor on or about November 20, 2024, which is the fifth business day following the date of the pricing of the notes (T+5).
Under Rule&nbsp;15c6-1&nbsp;of the&nbsp;Exchange Act, trades in the secondary market generally are required to settle in one business
day unless the parties to that trade expressly agree otherwise. Accordingly, purchasers who wish to trade the notes on or after the date
of pricing but prior to the closing date may be required, by virtue of the fact that the notes initially will settle in T+5, to specify
an alternative settlement cycle at the time of any such trade to prevent failed settlement and should consult their own advisers.</I></P></TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 43%"><B>Maturity Date:</B></TD>
    <TD STYLE="vertical-align: top; width: 57%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2029 Notes: November 15, 2029</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2035 Notes: June 15, 2035</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2054 Notes: November 15, 2054</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2064 Notes: November 15, 2064</P></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Price to Public:</B></P></TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2029 Notes: 99.988% of the principal amount</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2035 Notes: 99.599% of the principal amount</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2054 Notes: 99.709% of the principal amount</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2064 Notes: 99.290% of the principal amount</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top"><B>Yield to Maturity:</B></TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2029 Notes: 4.803%</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2035 Notes: 5.149%</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2054 Notes: 5.520%</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2064 Notes: 5.649%</P></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Spread to Benchmark Treasury:</B></P></TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2029 Notes: 50 basis points</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2035 Notes: 70 basis points</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2054 Notes: 87.5 basis points</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2064 Notes: 100 basis points</P></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Benchmark Treasury:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2029 Notes: 4.125% due October 31, 2029</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2035 Notes: 4.250% due November 15, 2034</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2054 Notes: 4.250% due August 15, 2054</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2064 Notes: 4.250% due August 15, 2054</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12pt; text-indent: -12pt"><B>Benchmark&nbsp;Treasury&nbsp;Price&nbsp;/
Yield:&nbsp;</B></P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2029 Notes: 99-06 &frac34; / 4.303%</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2035 Notes: 98-13 / 4.449%</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2054 Notes: 93-21 / 4.645%</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2064 Notes: 93-21 / 4.645%</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt; text-indent: -12.25pt"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt; text-indent: -12.25pt"><B>Interest Payment Dates:</B><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;</FONT></P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2029 Notes: May 15 and November 15, commencing May 15, 2025</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2035 Notes: June 15 and December 15, commencing June 15, 2025</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2054 Notes: May 15 and November 15, commencing May 15, 2025</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2064 Notes: May 15 and November 15, commencing May 15, 2025</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><B>Optional Redemption:</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><B>Make-Whole Call:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2029 Notes: T+10 basis points, prior to October 15, 2029 (assuming
    the notes called for redemption matured on October 15, 2029)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2035 Notes: T+15 basis points, prior to March 15, 2035 (assuming the
    notes called for redemption matured on March 15, 2035)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2054 Notes: T+15 basis points, prior to May 15, 2054 (assuming the
    notes called for redemption matured on May 15, 2054)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2064 Notes: T+15 basis points, prior to May 15, 2064 (assuming the
    notes called for redemption matured on May 15, 2064)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><B>Par Call:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2029 Notes: At 100%, on or after October 15, 2029</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2035 Notes: At 100%, on or after March 15, 2035</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2054 Notes: At 100%, on or after May 15, 2054</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2064 Notes: At 100%, on or after May 15, 2064</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 43%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12pt; text-indent: -12pt"><B>CUSIP / ISIN:</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12pt; text-indent: -12pt">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P></TD>
    <TD STYLE="width: 57%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2029 Notes: 375558 CB7 / US375558CB72</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2035 Notes: 375558 CC5 / US375558CC55</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2054 Notes: 375558 CD3 / US375558CD39</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2064 Notes: 375558 CE1 / US375558CE12</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><B>Day Count Convention:</B></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">360-day year consisting of twelve 30-day months</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><B>Joint&nbsp;Book-Running&nbsp;Managers:</B></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Barclays Capital Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BofA Securities, Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Citigroup Global Markets Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Goldman Sachs &amp; Co. LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">HSBC Securities (USA) Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">J.P. Morgan Securities LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mizuho Securities USA LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Morgan Stanley &amp; Co. LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RBC Capital Markets, LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">SG Americas Securities, LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TD Securities (USA) LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">U.S. Bancorp Investments, Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Wells Fargo Securities, LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 12pt; text-indent: -12pt"><B>Senior Co-Managers:</B></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Blaylock Van, LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Siebert Williams Shank &amp; Co., LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><B>Junior Co-Managers:</B></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">American Veterans Group, PBC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Independence Point Securities LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Loop Capital Markets LLC</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Samuel A. Ramirez &amp; Company, Inc.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The issuer has filed a registration statement (including a prospectus)
and a prospectus supplement with the SEC for the offering to which this communication relates. Before you invest, you should read the
prospectus in that registration statement, the prospectus supplement and other documents the issuer has filed with the SEC for more complete
information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov.
Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you
request it by calling Barclays Capital Inc. toll-free at 1-888-603-5847 or calling BofA Securities, Inc. toll free at 1-800-294-1322.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>This pricing term sheet supplements the Preliminary Prospectus Supplement
filed by Gilead Sciences, Inc. on November 13, 2024 relating to its Prospectus dated August 4, 2023.</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 33; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>tm2426602d4_ex4-2.htm
<DESCRIPTION>EXHIBIT 4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 0.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TENTH SUPPLEMENTAL INDENTURE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">GILEAD SCIENCES, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AND</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION,</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AS SUCCESSOR TO</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">WELLS FARGO BANK, NATIONAL ASSOCIATION, AS
TRUSTEE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tenth Supplemental Indenture</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dated as of November 20, 2024</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Supplementing the Indenture</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dated as of March 30, 2011</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">4.80% Senior Notes due 2029</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">5.10% Senior Notes due 2035</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">5.50% Senior Notes due 2054</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">5.60% Senior Notes due 2064</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 0.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>THIS TENTH SUPPLEMENTAL
INDENTURE</B>, is entered into as of November 20, 2024 (this &ldquo;<B>Tenth Supplemental Indenture</B>&rdquo;) by and between Gilead
Sciences, Inc., a corporation duly organized and existing under the laws of Delaware (herein called the &ldquo;<B>Company</B>&rdquo;),
and Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National Association, a national banking association,
as Trustee (herein called the &ldquo;<B>Trustee</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">RECITALS:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company and the
Trustee have heretofore executed and delivered an Indenture, dated as of March 30, 2011 (as heretofore supplemented, the &ldquo;<B>Base
Indenture</B>&rdquo; and, together with this Tenth Supplemental Indenture, the &ldquo;<B>Indenture</B>&rdquo;), providing for the issuance
from time to time of the Company&rsquo;s debentures, notes or other evidences of indebtedness (herein and therein called the &ldquo;<B>Securities</B>&rdquo;),
to be issued in one or more series as provided in the Base Indenture;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, Section 12.1 of the
Base Indenture permits the Company and the Trustee to enter into an indenture supplemental to the Base Indenture to establish the form
and terms of any series of Securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, Section 2.1 of the
Base Indenture permits the form of Securities of any series to be established in an indenture supplemental to the Base Indenture;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, Section 3.1 of the
Base Indenture permits certain terms of any series of Securities to be established pursuant to an indenture supplemental to the Base Indenture;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, pursuant to Sections
2.1 and 3.1 of the Base Indenture, the Company desires to provide for the establishment of four new series of Securities under the Base
Indenture, the form and substance of such Securities and the terms, provisions and conditions thereof to be set forth as provided in the
Base Indenture and this Tenth Supplemental Indenture; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, all things necessary
to make this Tenth Supplemental Indenture a valid agreement of the Company, in accordance with its terms, have been done.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, for and in
consideration of the foregoing and the purchase of the Securities of four new series established by this Tenth Supplemental Indenture
by the holders thereof (the &ldquo;<B>Holders</B>&rdquo;), it is mutually agreed, for the equal and proportionate benefit of all such
Holders, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-variant: normal; text-transform: uppercase"><B>Article
1</B></FONT><BR>
<BR>
<B><U>DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION</U></B></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 1.01<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Relation to Base Indenture</U></B>. This Tenth Supplemental Indenture constitutes a part of the Base Indenture (the provisions
of which, as modified by this Tenth Supplemental Indenture, shall apply to each series of Notes (as defined in Section 3.01(a))) in respect
of such series of Notes but shall not modify, amend or otherwise affect the Base Indenture insofar as it relates to any other series of
Securities or modify, amend or otherwise affect in any manner the terms and conditions of the Securities of any other series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 1.02<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT><U>Definitions</U></B>. For all purposes of this Tenth Supplemental Indenture, the capitalized terms used herein (i) which are
defined in this Section 1.02 have the respective meanings assigned hereto in this Section 1.02 and (ii) which are defined in the Base
Indenture (and which are not defined in this Section 1.02) have the respective meanings assigned thereto in the Base Indenture. For all
purposes of this Tenth Supplemental Indenture:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>Unless the context otherwise requires, any reference to an Article or Section refers to an Article or Section, as the case may
be, of this Tenth Supplemental Indenture;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>The words &ldquo;herein,&rdquo; &ldquo;hereof&rdquo; and &ldquo;hereunder&rdquo; and words of similar import refer to this Tenth
Supplemental Indenture as a whole and not to any particular Article, Section or other subdivision; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT>Headings are for convenience of reference only and do not affect interpretations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-variant: normal; text-transform: uppercase"><B>Article
2</B></FONT><BR>
<BR>
<B><U>GENERAL TERMS AND CONDITIONS OF THE 2029 NOTES</U></B></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 2.01<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Terms of the 2029 Notes</U></B>. Pursuant to Sections 2.1 and 3.1 of the Base Indenture, there is hereby established a new series
of Securities, the terms of which shall be as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Designation</U>. There is hereby authorized and established a new series of Securities under the Base Indenture, known and designated
as the &ldquo;<B>4.80% Senior Notes due 2029</B>&rdquo; (the &ldquo;<B>2029 Notes</B>&rdquo;) of the Company. This series of 2029 Notes
is unlimited in aggregate principal amount. The initial aggregate principal amount of the 2029 Notes to be issued under this Tenth Supplemental
Indenture shall be $750,000,000. Any additional amounts of the 2029 Notes to be issued shall be set forth in a Company Order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Form and Denominations</U>. The 2029 Notes will be issued only in fully registered form, and the authorized denominations of
the 2029 Notes shall be $2,000 principal amount and any integral multiple of $1,000 in excess thereof. The 2029 Notes will initially be
issued in the form of one or more Global Securities substantially in the form of <U>Exhibit A</U> attached hereto, with such modifications
thereto as may be approved by the authorized officer executing the same. The 2029 Notes will be denominated in U.S. dollars and payments
of principal, premium, if any, and interest will be made in U.S. dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Maturity Date</U>. The Stated Maturity of principal for the 2029 Notes shall be payable in full on November 15, 2029 (the &ldquo;<B>2029
Notes Maturity Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT><U>Interest</U>. Interest payable on any 2029 Notes Interest Payment Date (as defined below), the 2029 Notes Maturity Date or,
if applicable, the Redemption Date (as determined in accordance with Section 4.2 of the Base Indenture), shall be the amount accrued from,
and including, the immediately preceding 2029 Notes Interest Payment Date in respect of which interest has been paid or duly provided
for (or from and including the original issue date of November 20, 2024 if no interest has been paid or duly provided for with respect
to the 2029 Notes) to but excluding such 2029 Notes Interest Payment Date, 2029 Notes Maturity Date or, if applicable, the Redemption
Date, as the case may be (each, a &ldquo;<B>2029 Notes Interest Period</B>&rdquo;). The 2029 Notes will bear interest at the rate of 4.80%
per year from the original issue date thereof to the 2029 Notes Maturity Date. Interest on the 2029 Notes shall be payable semi-annually
in arrears on May 15 and November 15 of each year, beginning on May 15, 2025 (each such date, a &ldquo;<B>2029 Notes Interest Payment
Date</B>&rdquo;). The amount of interest payable for any semi-annual 2029 Notes Interest Period will be computed on the basis of a 360-day
year consisting of twelve 30-day months. In the event any 2029 Notes Interest Payment Date on or before the 2029 Notes Maturity Date falls
on a day that is not a Business Day, the interest payment due on that date will be postponed to the next day that is a Business Day and
no interest shall accrue as a result of such postponement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event the 2029 Notes
Maturity Date or, if applicable, the Redemption Date, falls on a day that is not a Business Day, then the related payments of principal,
premium, if any, and interest may be made on the next succeeding date that is a Business Day (and no additional interest will accumulate
on the amount payable for the period from and after the 2029 Notes Maturity Date or Redemption Date, as applicable, for such 2029 Note).
Interest due on the 2029 Notes Maturity Date or, if applicable, the Redemption Date, in each case (whether or not a 2029 Notes Interest
Payment Date) will be paid to the Person to whom principal of such 2029 Notes is payable, subject to DTC&rsquo;s applicable procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Sinking Fund; Holder Repurchase Right</U>. The 2029 Notes shall not be subject to any sinking fund or analogous provision or
be redeemable at the option of the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT><U>Forms</U>. The 2029 Notes shall be substantially in the form of <U>Exhibit A</U> attached hereto, with such modifications thereto
as may be approved by the authorized officer executing the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Appointment of Agent</U>. The Trustee will initially be the Registrar and Paying Agent with respect to the 2029 Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Defeasance</U>. Until the 2029 Notes Maturity Date, the 2029 Notes will be subject to Sections 11.2 and 11.3 of the Base Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT><U>Further Issues</U>. The Company may from time to time, without the consent of the Holders of 2029 Notes, issue additional 2029
Notes. Any such additional 2029 Notes will have the same ranking, interest rate, maturity date and other terms as the 2029 Notes. Any
such additional 2029 Notes, together with the 2029 Notes herein provided for, will constitute a single series of Securities under the
Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-variant: normal; text-transform: uppercase"><B>Article
3</B></FONT><B>&nbsp;</B></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><U>GENERAL TERMS
AND CONDITIONS OF THE 2035 NOTES</U></B></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3.01<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Terms of the 2035 Notes</U></B>. Pursuant to Sections 2.1 and 3.1 of the Base Indenture, there is hereby established a new series
of Securities, the terms of which shall be as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Designation</U>. There is hereby authorized and established a new series of Securities under the Base Indenture, known and designated
as the &ldquo;<B>5.10% Senior Notes due 2035</B>&rdquo; (the &ldquo;<B>2035 Notes</B>&rdquo;) of the Company. This series of 2035 Notes
is unlimited in aggregate principal amount. The initial aggregate principal amount of the 2035 Notes to be issued under this Tenth Supplemental
Indenture shall be $1,000,000,000. Any additional amounts of the 2035 Notes to be issued shall be set forth in a Company Order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Form and Denominations</U>. The 2035 Notes will be issued only in fully registered form, and the authorized denominations of
the 2035 Notes shall be $2,000 principal amount and any integral multiple of $1,000 in excess thereof. The 2035 Notes will initially be
issued in the form of one or more Global Securities substantially in the form of <U>Exhibit B</U> attached hereto, with such modifications
thereto as may be approved by the authorized officer executing the same. The 2035 Notes will be denominated in U.S. dollars and payments
of principal, premium, if any, and interest will be made in U.S. dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Maturity Date</U>. The Stated Maturity of principal for the 2035 Notes shall be payable in full on June 15, 2035 (the &ldquo;<B>2035
Notes Maturity Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Interest</U>. Interest payable on any 2035 Notes Interest Payment Date (as defined below), the 2035 Notes Maturity Date or,
if applicable, the Redemption Date (as determined in accordance with Section 4.2 of the Base Indenture), shall be the amount accrued from,
and including, the immediately preceding 2035 Notes Interest Payment Date in respect of which interest has been paid or duly provided
for (or from and including the original issue date of November 20, 2024 if no interest has been paid or duly provided for with respect
to the 2035 Notes) to but excluding such 2035 Notes Interest Payment Date, 2035 Notes Maturity Date or, if applicable, the Redemption
Date, as the case may be (each, a &ldquo;<B>2035 Notes Interest Period</B>&rdquo;). The 2035 Notes will bear interest at the rate of 5.10%
per year from the original issue date thereof to the 2035 Notes Maturity Date. Interest on the 2035 Notes shall be payable semi-annually
in arrears on June 15 and December 15 of each year, beginning on June 15, 2025 (each such date, a &ldquo;<B>2035 Notes Interest Payment
Date</B>&rdquo;). The amount of interest payable for any semi-annual 2035 Notes Interest Period will be computed on the basis of a 360-day
year consisting of twelve 30-day months. In the event any 2035 Notes Interest Payment Date on or before the 2035 Notes Maturity Date falls
on a day that is not a Business Day, the interest payment due on that date will be postponed to the next day that is a Business Day and
no interest shall accrue as a result of such postponement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event the 2035 Notes
Maturity Date or, if applicable, the Redemption Date, falls on a day that is not a Business Day, then the related payments of principal,
premium, if any, and interest may be made on the next succeeding date that is a Business Day (and no additional interest will accumulate
on the amount payable for the period from and after the 2035 Notes Maturity Date or Redemption Date, as applicable, for such 2035 Note).
Interest due on the 2035 Notes Maturity Date or, if applicable, the Redemption Date, in each case (whether or not a 2035 Notes Interest
Payment Date) will be paid to the Person to whom principal of such 2035 Notes is payable, subject to DTC&rsquo;s applicable procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Sinking Fund; Holder Repurchase Right</U>. The 2035 Notes shall not be subject to any sinking fund or analogous provision or
be redeemable at the option of the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT><U>Forms</U>. The 2035 Notes shall be substantially in the form of <U>Exhibit B</U> attached hereto, with such modifications thereto
as may be approved by the authorized officer executing the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Appointment of Agent</U>. The Trustee will initially be the Registrar and Paying Agent with respect to the 2035 Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Defeasance</U>. Until the 2035 Notes Maturity Date, the 2035 Notes will be subject to Sections 11.2 and 11.3 of the Base Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT><U>Further Issues</U>. The Company may from time to time, without the consent of the Holders of 2035 Notes, issue additional 2035
Notes. Any such additional 2035 Notes will have the same ranking, interest rate, maturity date and other terms as the 2035 Notes. Any
such additional 2035 Notes, together with the 2035 Notes herein provided for, will constitute a single series of Securities under the
Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-variant: normal; text-transform: uppercase"><B>Article
4</B></FONT><B>&nbsp;</B></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><U>GENERAL TERMS
AND CONDITIONS OF THE 2054 NOTES</U></B></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4.01<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Terms of the 2054 Notes</U></B>. Pursuant to Sections 2.1 and 3.1 of the Base Indenture, there is hereby established a new series
of Securities, the terms of which shall be as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;</FONT><U>Designation</U>.
There is hereby authorized and established a new series of Securities under the Base Indenture, known and designated as the &ldquo;<B>5.50%
Senior Notes due 2054</B>&rdquo; (the &ldquo;<B>2054 Notes</B>&rdquo;) of the Company. This series of 2054 Notes is unlimited in aggregate
principal amount. The initial aggregate principal amount of the 2054 Notes to be issued under this Tenth Supplemental Indenture shall
be $1,000,000,000. Any additional amounts of the 2054 Notes to be issued shall be set forth in a Company Order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Form and Denominations</U>. The 2054 Notes will be issued only in fully registered form, and the authorized denominations of
the 2054 Notes shall be $2,000 principal amount and any integral multiple of $1,000 in excess thereof. The 2054 Notes will initially be
issued in the form of one or more Global Securities substantially in the form of <U>Exhibit C</U> attached hereto, with such modifications
thereto as may be approved by the authorized officer executing the same. The 2054 Notes will be denominated in U.S. dollars and payments
of principal, premium, if any, and interest will be made in U.S. dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Maturity Date</U>. The Stated Maturity of principal for the 2054 Notes shall be payable in full on November 15, 2054 (the &ldquo;<B>2054
Notes Maturity Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT><U>Interest</U>. Interest payable on any 2054 Notes Interest Payment Date (as defined below), the 2054 Notes Maturity Date or,
if applicable, the Redemption Date (as determined in accordance with Section 4.2 of the Base Indenture), shall be the amount accrued from,
and including, the immediately preceding 2054 Notes Interest Payment Date in respect of which interest has been paid or duly provided
for (or from and including the original issue date of November 20, 2024 if no interest has been paid or duly provided for with respect
to the 2054 Notes) to but excluding such 2054 Notes Interest Payment Date, 2054 Notes Maturity Date or, if applicable, the Redemption
Date, as the case may be (each, a &ldquo;<B>2054 Notes Interest Period</B>&rdquo;). The 2054 Notes will bear interest at the rate of 5.50%
per year from the original issue date thereof to the 2054 Notes Maturity Date. Interest on the 2054 Notes shall be payable semi-annually
in arrears on May 15 and November 15 of each year, beginning on May 15, 2025 (each such date, a &ldquo;<B>2054 Notes Interest Payment
Date</B>&rdquo;). The amount of interest payable for any semi-annual 2054 Notes Interest Period will be computed on the basis of a 360-day
year consisting of twelve 30-day months. In the event any 2054 Notes Interest Payment Date on or before the 2054 Notes Maturity Date falls
on a day that is not a Business Day, the interest payment due on that date will be postponed to the next day that is a Business Day and
no interest shall accrue as a result of such postponement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event the 2054 Notes
Maturity Date or, if applicable, the Redemption Date, falls on a day that is not a Business Day, then the related payments of principal,
premium, if any, and interest may be made on the next succeeding date that is a Business Day (and no additional interest will accumulate
on the amount payable for the period from and after the 2054 Notes Maturity Date or Redemption Date, as applicable, for such 2054 Note).
Interest due on the 2054 Notes Maturity Date or, if applicable, the Redemption Date, in each case (whether or not a 2054 Notes Interest
Payment Date) will be paid to the Person to whom principal of such 2054 Notes is payable, subject to DTC&rsquo;s applicable procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Sinking Fund; Holder Repurchase Right</U>. The 2054 Notes shall not be subject to any sinking fund or analogous provision or
be redeemable at the option of the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT><U>Forms</U>. The 2054 Notes shall be substantially in the form of <U>Exhibit C</U> attached hereto, with such modifications thereto
as may be approved by the authorized officer executing the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Appointment of Agent</U>. The Trustee will initially be the Registrar and Paying Agent with respect to the 2054 Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Defeasance</U>. Until the 2054 Notes Maturity Date, the 2054 Notes will be subject to Sections 11.2 and 11.3 of the Base Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT><U>Further Issues</U>. The Company may from time to time, without the consent of the Holders of 2054 Notes, issue additional 2054
Notes. Any such additional 2054 Notes will have the same ranking, interest rate, maturity date and other terms as the 2054 Notes. Any
such additional 2054 Notes, together with the 2054 Notes herein provided for, will constitute a single series of Securities under the
Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-variant: normal; text-transform: uppercase"><B>Article
5</B></FONT><B>&nbsp;</B></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><U>GENERAL TERMS
AND CONDITIONS OF THE 2064 NOTES</U></B></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 5.01<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Terms of the 2064 Notes</U></B>. Pursuant to Sections 2.1 and 3.1 of the Base Indenture, there is hereby established a new series
of Securities, the terms of which shall be as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; </FONT><U>Designation</U>.
There is hereby authorized and established a new series of Securities under the Base Indenture, known and designated as the
 &ldquo;<B>5.60% Senior Notes due 2064</B>&rdquo; (the &ldquo;<B>2064 Notes</B>&rdquo; and, together with the 2029 Notes, the 2035
Notes and the 2054 Notes, the &ldquo;<B>Notes</B>&rdquo;) of the Company. This series of 2064 Notes is unlimited in aggregate
principal amount. The initial aggregate principal amount of the 2064 Notes to be issued under this Tenth Supplemental Indenture
shall be $750,000,000. Any additional amounts of the 2064 Notes to be issued shall be set forth in a Company Order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Form and Denominations</U>. The 2064 Notes will be issued only in fully registered form, and the authorized denominations of
the 2064 Notes shall be $2,000 principal amount and any integral multiple of $1,000 in excess thereof. The 2064 Notes will initially be
issued in the form of one or more Global Securities substantially in the form of <U>Exhibit D</U> attached hereto, with such modifications
thereto as may be approved by the authorized officer executing the same. The 2064 Notes will be denominated in U.S. dollars and payments
of principal, premium, if any, and interest will be made in U.S. dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Maturity Date</U>. The Stated Maturity of principal for the 2064 Notes shall be payable in full on November 15, 2064 (the &ldquo;<B>2064
Notes Maturity Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Interest</U>. Interest payable on any 2064 Notes Interest Payment Date (as defined below), the 2064 Notes Maturity Date or,
if applicable, the Redemption Date (as determined in accordance with Section 4.2 of the Base Indenture), shall be the amount accrued from,
and including, the immediately preceding 2064 Notes Interest Payment Date in respect of which interest has been paid or duly provided
for (or from and including the original issue date of November 20, 2024 if no interest has been paid or duly provided for with respect
to the 2064 Notes) to but excluding such 2064 Notes Interest Payment Date, 2064 Notes Maturity Date or, if applicable, the Redemption
Date, as the case may be (each, a &ldquo;<B>2064 Notes Interest Period</B>&rdquo;). The 2064 Notes will bear interest at the rate of 5.60%
per year from the original issue date thereof to the 2064 Notes Maturity Date. Interest on the 2064 Notes shall be payable semi-annually
in arrears on May 15 and November 15 of each year, beginning on May 15, 2025 (each such date, a &ldquo;<B>2064 Notes Interest Payment
Date</B>&rdquo;). The amount of interest payable for any semi-annual 2064 Notes Interest Period will be computed on the basis of a 360-day
year consisting of twelve 30-day months. In the event any 2064 Notes Interest Payment Date on or before the 2064 Notes Maturity Date falls
on a day that is not a Business Day, the interest payment due on that date will be postponed to the next day that is a Business Day and
no interest shall accrue as a result of such postponement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event the 2064 Notes
Maturity Date or, if applicable, the Redemption Date, falls on a day that is not a Business Day, then the related payments of principal,
premium, if any, and interest may be made on the next succeeding date that is a Business Day (and no additional interest will accumulate
on the amount payable for the period from and after the 2064 Notes Maturity Date or Redemption Date, as applicable, for such 2064 Note).
Interest due on the 2064 Notes Maturity Date or, if applicable, the Redemption Date, in each case (whether or not a 2064 Notes Interest
Payment Date) will be paid to the Person to whom principal of such 2064 Notes is payable, subject to DTC&rsquo;s applicable procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Sinking Fund; Holder Repurchase Right</U>. The 2064 Notes shall not be subject to any sinking fund or analogous provision or
be redeemable at the option of the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT><U>Forms</U>. The 2064 Notes shall be substantially in the form of <U>Exhibit D</U> attached hereto, with such modifications thereto
as may be approved by the authorized officer executing the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Appointment of Agent</U>. The Trustee will initially be the Registrar and Paying Agent with respect to the 2064 Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Defeasance</U>. Until the 2064 Notes Maturity Date, the 2064 Notes will be subject to Sections 11.2 and 11.3 of the Base Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Further Issues</U>. The Company may from time to time, without the consent of the Holders of 2064 Notes, issue additional 2064
Notes. Any such additional 2064 Notes will have the same ranking, interest rate, maturity date and other terms as the 2064 Notes. Any
such additional 2064 Notes, together with the 2064 Notes herein provided for, will constitute a single series of Securities under the
Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-variant: normal; text-transform: uppercase"><B>Article
6</B></FONT><BR>
<BR>
<B><U>COVENANTS</U></B></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 6.01<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Limitations on Liens</U></B>. The restriction set forth in Section 5.2 of the Base Indenture with respect to each series of
Notes shall not apply to, in addition to those otherwise set forth in Section 5.2 of the Base Indenture, the following: Leases, licenses,
subleases or sublicenses of assets (including with respect to real property and intellectual property rights) granted to others that do
not in the aggregate materially interfere with the ordinary conduct of the business of the Company and its Subsidiaries taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 6.02<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Limitations on Sale and Leaseback Transactions.</U></B> Section 5.3(iii) of the Base Indenture is eliminated in its entirety
and replaced, solely insofar as it relates to the Securities issued pursuant to this Tenth Supplemental Indenture on and after the date
of this Tenth Supplemental Indenture, with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&ldquo;(iii) The Corporation
or any Restricted Subsidiary, during the 360 days following the effective date of the Sale and Leaseback Transaction, applies an amount
equal to the greater of the net proceeds of such sale or transfer or the fair value of the Restricted Property that the Corporation or
our Restricted Subsidiary lease in the transaction to (x) the voluntary retirement of the debt securities or other Debt of the Corporation
or that of any Restricted Subsidiary, provided that such Debt (A) ranks <I>pari passu</I> or senior to the Securities and (B) has a stated
maturity which is either more than 12 months from the date of such application or which is extendable or renewable at the option of the
obligor thereon to a date more than 12 months from the date of such application or (y) the purchase, construction or development of a
Restricted Property.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 6.03<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT><U>Exempted Liens and Sale and Leaseback Transactions</U></B>. Section 5.4 of the Base Indenture is eliminated in its entirety
and replaced, solely insofar as it relates to the Securities issued pursuant to this Tenth Supplemental Indenture on and after the date
of this Tenth Supplemental Indenture, with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;Section 5.4 <I>Exempted Liens
and Sale and Leaseback Transactions</I>. Notwithstanding the restrictions described in Sections 5.2 and 5.3 above, the Corporation or
any Restricted Subsidiary may create or assume any Liens not otherwise permitted under Section 5.2 or enter into any Sale and Leaseback
Transactions not otherwise permitted under Section 5.3, if the sum of the following does not exceed 20% of Consolidated Net Tangible Assets:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;the
outstanding Indebtedness secured by such Liens (not including any Liens permitted under Section 5.2 above which amount does not include
any Liens permitted under the provisions of this Section 5.4); plus</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;all
Attributable Debt in respect of such Sale and Leaseback Transactions entered into (not including any Sale and Leaseback Transactions permitted
under Section 5.3 which amount does not include any Sale and Leaseback Transactions permitted under the provisions of this Section 5.4),</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">measured, in each case, at the time
such Lien is incurred or any such Sale and Leaseback Transaction is entered into by the Corporation or such Restricted Subsidiary.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-variant: normal; text-transform: uppercase"><B>Article
7</B></FONT><BR>
<BR>
<B><U>REDEMPTION OF THE NOTES</U></B></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7.01<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT><U>Optional Redemption by Company</U></B>. The Notes may be redeemed at the option of the Company on the terms and conditions set
forth in the form of Notes as set forth as <U>Exhibit A</U>, <U>Exhibit B</U>, <U>Exhibit C</U> or <U>Exhibit D</U> as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-variant: normal; text-transform: uppercase"><B>Article
8</B></FONT><BR>
<BR>
<B><U>CHANGE OF CONTROL</U></B></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 8.01<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT><U>Offer to Purchase Upon Change of Control Triggering Event</U></B>. Upon the occurrence of a Change of Control Triggering Event
(as defined in the form of Note set forth as <U>Exhibit A</U>, <U>Exhibit B</U>, <U>Exhibit C</U> and <U>Exhibit D</U>, as applicable),
except with respect to any series of Notes for which the Company has exercised its option to redeem the Notes of such series in full pursuant
to Section 5.01, the Company shall be required to make an offer to each Holder of the applicable series of Notes to repurchase all or
any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of that Holder&rsquo;s applicable series of Notes on the
terms and conditions set forth in the form of Note set forth as <U>Exhibit A</U>, <U>Exhibit B</U>, <U>Exhibit C</U> or <U>Exhibit D</U>,
as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-variant: normal; text-transform: uppercase"><B>Article
9</B></FONT><BR>
<BR>
<B><U>MISCELLANEOUS</U></B></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 9.01<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Relationship
to Existing Base Indenture</U></B>. This Tenth Supplemental Indenture is a supplemental indenture within the meaning of the Base Indenture.
The Base Indenture, as supplemented and amended by this Tenth Supplemental Indenture, is in all respects ratified, confirmed and approved
and, with respect to each series of Notes, the Base Indenture, as supplemented and amended by this Tenth Supplemental Indenture, shall
be read, taken and construed as one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 9.02<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Modification of the Existing Base Indenture</U></B>. Except as expressly modified by this Tenth Supplemental Indenture, the
provisions of the Base Indenture shall govern the terms and conditions of each series of Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 9.03<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Governing Law</U></B>. This Tenth Supplemental Indenture shall be governed by and construed in accordance with the laws of the
State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 9.04<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><U>Counterparts</U></B>.
This Tenth Supplemental Indenture may be executed in any number of counterparts, each of which when so executed shall be deemed to be
an original, but all such counterparts shall together constitute but one and the same instrument. This Tenth Supplemental Indenture (or
to any document executed in connection with this supplemental indenture, excluding the notes) shall be valid, binding, and enforceable
against a party only when executed and delivered by an authorized individual on behalf of the party by means of (i) any electronic signature
permitted by the federal Electronic Signatures in Global and National Commerce Act, state enactments of the Uniform Electronic Transactions
Act, and/or any other relevant electronic signatures law, including relevant provisions of the Uniform Commercial Code (collectively,
 &ldquo;Signature Law&rdquo;); (ii) an original manual signature; or (iii) a faxed, scanned, or photocopied manual signature. Each electronic
signature or faxed, scanned, or photocopied manual signature shall for all purposes have the same validity, legal effect, and admissibility
in evidence as an original manual signature. Each party hereto shall be entitled to conclusively rely upon, and shall have no liability
with respect to, any faxed, scanned, or photocopied manual signature, or other electronic signature, of any party and shall have no duty
to investigate, confirm or otherwise verify the validity or authenticity thereof. The exchange of copies of this Tenth Supplemental Indenture
and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this Tenth Supplemental
Indenture as to the parties hereto and may be used in lieu of the original Tenth Supplemental Indenture for all purposes. Signatures
of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 9.05<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
</FONT><U>Trustee Makes No Representation</U></B>. The recitals contained herein are made by the Company and not by the Trustee, and the
Trustee assumes no responsibility for the correctness thereof. The Trustee makes no representation as to the validity or sufficiency of
this Tenth Supplemental Indenture (except for its execution thereof and its certificates of authentication of any series of Notes).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 9.06<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;
</FONT><U>Separability</U></B>. In case any provision in the Base Indenture, this Tenth Supplemental Indenture or any series of Notes
shall for any reason be held to be invalid, illegal or unenforceable, the validity, legality or enforceability of the remaining provisions
shall not in any way be affected or impaired thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature page follows]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the parties hereto have caused this Tenth Supplemental Indenture to be duly executed and attested all as of the day and year first above
written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: November 20, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: left"><B>GILEAD SCIENCES, INC.,</B> <BR>
as Issuer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify">/s/ Andrew D. Dickinson</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 3%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%">Name:</TD>
    <TD STYLE="text-align: justify; width: 42%">Andrew D. Dickinson</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: left">Title:</TD>
    <TD STYLE="text-align: left">Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: left"><B>COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION, </B><BR>
as Trustee</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify">/s/ Corey J. Dahlstrand</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 3%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%">Name:</TD>
    <TD STYLE="text-align: justify; width: 42%">Corey J. Dahlstrand</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:</TD>
    <TD STYLE="text-align: justify">Vice President</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>[Signature Page to Tenth
Supplemental Indenture]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>EXHIBIT A</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM OF 2029 NOTE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS SECURITY IS A GLOBAL
SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE OF THE
DEPOSITARY WHICH MAY BE TREATED BY THE COMPANY, THE TRUSTEE OR ANY AGENT THEREOF AS OWNER AND HOLDER OF THIS SECURITY FOR ALL PURPOSES.
THIS SECURITY MAY NOT BE EXCHANGED IN WHOLE OR IN PART FOR A SECURITY REGISTERED, AND NO TRANSFER OF THIS SECURITY IN WHOLE OR IN PART
MAY BE REGISTERED, IN THE NAME OF ANY PERSON OTHER THAN SUCH DEPOSITARY OR A NOMINEE THEREOF, EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED
IN THE INDENTURE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">UNLESS THIS CERTIFICATE IS
PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&ldquo;<B>DTC</B>&rdquo;), TO THE ISSUER
OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE &amp; CO.
OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE &amp; CO. OR TO SUCH OTHER
ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR
TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &amp; CO., HAS AN INTEREST HEREIN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">GILEAD SCIENCES, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%; text-align: left">No. ___</TD><TD STYLE="text-align: right; width: 50%">CUSIP NO. 375558 CB7</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">$______________</TD></TR>
     </TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Interest</I>. Gilead Sciences,
Inc., a corporation duly incorporated and existing under the laws of the State of Delaware (herein called the &ldquo;<B>Company</B>&rdquo;,
which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to Cede
 &amp; Co., or registered assigns, the principal sum of _____________ DOLLARS ($_________), as revised by the Schedule of Increases or
Decreases in Global Security attached hereto, on November 15, 2029 and to pay interest thereon from November 20, 2024 or from the most
recent 2029 Notes Interest Payment Date to which interest has been paid or duly provided for, semi-annually on May 15 and November 15,
in each year, commencing May 15, 2025 at the interest rate of 4.80% per annum, until the principal hereof is paid or made available for
payment. The amount of interest payable for any semi-annual period will be computed on the basis of a 360-day year consisting of twelve
30-day months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Method of Payment</I>.
The interest so payable, and punctually paid or duly provided for, on any 2029 Notes Interest Payment Date will, as provided in such
Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business
on the Regular Record Date for such interest, which shall be the May 1 or November 1 (whether or not a Business Day), as the case may
be, next preceding such Interest Payment Date. Any such interest not so punctually paid or duly provided for will forthwith cease to
be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Security (or one or more
Predecessor Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to
be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such Special
Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange on which
the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in
said Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payment of the principal of
(and premium, if any) and interest on this Security will be made at the office or agency of the Trustee maintained for that purpose in
the continental United States, in such coin or currency of the United States of America as at the time of payment is legal tender for
payment of public and private debts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is hereby made to
the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same
effect as if set forth at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Authentication</I>. Unless
the certificate of authentication hereon has been executed by the Trustee referred to on the reverse hereof by manual signature, this
Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the Company has caused this instrument to be duly executed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>GILEAD SCIENCES, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Name:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Global 2029 Note]</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[FORM OF CERTIFICATION OF AUTHENTICATION]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CERTIFICATE OF AUTHENTICATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This is one of the Securities
of the series designated therein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Date of authentication:</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><B>COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION,</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">as Trustee</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 7%; text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 42%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Authorized Signatory</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[FORM OF REVERSE OF 2029 NOTE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Indenture</I>. This Security
is one of a duly authorized issue of securities of the Company (herein called the &ldquo;<B>Securities</B>&rdquo;), issued and to be issued
in one or more series under an Indenture, dated as of March 30, 2011 (as heretofore supplemented, herein called the &ldquo;<B>Base Indenture</B>&rdquo;,
which term shall have the meaning assigned to it in such instrument), as supplemented by a Tenth Supplemental Indenture dated as of November
20, 2024 (herein called the &ldquo;<B>Tenth Supplemental Indenture</B>&rdquo;, and together with the Base Indenture, the &ldquo;<B>Indenture</B>&rdquo;),
between the Company and Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National Association, as
Trustee (herein called the &ldquo;<B>Trustee</B>&rdquo;, which term includes any successor trustee under the Indenture), and reference
is hereby made to the Indenture for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the
Company, the Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are to be, authenticated and
delivered. This Security is one of the series designated on the face hereof, initially limited in aggregate principal amount to $750,000,000.
The Company may at any time issue additional securities under the Indenture in unlimited amounts having the same terms as the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Optional Redemption</I>.
The Securities of this series are subject to redemption at the Company&rsquo;s option, at any time and from time to time, in whole or
in part, prior to the Par Call Date (as defined below), upon not less than 10 nor more than 60 days&rsquo; notice mailed or electronically
delivered (or otherwise transmitted in accordance with the depositary&rsquo;s procedures) to each Holder of Securities to be redeemed
at his address as it appears in the records of the Registrar, on any date prior to their Stated Maturity at a Redemption Price (expressed
as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a) the sum of the present values
of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming the Securities matured
on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined
below) plus 10 basis points, less (b) interest accrued to the Redemption Date; and (ii) 100% of the principal amount of the Securities
to be redeemed; plus, in either case, accrued and unpaid interest thereon to the Redemption Date (the &ldquo;<B>Redemption Price</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any time on or after October
15, 2029 (the &ldquo;<B>Par Call Date</B>&rdquo;), the Company may redeem the Securities of this series at the Company&rsquo;s option,
in whole or in part, at any time and from time to time, at a Redemption Price equal to 100% of the principal amount of the Securities
to be redeemed, plus accrued and unpaid interest on the Securities being redeemed to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of determining
the Redemption Price, the following definition is applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Treasury Rate</B>&rdquo;
means, with respect to any Redemption Date, the yield determined by the Company in accordance with the following two paragraphs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Treasury Rate shall be
determined by the Company after 4:15 p.m., New York City time (or after such time as yields on U.S. government securities are posted daily
by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the Redemption Date based upon the yield
or yields for the most recent day that appear after such time on such day in the most recent statistical release published by the Board
of Governors of the Federal Reserve System designated as &ldquo;Selected Interest Rates (Daily) - H.15&rdquo; (or any successor designation
or publication) (&ldquo;H.15&rdquo;) under the caption &ldquo;U.S. government securities&ndash;Treasury constant maturities&ndash;Nominal&rdquo;
(or any successor caption or heading). In determining the Treasury Rate, the Company shall select, as applicable: (1) the yield for the
Treasury constant maturity on H.15 exactly equal to the period from the Redemption Date to the Par Call Date (the &ldquo;Remaining Life&rdquo;);
or (2) if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields &ndash; one yield corresponding
to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15
immediately longer than the Remaining Life &ndash; and shall interpolate to the Par Call Date on a straight-line basis (using the actual
number of days) using such yields and rounding the result to three decimal places; or (3) if there is no such Treasury constant maturity
on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining
Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity
date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the Redemption Date.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If on the third Business Day
preceding the Redemption Date H.15 or any successor designation or publication is no longer published, the Company shall calculate the
Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on
the second Business Day preceding such Redemption Date of the United States Treasury security maturing on, or with a maturity that is
closest to, the Par Call Date, as applicable. If there is no United States Treasury security maturing on the Par Call Date but there are
two or more United States Treasury securities with a maturity date equally distant from the Par Call Date, one with a maturity date preceding
the Par Call Date and one with a maturity date following the Par Call Date, the Company shall select the United States Treasury security
with a maturity date preceding the Par Call Date. If there are two or more United States Treasury securities maturing on the Par Call
Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among
these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the
average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury
Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security
shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City
time, of such United States Treasury security, and rounded to three decimal places.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s actions
and determinations in determining the Redemption Price shall be conclusive and binding for all purposes, absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the case of a partial redemption,
selection of the Securities for redemption will be made pro rata, by lot or by such other method as the Trustee deems appropriate and
fair. No Securities of a principal amount of $2,000 or less will be redeemed in part. If any Security is to be redeemed in part only,
the notice of redemption that relates to the Security will state the portion of the principal amount of the Security to be redeemed. A
new Security in a principal amount equal to the unredeemed portion of the Security will be issued in the name of the holder of the Security
upon surrender for cancellation of the original Security. For so long as the Securities are held by DTC (or another depositary), the redemption
of the Securities shall be done in accordance with the policies and procedures of the depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the Company defaults
in payment of the Redemption Price, on and after the Redemption Date interest will cease to accrue on the Securities or portions thereof
called for redemption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of redemption
of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed portion hereof will be
issued in the name of the Holder hereof upon the cancellation hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Change of Control</I>.
If a Change of Control Triggering Event occurs, unless the Company has exercised its right to redeem the Securities as described in &ldquo;Optional
Redemption&rdquo; above, the Company will be required to make an offer to repurchase all, or any part (equal to $2,000 or an integral
multiple of $1,000 in excess thereof), of each Holder&rsquo;s Securities pursuant to the offer described below (the &ldquo;<B>Change of
Control Offer</B>&rdquo;) on the terms set forth herein. In the Change of Control Offer, the Company will be required to offer payment
in cash equal to 101% of the aggregate principal amount of Securities repurchased plus accrued and unpaid interest, if any, on the Securities
repurchased, to the date of repurchase (the &ldquo;<B>Change of Control Payment</B>&rdquo;), subject to the rights of Holders of Securities
on the relevant record date to receive interest due on the relevant Interest Payment Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Within 30 days following any
Change of Control Triggering Event or, at the Company&rsquo;s option, prior to any Change of Control but after the public announcement
of the pending Change of Control, the Company will be required to send, or cause the Trustee to send on the Company&rsquo;s behalf and
at the Company&rsquo;s sole expense, by first class mail or in accordance with applicable depositary procedures, a notice to Holders of
Securities describing the transaction or transactions that constitute or may constitute the Change of Control Triggering Event and offering
to repurchase the Securities on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days
from the date such notice is sent (the &ldquo;<B>Change of Control Payment Date</B>&rdquo;), pursuant to the procedures required herein
and described in such notice. The Company must comply with the requirements of Rule 14e-1 under the Securities Exchange Act of 1934, as
amended (the &ldquo;<B>Exchange Act</B>&rdquo;), and any other securities laws and regulations thereunder to the extent those laws and
regulations are applicable in connection with the repurchase of the Securities as a result of a Change of Control Triggering Event. To
the extent that the provisions of any securities laws or regulations conflict with the Change of Control provisions herein, the Company
will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations
under the Change of Control provisions herein by virtue of such conflicts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On the Change of Control Payment
Date, the Company will be required, to the extent lawful, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) accept for payment all
Securities or portions of Securities properly tendered, and not validly withdrawn, pursuant to the Change of Control Offer;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) no later than 11:00 a.m.
New York City time, deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Securities or portions
of Securities properly tendered and not validly withdrawn; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) deliver or cause to be
delivered to the Trustee the Securities properly accepted together with an Officers&rsquo; Certificate stating the aggregate principal
amount of Securities or portions of Securities being purchased by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Paying Agent will be required
to send promptly to each Holder who properly tendered Securities the purchase price for such Securities and the Trustee will be required
to authenticate and send (or cause to be transferred by book entry) promptly to each such Holder a new Security equal in principal amount
to any unpurchased portion of the Securities surrendered, if any, <I>provided</I> that each new Security will be in a principal amount
of $2,000 or an integral multiple of $1,000 in excess thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing,
the Company will not be required to make a Change of Control Offer with respect to the Securities upon the occurrence of a Change of Control
Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for
such an offer made by the Company and the third party purchases all such Securities properly tendered and not validly withdrawn under
its offer. Further, the Company will not be required to repurchase any Securities if there has occurred and is continuing on the Change
of Control Payment Date an Event of Default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Holders of not less than
90% in aggregate principal amount of the outstanding Notes of any series validly tender and do not withdraw such notes in a Change of
Control Offer and the Company, or any third party making such an offer in lieu of the Company as described above, purchases all of such
notes validly tendered and not withdrawn by such Holders, the Company or such third party will have the right, upon not less than 30 days
nor more than 60 days&rsquo; prior notice, provided that such notice is given not more than 30 days following such repurchase pursuant
to the Change of Control Offer described above, to redeem all Notes of such series that remain outstanding following such purchase on
a date specified in such notice (the &ldquo;Second Change of Control Payment Date&rdquo;) and at a price in cash equal to 101% of the
aggregate principal amount of the notes repurchased plus any accrued and unpaid interest on the Notes repurchased to, but not including,
the Second Change of Control Payment Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of the foregoing
discussion of a repurchase at the option of Holders, the following definitions are applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Capital Stock</B>&rdquo;
means the capital stock of every class whether now or hereafter authorized, regardless of whether such capital stock shall be limited
to a fixed sum or percentage with respect to the rights of the holders thereof to participate in dividends and in the distribution of
assets upon the voluntary or involuntary liquidation, dissolution or winding up of such corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Change of Control</B>&rdquo;
means the occurrence of any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;the
direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or more
series of related transactions, of all or substantially all of the Company&rsquo;s assets and the assets of its Subsidiaries, taken as
a whole, to any &ldquo;person&rdquo; (as that term is used in Section 13(d)(3) of the Exchange Act), other than the Company or one of
its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;the
consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any &ldquo;person&rdquo;
(as that term is used in Section 13(d)(3) of the Exchange Act) other than the Company or one of its Subsidiaries, becomes the &ldquo;beneficial
owner&rdquo; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of more than 50% of the Company&rsquo;s then outstanding
Voting Stock or other Voting Stock into which the Company&rsquo;s Voting Stock is reclassified, consolidated, exchanged or changed, measured
by voting power rather than number of shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;the
Company consolidates, or merges with or into any person, or any person consolidates with, or merges with or into, the Company, in any
such event pursuant to a transaction in which any of its Voting Stock or the Voting Stock of such other person is converted into or exchanged
for cash, securities or other property, other than any such transaction where the shares of the Company&rsquo;s Voting Stock outstanding
immediately prior to such transaction constitute, or are converted into or exchanged for, a majority of the Voting Stock of the surviving
person or any direct or indirect parent company of the surviving person immediately after giving effect to such transaction; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;the
adoption of a plan relating to the Company&rsquo;s liquidation or dissolution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding paragraphs
(a), (b) and (c) above, a transaction will not be considered to be a Change of Control if (a) the Company becomes a direct or indirect
wholly-owned subsidiary of a holding company and (b)(x) immediately following that transaction, the direct or indirect holders of the
Voting Stock of the holding company are substantially the same as the holders of the Company&rsquo;s Voting Stock immediately prior to
that transaction or (y) immediately following that transaction, no person is the beneficial owner, directly or indirectly, of more than
50% of the Voting Stock of such holding company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Change of Control
Triggering Event</B>&rdquo; means the occurrence of both a Change of Control and a Rating Event. Notwithstanding anything herein to the
contrary, no Change of Control Triggering Event will be deemed to have occurred in connection with (i) any particular Change of Control
unless and until such Change of Control has actually been consummated or (ii) any reduction in rating if the Rating Agencies making the
reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or inform the Trustee in writing
at its request that the reduction was the result of any event or circumstance comprised of or arising as a result of, or in respect of,
a Change of Control (whether or not the Change of Control shall have occurred at the time of the reduction in rating).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investment Grade</B>&rdquo;
means a rating of Baa3 or better by Moody&rsquo;s (or its equivalent under any successor rating categories of Moody&rsquo;s) and a rating
of BBB- or better by S&amp;P (or its equivalent under any successor rating categories of S&amp;P) or the equivalent investment grade credit
rating from any additional Rating Agency or Rating Agencies selected by the Company in accordance with the definition of &ldquo;Rating
Agencies.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Moody&rsquo;s</B>&rdquo;
means Moody&rsquo;s Investors Service, Inc., a subsidiary of Moody&rsquo;s Corporation, and its successors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Rating Agencies</B>&rdquo;
means (a) each of Moody&rsquo;s and S&amp;P; and (b) if any of Moody&rsquo;s or S&amp;P ceases to rate the Securities or fails to make
a rating of the Securities publicly available for reasons outside of the Company&rsquo;s control, a &ldquo;nationally recognized statistical
rating organization&rdquo; within the meaning of Section 3(a)(62) of the Exchange Act that is selected by the Company (as certified by
a resolution of the Company&rsquo;s board of directors) as a replacement agency for Moody&rsquo;s or S&amp;P, or both of them, as the
case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Rating Event</B>&rdquo;
means, with respect to the Securities, the rating on the Securities is lowered below Investment Grade by each of the Rating Agencies then
providing a rating for such Securities on any date beginning on the date of public notice of an arrangement that could result in a Change
of Control until the end of the 60-day period following public notice of the occurrence of the Change of Control (which 60-day period
shall be extended so long as the rating of such Securities is under publicly announced consideration for possible downgrade by any of
the Rating Agencies, such extension to last with respect to each such Rating Agency until the date on which such Rating Agency considering
such possible downgrade either (x) rates such Securities below Investment Grade or (y) publicly announces that it is no longer considering
such Securities for possible downgrade).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>S&amp;P</B>&rdquo;
means Standard &amp; Poor&rsquo;s Ratings Services, a division of The McGraw-Hill Companies, Inc., and its successors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Voting Stock</B>&rdquo;
means, with respect to any specified person as of any date, the Capital Stock of such person that is at the time entitled to vote generally
in the election of the board of directors of such person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture contains provisions
for defeasance at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect
to this Security, in each case upon compliance with certain conditions set forth in the Indenture, which provisions apply to this Security.
This Security is not subject to repayment at the Holder&rsquo;s option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No reference herein to the
Indenture and no provision of this Security or the Indenture shall affect or impair the obligation of the Company, which is absolute and
unconditional, to pay the principal of, premium, if any, and interest on this Security at the respective due dates, place and rate, and
in the Currency herein prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Default and Remedies</I>.
If an Event of Default with respect to Securities of this series shall occur and be continuing, the principal of the Securities of this
series may be declared due and payable in the manner and with the effect provided in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Amendment, Modification
and Waiver</I>. The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the
rights and obligations of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture
at any time by the Company and the Trustee with the consent of the Holders of a majority in principal amount of the Securities at the
time outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages
in principal amount of the Securities of each series at the time outstanding, on behalf of the Holders of all Securities of such series,
to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences.
Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders
of this Security and of any Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether
or not notation of such consent or waiver is made upon this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Denominations; Transfer
and Exchange</I>. As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security is
registrable in the records of the Registrar, upon surrender of this Security for registration of transfer at the office or agency of the
Company in any place where the principal of and any premium and interest on this Security are payable, duly endorsed by, or accompanied
by a written instrument of transfer in form satisfactory to the Company and the Registrar duly executed by, the Holder hereof or the Holder&rsquo;s
attorney duly authorized in writing, and thereupon one or more new Securities of this series and of like tenor, of authorized denominations
and for the same aggregate principal amount, will be issued to the designated transferee or transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
are issuable only in registered form in denominations of $2,000 and any integral multiple of $1,000 in excess thereof. As provided in
the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal
amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder surrendering
the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No service charge shall be
made to a Holder for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any
tax or other governmental charge payable in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Persons Deemed Owners</I>.
Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee
may treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security be overdue,
and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Miscellaneous</I>. <B>The
Indenture and the Securities, including this Security, shall be governed by and construed in accordance with the laws of the State of
New York.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All terms used in this Security
and not defined herein shall have the meanings assigned to them in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to a recommendation
promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused &ldquo;CUSIP&rdquo; numbers to be printed
on the Securities as a convenience to the Holders of the Securities. No representation is made as to the correctness or accuracy of such
CUSIP numbers as printed on the Securities, and reliance may be placed only on the other identification numbers printed hereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the certificate of
authentication hereon has been executed by or on behalf of the Trustee by manual signature, this Security shall not be entitled to any
benefit under the Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FOR VALUE RECEIVED, the undersigned hereby<BR>
sells, assigns and transfers unto</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PLEASE INSERT SOCIAL SECURITY OR OTHER
IDENTIFYING NUMBER OF ASSIGNEE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">(Please Print or Typewrite Name and Address, including Zip Code, of Assignee)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">the within Security of Gilead Sciences, Inc. and________________ hereby does irrevocably constitute and appoint</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">Attorney to transfer said Security on the books of the within-named Company with full power of substitution in the premises</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">Dated:</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">Signature</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="4" STYLE="text-align: justify">NOTICE: The signature to this assignment must correspond with the name as it appears on the first page of the within Security in every particular, without alteration or enlargement or any change whatever.</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">Signature<BR>
Guaranteed:</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="4" STYLE="text-align: justify">NOTICE: Signature(s) must be guaranteed by an &ldquo;<I>eligible guarantor institution</I>&rdquo; that is a member or participant in a &ldquo;<I>signature guarantee program</I>&rdquo; (e.g., the Securities Transfer Agents Medallion Program, the Stock Exchange Medallion Program and the New York Stock Exchange Medallion Program).</TD></TR>
  <TR>
    <TD STYLE="width: 14%"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 13%"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 48%"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 25%"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE OF INCREASES OR DECREASES IN GLOBAL SECURITY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following increases or
decreases in this Global Security have been made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: left">Date of Exchange</TD><TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center">Amount of <BR>
increase in<BR>
 Principal <BR>
Amount of this <BR>
Global Security</TD><TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center">Amount of <BR>
decrease in <BR>
Principal<BR>
 Amount of this <BR>
Global Security</TD><TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center">Principal <BR>
Amount of this <BR>
Global Security <BR>
following such<BR>
 decrease or <BR>
increase</TD><TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center">Signature of<BR>
 authorized <BR>
signatory of<BR>
 Trustee</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>EXHIBIT B</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 27; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM OF 2035 NOTE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS SECURITY IS A GLOBAL
SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE OF THE
DEPOSITARY WHICH MAY BE TREATED BY THE COMPANY, THE TRUSTEE OR ANY AGENT THEREOF AS OWNER AND HOLDER OF THIS SECURITY FOR ALL PURPOSES.
THIS SECURITY MAY NOT BE EXCHANGED IN WHOLE OR IN PART FOR A SECURITY REGISTERED, AND NO TRANSFER OF THIS SECURITY IN WHOLE OR IN PART
MAY BE REGISTERED, IN THE NAME OF ANY PERSON OTHER THAN SUCH DEPOSITARY OR A NOMINEE THEREOF, EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED
IN THE INDENTURE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">UNLESS THIS CERTIFICATE IS
PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&ldquo;<B>DTC</B>&rdquo;), TO THE ISSUER
OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE &amp; CO.
OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE &amp; CO. OR TO SUCH OTHER
ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR
TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &amp; CO., HAS AN INTEREST HEREIN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">GILEAD SCIENCES, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 50%">No. ___ </TD>
  <TD STYLE="text-align: right; width: 50%">CUSIP NO. 375558 CC5<BR>
$______________</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Interest</I>. Gilead Sciences,
Inc., a corporation duly incorporated and existing under the laws of the State of Delaware (herein called the &ldquo;<B>Company</B>&rdquo;,
which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to Cede
 &amp; Co., or registered assigns, the principal sum of _____________ DOLLARS ($_________), as revised by the Schedule of Increases or
Decreases in Global Security attached hereto, on June 15, 2035 and to pay interest thereon from November 20, 2024 or from the most recent
2035 Notes Interest Payment Date to which interest has been paid or duly provided for, semi-annually on June 15 and December 15, in each
year, commencing June 15, 2025 at the interest rate of 5.10% per annum, until the principal hereof is paid or made available for payment.
The amount of interest payable for any semi-annual period will be computed on the basis of a 360-day year consisting of twelve 30-day
months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Method of Payment</I>.
The interest so payable, and punctually paid or duly provided for, on any 2035 Notes Interest Payment Date will, as provided in such Indenture,
be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on the
Regular Record Date for such interest, which shall be the June 1 or December 1 (whether or not a Business Day), as the case may be, next
preceding such Interest Payment Date. Any such interest not so punctually paid or duly provided for will forthwith cease to be payable
to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Security (or one or more Predecessor
Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed by
the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such Special Record
Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange on which the
Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said
Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payment of the principal of
(and premium, if any) and interest on this Security will be made at the office or agency of the Trustee maintained for that purpose in
the continental United States, in such coin or currency of the United States of America as at the time of payment is legal tender for
payment of public and private debts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is hereby made to
the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same
effect as if set forth at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Authentication</I>. Unless
the certificate of authentication hereon has been executed by the Trustee referred to on the reverse hereof by manual signature, this
Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the Company has caused this instrument to be duly executed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><B>GILEAD SCIENCES, INC.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Name:&#9;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Title:&#9;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Global 2035 Note]</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[FORM OF CERTIFICATION OF AUTHENTICATION]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CERTIFICATE OF AUTHENTICATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This is one of the Securities
of the series designated therein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Date of authentication:</TD>
    <TD COLSPAN="2" STYLE="text-align: left"><B>COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION,</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">as Trustee</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Authorized Signatory</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[FORM OF REVERSE OF 2035 NOTE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Indenture</I>. This Security
is one of a duly authorized issue of securities of the Company (herein called the &ldquo;<B>Securities</B>&rdquo;), issued and to be issued
in one or more series under an Indenture, dated as of March 30, 2011 (as heretofore supplemented, herein called the &ldquo;<B>Base Indenture</B>&rdquo;,
which term shall have the meaning assigned to it in such instrument), as supplemented by a Tenth Supplemental Indenture dated as of November
20, 2024 (herein called the &ldquo;<B>Tenth Supplemental Indenture</B>&rdquo;, and together with the Base Indenture, the &ldquo;<B>Indenture</B>&rdquo;),
between the Company and Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National Association, as
Trustee (herein called the &ldquo;<B>Trustee</B>&rdquo;, which term includes any successor trustee under the Indenture), and reference
is hereby made to the Indenture for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the
Company, the Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are to be, authenticated and
delivered. This Security is one of the series designated on the face hereof, initially limited in aggregate principal amount to $1,000,000,000.
The Company may at any time issue additional securities under the Indenture in unlimited amounts having the same terms as the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Optional Redemption</I>.
The Securities of this series are subject to redemption at the Company&rsquo;s option, at any time and from time to time, in whole or
in part, prior to the Par Call Date (as defined below), upon not less than 10 nor more than 60 days&rsquo; notice mailed or electronically
delivered (or otherwise transmitted in accordance with the depositary&rsquo;s procedures) to each Holder of Securities to be redeemed
at his address as it appears in the records of the Registrar, on any date prior to their Stated Maturity at a Redemption Price (expressed
as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a) the sum of the present values
of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming the Securities matured
on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined
below) plus 15 basis points, less (b) interest accrued to the Redemption Date; and (ii) 100% of the principal amount of the Securities
to be redeemed; plus, in either case, accrued and unpaid interest thereon to the Redemption Date (the &ldquo;<B>Redemption Price</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any time on or after March
15, 2035 (the &ldquo;<B>Par Call Date</B>&rdquo;), the Company may redeem the Securities of this series at the Company&rsquo;s option,
in whole or in part, at any time and from time to time, at a Redemption Price equal to 100% of the principal amount of the Securities
to be redeemed, plus accrued and unpaid interest on the Securities being redeemed to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of determining
the Redemption Price, the following definition is applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Treasury Rate</B>&rdquo;
means, with respect to any Redemption Date, the yield determined by the Company in accordance with the following two paragraphs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Treasury Rate shall be
determined by the Company after 4:15 p.m., New York City time (or after such time as yields on U.S. government securities are posted daily
by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the Redemption Date based upon the yield
or yields for the most recent day that appear after such time on such day in the most recent statistical release published by the Board
of Governors of the Federal Reserve System designated as &ldquo;Selected Interest Rates (Daily) - H.15&rdquo; (or any successor designation
or publication) (&ldquo;H.15&rdquo;) under the caption &ldquo;U.S. government securities&ndash;Treasury constant maturities&ndash;Nominal&rdquo;
(or any successor caption or heading). In determining the Treasury Rate, the Company shall select, as applicable: (1) the yield for the
Treasury constant maturity on H.15 exactly equal to the period from the Redemption Date to the Par Call Date (the &ldquo;Remaining Life&rdquo;);
or (2) if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields &ndash; one yield corresponding
to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15
immediately longer than the Remaining Life &ndash; and shall interpolate to the Par Call Date on a straight-line basis (using the actual
number of days) using such yields and rounding the result to three decimal places; or (3) if there is no such Treasury constant maturity
on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining
Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity
date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the Redemption Date.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If on the third Business Day
preceding the Redemption Date H.15 or any successor designation or publication is no longer published, the Company shall calculate the
Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on
the second Business Day preceding such Redemption Date of the United States Treasury security maturing on, or with a maturity that is
closest to, the Par Call Date, as applicable. If there is no United States Treasury security maturing on the Par Call Date but there are
two or more United States Treasury securities with a maturity date equally distant from the Par Call Date, one with a maturity date preceding
the Par Call Date and one with a maturity date following the Par Call Date, the Company shall select the United States Treasury security
with a maturity date preceding the Par Call Date. If there are two or more United States Treasury securities maturing on the Par Call
Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among
these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the
average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury
Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security
shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City
time, of such United States Treasury security, and rounded to three decimal places.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s actions
and determinations in determining the Redemption Price shall be conclusive and binding for all purposes, absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the case of a partial redemption,
selection of the Securities for redemption will be made pro rata, by lot or by such other method as the Trustee deems appropriate and
fair. No Securities of a principal amount of $2,000 or less will be redeemed in part. If any Security is to be redeemed in part only,
the notice of redemption that relates to the Security will state the portion of the principal amount of the Security to be redeemed. A
new Security in a principal amount equal to the unredeemed portion of the Security will be issued in the name of the holder of the Security
upon surrender for cancellation of the original Security. For so long as the Securities are held by DTC (or another depositary), the redemption
of the Securities shall be done in accordance with the policies and procedures of the depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the Company defaults
in payment of the Redemption Price, on and after the Redemption Date interest will cease to accrue on the Securities or portions thereof
called for redemption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of redemption
of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed portion hereof will be
issued in the name of the Holder hereof upon the cancellation hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Change of Control</I>.
If a Change of Control Triggering Event occurs, unless the Company has exercised its right to redeem the Securities as described in &ldquo;Optional
Redemption&rdquo; above, the Company will be required to make an offer to repurchase all, or any part (equal to $2,000 or an integral
multiple of $1,000 in excess thereof), of each Holder&rsquo;s Securities pursuant to the offer described below (the &ldquo;<B>Change of
Control Offer</B>&rdquo;) on the terms set forth herein. In the Change of Control Offer, the Company will be required to offer payment
in cash equal to 101% of the aggregate principal amount of Securities repurchased plus accrued and unpaid interest, if any, on the Securities
repurchased, to the date of repurchase (the &ldquo;<B>Change of Control Payment</B>&rdquo;), subject to the rights of Holders of Securities
on the relevant record date to receive interest due on the relevant Interest Payment Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Within 30 days following any
Change of Control Triggering Event or, at the Company&rsquo;s option, prior to any Change of Control but after the public announcement
of the pending Change of Control, the Company will be required to send, or cause the Trustee to send on the Company&rsquo;s behalf and
at the Company&rsquo;s sole expense, by first class mail or in accordance with applicable depositary procedures, a notice to Holders of
Securities describing the transaction or transactions that constitute or may constitute the Change of Control Triggering Event and offering
to repurchase the Securities on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days
from the date such notice is sent (the &ldquo;<B>Change of Control Payment Date</B>&rdquo;), pursuant to the procedures required herein
and described in such notice. The Company must comply with the requirements of Rule 14e-1 under the Securities Exchange Act of 1934, as
amended (the &ldquo;<B>Exchange Act</B>&rdquo;), and any other securities laws and regulations thereunder to the extent those laws and
regulations are applicable in connection with the repurchase of the Securities as a result of a Change of Control Triggering Event. To
the extent that the provisions of any securities laws or regulations conflict with the Change of Control provisions herein, the Company
will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations
under the Change of Control provisions herein by virtue of such conflicts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On the Change of Control Payment
Date, the Company will be required, to the extent lawful, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) accept for payment all
Securities or portions of Securities properly tendered, and not validly withdrawn, pursuant to the Change of Control Offer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) no later than 11:00 a.m.
New York City time, deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Securities or portions
of Securities properly tendered and not validly withdrawn; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) deliver or cause to be
delivered to the Trustee the Securities properly accepted together with an Officers&rsquo; Certificate stating the aggregate principal
amount of Securities or portions of Securities being purchased by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Paying Agent will be required
to send promptly to each Holder who properly tendered Securities the purchase price for such Securities and the Trustee will be required
to authenticate and send (or cause to be transferred by book entry) promptly to each such Holder a new Security equal in principal amount
to any unpurchased portion of the Securities surrendered, if any, <I>provided</I> that each new Security will be in a principal amount
of $2,000 or an integral multiple of $1,000 in excess thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing,
the Company will not be required to make a Change of Control Offer with respect to the Securities upon the occurrence of a Change of Control
Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for
such an offer made by the Company and the third party purchases all such Securities properly tendered and not validly withdrawn under
its offer. Further, the Company will not be required to repurchase any Securities if there has occurred and is continuing on the Change
of Control Payment Date an Event of Default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Holders of not less than
90% in aggregate principal amount of the outstanding Notes of any series validly tender and do not withdraw such notes in a Change of
Control Offer and the Company, or any third party making such an offer in lieu of the Company as described above, purchases all of such
notes validly tendered and not withdrawn by such Holders, the Company or such third party will have the right, upon not less than 30 days
nor more than 60 days&rsquo; prior notice, provided that such notice is given not more than 30 days following such repurchase pursuant
to the Change of Control Offer described above, to redeem all Notes of such series that remain outstanding following such purchase on
a date specified in such notice (the &ldquo;Second Change of Control Payment Date&rdquo;) and at a price in cash equal to 101% of the
aggregate principal amount of the notes repurchased plus any accrued and unpaid interest on the Notes repurchased to, but not including,
the Second Change of Control Payment Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of the foregoing
discussion of a repurchase at the option of Holders, the following definitions are applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Capital Stock</B>&rdquo;
means the capital stock of every class whether now or hereafter authorized, regardless of whether such capital stock shall be limited
to a fixed sum or percentage with respect to the rights of the holders thereof to participate in dividends and in the distribution of
assets upon the voluntary or involuntary liquidation, dissolution or winding up of such corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Change of Control</B>&rdquo;
means the occurrence of any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;the
direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or more
series of related transactions, of all or substantially all of the Company&rsquo;s assets and the assets of its Subsidiaries, taken as
a whole, to any &ldquo;person&rdquo; (as that term is used in Section 13(d)(3) of the Exchange Act), other than the Company or one of
its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;the
consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any &ldquo;person&rdquo;
(as that term is used in Section 13(d)(3) of the Exchange Act) other than the Company or one of its Subsidiaries, becomes the &ldquo;beneficial
owner&rdquo; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of more than 50% of the Company&rsquo;s then outstanding
Voting Stock or other Voting Stock into which the Company&rsquo;s Voting Stock is reclassified, consolidated, exchanged or changed, measured
by voting power rather than number of shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;the
Company consolidates, or merges with or into any person, or any person consolidates with, or merges with or into, the Company, in any
such event pursuant to a transaction in which any of its Voting Stock or the Voting Stock of such other person is converted into or exchanged
for cash, securities or other property, other than any such transaction where the shares of the Company&rsquo;s Voting Stock outstanding
immediately prior to such transaction constitute, or are converted into or exchanged for, a majority of the Voting Stock of the surviving
person or any direct or indirect parent company of the surviving person immediately after giving effect to such transaction; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;the
adoption of a plan relating to the Company&rsquo;s liquidation or dissolution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding paragraphs
(a), (b) and (c) above, a transaction will not be considered to be a Change of Control if (a) the Company becomes a direct or indirect
wholly-owned subsidiary of a holding company and (b)(x) immediately following that transaction, the direct or indirect holders of the
Voting Stock of the holding company are substantially the same as the holders of the Company&rsquo;s Voting Stock immediately prior to
that transaction or (y) immediately following that transaction, no person is the beneficial owner, directly or indirectly, of more than
50% of the Voting Stock of such holding company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Change of Control
Triggering Event</B>&rdquo; means the occurrence of both a Change of Control and a Rating Event. Notwithstanding anything herein to the
contrary, no Change of Control Triggering Event will be deemed to have occurred in connection with (i) any particular Change of Control
unless and until such Change of Control has actually been consummated or (ii) any reduction in rating if the Rating Agencies making the
reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or inform the Trustee in writing
at its request that the reduction was the result of any event or circumstance comprised of or arising as a result of, or in respect of,
a Change of Control (whether or not the Change of Control shall have occurred at the time of the reduction in rating).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investment Grade</B>&rdquo;
means a rating of Baa3 or better by Moody&rsquo;s (or its equivalent under any successor rating categories of Moody&rsquo;s) and a rating
of BBB- or better by S&amp;P (or its equivalent under any successor rating categories of S&amp;P) or the equivalent investment grade credit
rating from any additional Rating Agency or Rating Agencies selected by the Company in accordance with the definition of &ldquo;Rating
Agencies.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Moody&rsquo;s</B>&rdquo;
means Moody&rsquo;s Investors Service, Inc., a subsidiary of Moody&rsquo;s Corporation, and its successors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Rating Agencies</B>&rdquo;
means (a) each of Moody&rsquo;s and S&amp;P; and (b) if any of Moody&rsquo;s or S&amp;P ceases to rate the Securities or fails to make
a rating of the Securities publicly available for reasons outside of the Company&rsquo;s control, a &ldquo;nationally recognized statistical
rating organization&rdquo; within the meaning of Section 3(a)(62) of the Exchange Act that is selected by the Company (as certified by
a resolution of the Company&rsquo;s board of directors) as a replacement agency for Moody&rsquo;s or S&amp;P, or both of them, as the
case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Rating Event</B>&rdquo;
means, with respect to the Securities, the rating on the Securities is lowered below Investment Grade by each of the Rating Agencies then
providing a rating for such Securities on any date beginning on the date of public notice of an arrangement that could result in a Change
of Control until the end of the 60-day period following public notice of the occurrence of the Change of Control (which 60-day period
shall be extended so long as the rating of such Securities is under publicly announced consideration for possible downgrade by any of
the Rating Agencies, such extension to last with respect to each such Rating Agency until the date on which such Rating Agency considering
such possible downgrade either (x) rates such Securities below Investment Grade or (y) publicly announces that it is no longer considering
such Securities for possible downgrade).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>S&amp;P</B>&rdquo;
means Standard &amp; Poor&rsquo;s Ratings Services, a division of The McGraw-Hill Companies, Inc., and its successors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Voting Stock</B>&rdquo;
means, with respect to any specified person as of any date, the Capital Stock of such person that is at the time entitled to vote generally
in the election of the board of directors of such person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture contains provisions
for defeasance at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect
to this Security, in each case upon compliance with certain conditions set forth in the Indenture, which provisions apply to this Security.
This Security is not subject to repayment at the Holder&rsquo;s option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No reference herein to the
Indenture and no provision of this Security or the Indenture shall affect or impair the obligation of the Company, which is absolute and
unconditional, to pay the principal of, premium, if any, and interest on this Security at the respective due dates, place and rate, and
in the Currency herein prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Default and Remedies</I>.
If an Event of Default with respect to Securities of this series shall occur and be continuing, the principal of the Securities of this
series may be declared due and payable in the manner and with the effect provided in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Amendment, Modification
and Waiver</I>. The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the
rights and obligations of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture
at any time by the Company and the Trustee with the consent of the Holders of a majority in principal amount of the Securities at the
time outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages
in principal amount of the Securities of each series at the time outstanding, on behalf of the Holders of all Securities of such series,
to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences.
Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders
of this Security and of any Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether
or not notation of such consent or waiver is made upon this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Denominations; Transfer
and Exchange</I>. As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security is
registrable in the records of the Registrar, upon surrender of this Security for registration of transfer at the office or agency of the
Company in any place where the principal of and any premium and interest on this Security are payable, duly endorsed by, or accompanied
by a written instrument of transfer in form satisfactory to the Company and the Registrar duly executed by, the Holder hereof or the Holder&rsquo;s
attorney duly authorized in writing, and thereupon one or more new Securities of this series and of like tenor, of authorized denominations
and for the same aggregate principal amount, will be issued to the designated transferee or transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
are issuable only in registered form in denominations of $2,000 and any integral multiple of $1,000 in excess thereof. As provided in
the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal
amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder surrendering
the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No service charge shall be
made to a Holder for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any
tax or other governmental charge payable in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Persons Deemed Owners</I>.
Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee
may treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security be overdue,
and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Miscellaneous</I>. <B>The
Indenture and the Securities, including this Security, shall be governed by and construed in accordance with the laws of the State of
New York.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All terms used in this Security
and not defined herein shall have the meanings assigned to them in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to a recommendation
promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused &ldquo;CUSIP&rdquo; numbers to be printed
on the Securities as a convenience to the Holders of the Securities. No representation is made as to the correctness or accuracy of such
CUSIP numbers as printed on the Securities, and reliance may be placed only on the other identification numbers printed hereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the certificate of
authentication hereon has been executed by or on behalf of the Trustee by manual signature, this Security shall not be entitled to any
benefit under the Indenture or be valid or obligatory for any purpose.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FOR VALUE RECEIVED, the undersigned hereby<BR>
sells, assigns and transfers unto</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING
NUMBER OF ASSIGNEE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">(Please Print or Typewrite Name and Address, including Zip Code, of Assignee)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">the within Security of Gilead Sciences, Inc. and________________ hereby does irrevocably constitute and appoint</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">Attorney to transfer said Security on the books of the within-named Company with full power of substitution in the premises</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">Dated:</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">Signature</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="4" STYLE="text-align: justify">NOTICE: The signature to this assignment must correspond with the name as it appears on the first page of the within Security in every particular, without alteration or enlargement or any change whatever.</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">Signature<BR>
Guaranteed:</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="4" STYLE="text-align: justify">NOTICE: Signature(s) must be guaranteed by an &ldquo;<I>eligible guarantor institution</I>&rdquo; that is a member or participant in a &ldquo;<I>signature guarantee program</I>&rdquo; (e.g., the Securities Transfer Agents Medallion Program, the Stock Exchange Medallion Program and the New York Stock Exchange Medallion Program).</TD></TR>
  <TR>
    <TD STYLE="width: 14%"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 13%"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 48%"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 25%"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE OF INCREASES OR DECREASES IN GLOBAL SECURITY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following increases or
decreases in this Global Security have been made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: justify">Date of Exchange</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center">Amount of <BR>
increase in<BR>
 Principal <BR>
Amount of this <BR>
Global Security</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center">Amount of <BR>
decrease in <BR>
Principal<BR>
 Amount of this <BR>
Global Security</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center">Principal <BR>
Amount of this <BR>
Global Security <BR>
following such<BR>
 decrease or <BR>
increase</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center">Signature of<BR>
 authorized <BR>
signatory of<BR>
 Trustee</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>EXHIBIT C</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 41; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM OF 2054 NOTE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS SECURITY IS A GLOBAL
SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE OF THE
DEPOSITARY WHICH MAY BE TREATED BY THE COMPANY, THE TRUSTEE OR ANY AGENT THEREOF AS OWNER AND HOLDER OF THIS SECURITY FOR ALL PURPOSES.
THIS SECURITY MAY NOT BE EXCHANGED IN WHOLE OR IN PART FOR A SECURITY REGISTERED, AND NO TRANSFER OF THIS SECURITY IN WHOLE OR IN PART
MAY BE REGISTERED, IN THE NAME OF ANY PERSON OTHER THAN SUCH DEPOSITARY OR A NOMINEE THEREOF, EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED
IN THE INDENTURE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">UNLESS THIS CERTIFICATE IS
PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&ldquo;<B>DTC</B>&rdquo;), TO THE ISSUER
OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE &amp; CO.
OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE &amp; CO. OR TO SUCH OTHER
ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR
TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &amp; CO., HAS AN INTEREST HEREIN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">GILEAD SCIENCES, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: justify">No. ___</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: right">CUSIP NO. 375558 CD3</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">$______________</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Interest</I>. Gilead Sciences,
Inc., a corporation duly incorporated and existing under the laws of the State of Delaware (herein called the &ldquo;<B>Company</B>&rdquo;,
which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to Cede
 &amp; Co., or registered assigns, the principal sum of _____________ DOLLARS ($_________), as revised by the Schedule of Increases or
Decreases in Global Security attached hereto, on November 15, 2054 and to pay interest thereon from November 20, 2024 or from the most
recent 2054 Notes Interest Payment Date to which interest has been paid or duly provided for, semi-annually on May 15 and November 15,
in each year, commencing May 15, 2025 at the interest rate of 5.50% per annum, until the principal hereof is paid or made available for
payment. The amount of interest payable for any semi-annual period will be computed on the basis of a 360-day year consisting of twelve
30-day months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Method of Payment</I>.
The interest so payable, and punctually paid or duly provided for, on any 2054 Notes Interest Payment Date will, as provided in such Indenture,
be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on the
Regular Record Date for such interest, which shall be the May 1 or November 1 (whether or not a Business Day), as the case may be, next
preceding such Interest Payment Date. Any such interest not so punctually paid or duly provided for will forthwith cease to be payable
to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Security (or one or more Predecessor
Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed by
the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such Special Record
Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange on which the
Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said
Indenture.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payment of the principal of
(and premium, if any) and interest on this Security will be made at the office or agency of the Trustee maintained for that purpose in
the continental United States, in such coin or currency of the United States of America as at the time of payment is legal tender for
payment of public and private debts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is hereby made to
the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same
effect as if set forth at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Authentication</I>. Unless
the certificate of authentication hereon has been executed by the Trustee referred to on the reverse hereof by manual signature, this
Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the Company has caused this instrument to be duly executed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><B>GILEAD SCIENCES, INC.</B></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 3%; text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; width: 47%; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Name:&#9;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Title:&#9;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Global 2054 Note]</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[FORM OF CERTIFICATION OF AUTHENTICATION]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CERTIFICATE OF AUTHENTICATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This is one of the Securities
of the series designated therein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Date of authentication:</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: left"><B>COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION,</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: left">as Trustee</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Authorized Signatory</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[FORM OF REVERSE OF 2054 NOTE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Indenture</I>. This Security
is one of a duly authorized issue of securities of the Company (herein called the &ldquo;<B>Securities</B>&rdquo;), issued and to be issued
in one or more series under an Indenture, dated as of March 30, 2011 (as heretofore supplemented, herein called the &ldquo;<B>Base Indenture</B>&rdquo;,
which term shall have the meaning assigned to it in such instrument), as supplemented by a Tenth Supplemental Indenture dated as of November
20, 2024 (herein called the &ldquo;<B>Tenth Supplemental Indenture</B>&rdquo;, and together with the Base Indenture, the &ldquo;<B>Indenture</B>&rdquo;),
between the Company and Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National Association, as
Trustee (herein called the &ldquo;<B>Trustee</B>&rdquo;, which term includes any successor trustee under the Indenture), and reference
is hereby made to the Indenture for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the
Company, the Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are to be, authenticated and
delivered. This Security is one of the series designated on the face hereof, initially limited in aggregate principal amount to $1,000,000,000.
The Company may at any time issue additional securities under the Indenture in unlimited amounts having the same terms as the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Optional Redemption</I>.
The Securities of this series are subject to redemption at the Company&rsquo;s option, at any time and from time to time, in whole or
in part, prior to the Par Call Date (as defined below), upon not less than 10 nor more than 60 days&rsquo; notice mailed or electronically
delivered (or otherwise transmitted in accordance with the depositary&rsquo;s procedures) to each Holder of Securities to be redeemed
at his address as it appears in the records of the Registrar, on any date prior to their Stated Maturity at a Redemption Price (expressed
as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a) the sum of the present values
of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming the Securities matured
on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined
below) plus 15 basis points, less (b) interest accrued to the Redemption Date; and (ii) 100% of the principal amount of the Securities
to be redeemed; plus, in either case, accrued and unpaid interest thereon to the Redemption Date (the &ldquo;<B>Redemption Price</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any time on or after May
15, 2054 (the &ldquo;<B>Par Call Date</B>&rdquo;), the Company may redeem the Securities of this series at the Company&rsquo;s option,
in whole or in part, at any time and from time to time, at a Redemption Price equal to 100% of the principal amount of the Securities
to be redeemed, plus accrued and unpaid interest on the Securities being redeemed to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of determining
the Redemption Price, the following definition is applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Treasury Rate</B>&rdquo;
means, with respect to any Redemption Date, the yield determined by the Company in accordance with the following two paragraphs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Treasury Rate shall be
determined by the Company after 4:15 p.m., New York City time (or after such time as yields on U.S. government securities are posted daily
by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the Redemption Date based upon the yield
or yields for the most recent day that appear after such time on such day in the most recent statistical release published by the Board
of Governors of the Federal Reserve System designated as &ldquo;Selected Interest Rates (Daily) - H.15&rdquo; (or any successor designation
or publication) (&ldquo;H.15&rdquo;) under the caption &ldquo;U.S. government securities&ndash;Treasury constant maturities&ndash;Nominal&rdquo;
(or any successor caption or heading). In determining the Treasury Rate, the Company shall select, as applicable: (1) the yield for the
Treasury constant maturity on H.15 exactly equal to the period from the Redemption Date to the Par Call Date (the &ldquo;Remaining Life&rdquo;);
or (2) if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields &ndash; one yield corresponding
to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15
immediately longer than the Remaining Life &ndash; and shall interpolate to the Par Call Date on a straight-line basis (using the actual
number of days) using such yields and rounding the result to three decimal places; or (3) if there is no such Treasury constant maturity
on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining
Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity
date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the Redemption Date.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If on the third Business Day
preceding the Redemption Date H.15 or any successor designation or publication is no longer published, the Company shall calculate the
Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on
the second Business Day preceding such Redemption Date of the United States Treasury security maturing on, or with a maturity that is
closest to, the Par Call Date, as applicable. If there is no United States Treasury security maturing on the Par Call Date but there are
two or more United States Treasury securities with a maturity date equally distant from the Par Call Date, one with a maturity date preceding
the Par Call Date and one with a maturity date following the Par Call Date, the Company shall select the United States Treasury security
with a maturity date preceding the Par Call Date. If there are two or more United States Treasury securities maturing on the Par Call
Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among
these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the
average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury
Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security
shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City
time, of such United States Treasury security, and rounded to three decimal places.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s actions
and determinations in determining the Redemption Price shall be conclusive and binding for all purposes, absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the case of a partial redemption,
selection of the Securities for redemption will be made pro rata, by lot or by such other method as the Trustee deems appropriate and
fair. No Securities of a principal amount of $2,000 or less will be redeemed in part. If any Security is to be redeemed in part only,
the notice of redemption that relates to the Security will state the portion of the principal amount of the Security to be redeemed. A
new Security in a principal amount equal to the unredeemed portion of the Security will be issued in the name of the holder of the Security
upon surrender for cancellation of the original Security. For so long as the Securities are held by DTC (or another depositary), the redemption
of the Securities shall be done in accordance with the policies and procedures of the depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the Company defaults
in payment of the Redemption Price, on and after the Redemption Date interest will cease to accrue on the Securities or portions thereof
called for redemption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of redemption
of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed portion hereof will be
issued in the name of the Holder hereof upon the cancellation hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Change of Control</I>.
If a Change of Control Triggering Event occurs, unless the Company has exercised its right to redeem the Securities as described in &ldquo;Optional
Redemption&rdquo; above, the Company will be required to make an offer to repurchase all, or any part (equal to $2,000 or an integral
multiple of $1,000 in excess thereof), of each Holder&rsquo;s Securities pursuant to the offer described below (the &ldquo;<B>Change of
Control Offer</B>&rdquo;) on the terms set forth herein. In the Change of Control Offer, the Company will be required to offer payment
in cash equal to 101% of the aggregate principal amount of Securities repurchased plus accrued and unpaid interest, if any, on the Securities
repurchased, to the date of repurchase (the &ldquo;<B>Change of Control Payment</B>&rdquo;), subject to the rights of Holders of Securities
on the relevant record date to receive interest due on the relevant Interest Payment Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Within 30 days following any
Change of Control Triggering Event or, at the Company&rsquo;s option, prior to any Change of Control but after the public announcement
of the pending Change of Control, the Company will be required to send, or cause the Trustee to send on the Company&rsquo;s behalf and
at the Company&rsquo;s sole expense, by first class mail or in accordance with applicable depositary procedures, a notice to Holders of
Securities describing the transaction or transactions that constitute or may constitute the Change of Control Triggering Event and offering
to repurchase the Securities on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days
from the date such notice is sent (the &ldquo;<B>Change of Control Payment Date</B>&rdquo;), pursuant to the procedures required herein
and described in such notice. The Company must comply with the requirements of Rule 14e-1 under the Securities Exchange Act of 1934, as
amended (the &ldquo;<B>Exchange Act</B>&rdquo;), and any other securities laws and regulations thereunder to the extent those laws and
regulations are applicable in connection with the repurchase of the Securities as a result of a Change of Control Triggering Event. To
the extent that the provisions of any securities laws or regulations conflict with the Change of Control provisions herein, the Company
will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations
under the Change of Control provisions herein by virtue of such conflicts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On the Change of Control Payment
Date, the Company will be required, to the extent lawful, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) accept for payment all
Securities or portions of Securities properly tendered, and not validly withdrawn, pursuant to the Change of Control Offer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) no later than 11:00 a.m.
New York City time, deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Securities or portions
of Securities properly tendered and not validly withdrawn; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) deliver or cause to be
delivered to the Trustee the Securities properly accepted together with an Officers&rsquo; Certificate stating the aggregate principal
amount of Securities or portions of Securities being purchased by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Paying Agent will be required
to send promptly to each Holder who properly tendered Securities the purchase price for such Securities and the Trustee will be required
to authenticate and send (or cause to be transferred by book entry) promptly to each such Holder a new Security equal in principal amount
to any unpurchased portion of the Securities surrendered, if any, <I>provided</I> that each new Security will be in a principal amount
of $2,000 or an integral multiple of $1,000 in excess thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing,
the Company will not be required to make a Change of Control Offer with respect to the Securities upon the occurrence of a Change of Control
Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for
such an offer made by the Company and the third party purchases all such Securities properly tendered and not validly withdrawn under
its offer. Further, the Company will not be required to repurchase any Securities if there has occurred and is continuing on the Change
of Control Payment Date an Event of Default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Holders of not less than
90% in aggregate principal amount of the outstanding Notes of any series validly tender and do not withdraw such notes in a Change of
Control Offer and the Company, or any third party making such an offer in lieu of the Company as described above, purchases all of such
notes validly tendered and not withdrawn by such Holders, the Company or such third party will have the right, upon not less than 30 days
nor more than 60 days&rsquo; prior notice, provided that such notice is given not more than 30 days following such repurchase pursuant
to the Change of Control Offer described above, to redeem all Notes of such series that remain outstanding following such purchase on
a date specified in such notice (the &ldquo;Second Change of Control Payment Date&rdquo;) and at a price in cash equal to 101% of the
aggregate principal amount of the notes repurchased plus any accrued and unpaid interest on the Notes repurchased to, but not including,
the Second Change of Control Payment Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of the foregoing
discussion of a repurchase at the option of Holders, the following definitions are applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Capital Stock</B>&rdquo;
means the capital stock of every class whether now or hereafter authorized, regardless of whether such capital stock shall be limited
to a fixed sum or percentage with respect to the rights of the holders thereof to participate in dividends and in the distribution of
assets upon the voluntary or involuntary liquidation, dissolution or winding up of such corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Change of Control</B>&rdquo;
means the occurrence of any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or more
series of related transactions, of all or substantially all of the Company&rsquo;s assets and the assets of its Subsidiaries, taken as
a whole, to any &ldquo;person&rdquo; (as that term is used in Section 13(d)(3) of the Exchange Act), other than the Company or one of
its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any &ldquo;person&rdquo;
(as that term is used in Section 13(d)(3) of the Exchange Act) other than the Company or one of its Subsidiaries, becomes the &ldquo;beneficial
owner&rdquo; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of more than 50% of the Company&rsquo;s then outstanding
Voting Stock or other Voting Stock into which the Company&rsquo;s Voting Stock is reclassified, consolidated, exchanged or changed, measured
by voting power rather than number of shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company consolidates, or merges with or into any person, or any person consolidates with, or merges with or into, the Company, in any
such event pursuant to a transaction in which any of its Voting Stock or the Voting Stock of such other person is converted into or exchanged
for cash, securities or other property, other than any such transaction where the shares of the Company&rsquo;s Voting Stock outstanding
immediately prior to such transaction constitute, or are converted into or exchanged for, a majority of the Voting Stock of the surviving
person or any direct or indirect parent company of the surviving person immediately after giving effect to such transaction; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
adoption of a plan relating to the Company&rsquo;s liquidation or dissolution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding paragraphs
(a), (b) and (c) above, a transaction will not be considered to be a Change of Control if (a) the Company becomes a direct or indirect
wholly-owned subsidiary of a holding company and (b)(x) immediately following that transaction, the direct or indirect holders of the
Voting Stock of the holding company are substantially the same as the holders of the Company&rsquo;s Voting Stock immediately prior to
that transaction or (y) immediately following that transaction, no person is the beneficial owner, directly or indirectly, of more than
50% of the Voting Stock of such holding company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Change of Control
Triggering Event</B>&rdquo; means the occurrence of both a Change of Control and a Rating Event. Notwithstanding anything herein to the
contrary, no Change of Control Triggering Event will be deemed to have occurred in connection with (i) any particular Change of Control
unless and until such Change of Control has actually been consummated or (ii) any reduction in rating if the Rating Agencies making the
reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or inform the Trustee in writing
at its request that the reduction was the result of any event or circumstance comprised of or arising as a result of, or in respect of,
a Change of Control (whether or not the Change of Control shall have occurred at the time of the reduction in rating).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investment Grade</B>&rdquo;
means a rating of Baa3 or better by Moody&rsquo;s (or its equivalent under any successor rating categories of Moody&rsquo;s) and a rating
of BBB- or better by S&amp;P (or its equivalent under any successor rating categories of S&amp;P) or the equivalent investment grade credit
rating from any additional Rating Agency or Rating Agencies selected by the Company in accordance with the definition of &ldquo;Rating
Agencies.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Moody&rsquo;s</B>&rdquo;
means Moody&rsquo;s Investors Service, Inc., a subsidiary of Moody&rsquo;s Corporation, and its successors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Rating Agencies</B>&rdquo;
means (a) each of Moody&rsquo;s and S&amp;P; and (b) if any of Moody&rsquo;s or S&amp;P ceases to rate the Securities or fails to make
a rating of the Securities publicly available for reasons outside of the Company&rsquo;s control, a &ldquo;nationally recognized statistical
rating organization&rdquo; within the meaning of Section 3(a)(62) of the Exchange Act that is selected by the Company (as certified by
a resolution of the Company&rsquo;s board of directors) as a replacement agency for Moody&rsquo;s or S&amp;P, or both of them, as the
case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Rating Event</B>&rdquo;
means, with respect to the Securities, the rating on the Securities is lowered below Investment Grade by each of the Rating Agencies then
providing a rating for such Securities on any date beginning on the date of public notice of an arrangement that could result in a Change
of Control until the end of the 60-day period following public notice of the occurrence of the Change of Control (which 60-day period
shall be extended so long as the rating of such Securities is under publicly announced consideration for possible downgrade by any of
the Rating Agencies, such extension to last with respect to each such Rating Agency until the date on which such Rating Agency considering
such possible downgrade either (x) rates such Securities below Investment Grade or (y) publicly announces that it is no longer considering
such Securities for possible downgrade).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>S&amp;P</B>&rdquo;
means Standard &amp; Poor&rsquo;s Ratings Services, a division of The McGraw-Hill Companies, Inc., and its successors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Voting Stock</B>&rdquo;
means, with respect to any specified person as of any date, the Capital Stock of such person that is at the time entitled to vote generally
in the election of the board of directors of such person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture contains provisions
for defeasance at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect
to this Security, in each case upon compliance with certain conditions set forth in the Indenture, which provisions apply to this Security.
This Security is not subject to repayment at the Holder&rsquo;s option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No reference herein to the
Indenture and no provision of this Security or the Indenture shall affect or impair the obligation of the Company, which is absolute and
unconditional, to pay the principal of, premium, if any, and interest on this Security at the respective due dates, place and rate, and
in the Currency herein prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Default and Remedies</I>.
If an Event of Default with respect to Securities of this series shall occur and be continuing, the principal of the Securities of this
series may be declared due and payable in the manner and with the effect provided in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Amendment, Modification
and Waiver</I>. The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the
rights and obligations of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture
at any time by the Company and the Trustee with the consent of the Holders of a majority in principal amount of the Securities at the
time outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages
in principal amount of the Securities of each series at the time outstanding, on behalf of the Holders of all Securities of such series,
to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences.
Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders
of this Security and of any Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether
or not notation of such consent or waiver is made upon this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Denominations; Transfer
and Exchange</I>. As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security is
registrable in the records of the Registrar, upon surrender of this Security for registration of transfer at the office or agency of the
Company in any place where the principal of and any premium and interest on this Security are payable, duly endorsed by, or accompanied
by a written instrument of transfer in form satisfactory to the Company and the Registrar duly executed by, the Holder hereof or the Holder&rsquo;s
attorney duly authorized in writing, and thereupon one or more new Securities of this series and of like tenor, of authorized denominations
and for the same aggregate principal amount, will be issued to the designated transferee or transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
are issuable only in registered form in denominations of $2,000 and any integral multiple of $1,000 in excess thereof. As provided in
the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal
amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder surrendering
the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No service charge shall be
made to a Holder for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any
tax or other governmental charge payable in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Persons Deemed Owners</I>.
Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee
may treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security be overdue,
and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Miscellaneous</I>. <B>The
Indenture and the Securities, including this Security, shall be governed by and construed in accordance with the laws of the State of
New York.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All terms used in this Security
and not defined herein shall have the meanings assigned to them in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to a recommendation
promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused &ldquo;CUSIP&rdquo; numbers to be printed
on the Securities as a convenience to the Holders of the Securities. No representation is made as to the correctness or accuracy of such
CUSIP numbers as printed on the Securities, and reliance may be placed only on the other identification numbers printed hereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the certificate of
authentication hereon has been executed by or on behalf of the Trustee by manual signature, this Security shall not be entitled to any
benefit under the Indenture or be valid or obligatory for any purpose.<BR STYLE="clear: both">
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FOR VALUE RECEIVED, the undersigned hereby<BR>
sells, assigns and transfers unto</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING
NUMBER OF ASSIGNEE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">(Please Print or Typewrite Name and Address, including Zip Code, of Assignee)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">the within Security of Gilead Sciences, Inc. and________________ hereby does irrevocably constitute and appoint</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">Attorney to transfer said Security on the books of the within-named Company with full power of substitution in the premises</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">Dated:</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">Signature</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="4" STYLE="text-align: justify">NOTICE: The signature to this assignment must correspond with the name as it appears on the first page of the within Security in every particular, without alteration or enlargement or any change whatever.</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">Signature<BR>
Guaranteed:</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="4" STYLE="text-align: justify">NOTICE: Signature(s) must be guaranteed by an &ldquo;<I>eligible guarantor institution</I>&rdquo; that is a member or participant in a &ldquo;<I>signature guarantee program</I>&rdquo; (e.g., the Securities Transfer Agents Medallion Program, the Stock Exchange Medallion Program and the New York Stock Exchange Medallion Program).</TD></TR>
  <TR>
    <TD STYLE="width: 14%"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 13%"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 48%"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 25%"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE OF INCREASES OR DECREASES IN GLOBAL SECURITY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following increases or
decreases in this Global Security have been made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: justify">Date of Exchange</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center">Amount of <BR>
increase in<BR>
 Principal <BR>
Amount of this <BR>
Global Security</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center">Amount of <BR>
decrease in <BR>
Principal<BR>
 Amount of this <BR>
Global Security</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center">Principal <BR>
Amount of this <BR>
Global Security <BR>
following such<BR>
 decrease or <BR>
increase</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center">Signature of<BR>
 authorized <BR>
signatory of<BR>
 Trustee</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>EXHIBIT D</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 55; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM OF 2064 NOTE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS SECURITY IS A GLOBAL
SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE OF THE
DEPOSITARY WHICH MAY BE TREATED BY THE COMPANY, THE TRUSTEE OR ANY AGENT THEREOF AS OWNER AND HOLDER OF THIS SECURITY FOR ALL PURPOSES.
THIS SECURITY MAY NOT BE EXCHANGED IN WHOLE OR IN PART FOR A SECURITY REGISTERED, AND NO TRANSFER OF THIS SECURITY IN WHOLE OR IN PART
MAY BE REGISTERED, IN THE NAME OF ANY PERSON OTHER THAN SUCH DEPOSITARY OR A NOMINEE THEREOF, EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED
IN THE INDENTURE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">UNLESS THIS CERTIFICATE IS
PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&ldquo;<B>DTC</B>&rdquo;), TO THE ISSUER
OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE &amp; CO.
OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE &amp; CO. OR TO SUCH OTHER
ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR
TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &amp; CO., HAS AN INTEREST HEREIN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">GILEAD SCIENCES, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">No. ___</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: right">CUSIP NO. 375558 CE1</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">$______________</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Interest</I>. Gilead Sciences,
Inc., a corporation duly incorporated and existing under the laws of the State of Delaware (herein called the &ldquo;<B>Company</B>&rdquo;,
which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to Cede
 &amp; Co., or registered assigns, the principal sum of _____________ DOLLARS ($_________), as revised by the Schedule of Increases or
Decreases in Global Security attached hereto, on November 15, 2064 and to pay interest thereon from November 20, 2024 or from the most
recent 2064 Notes Interest Payment Date to which interest has been paid or duly provided for, semi-annually on May 15 and November 15,
in each year, commencing May 15, 2025 at the interest rate of 5.60% per annum, until the principal hereof is paid or made available for
payment. The amount of interest payable for any semi-annual period will be computed on the basis of a 360-day year consisting of twelve
30-day months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Method of Payment</I>.
The interest so payable, and punctually paid or duly provided for, on any 2064 Notes Interest Payment Date will, as provided in such Indenture,
be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on the
Regular Record Date for such interest, which shall be the May 1 or November 1 (whether or not a Business Day), as the case may be, next
preceding such Interest Payment Date. Any such interest not so punctually paid or duly provided for will forthwith cease to be payable
to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Security (or one or more Predecessor
Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed by
the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such Special Record
Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange on which the
Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said
Indenture.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payment of the principal of
(and premium, if any) and interest on this Security will be made at the office or agency of the Trustee maintained for that purpose in
the continental United States, in such coin or currency of the United States of America as at the time of payment is legal tender for
payment of public and private debts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is hereby made to
the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same
effect as if set forth at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Authentication</I>. Unless
the certificate of authentication hereon has been executed by the Trustee referred to on the reverse hereof by manual signature, this
Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the Company has caused this instrument to be duly executed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify"><B>GILEAD SCIENCES, INC.</B></TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 3%; text-align: justify">By:</TD>
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid; width: 47%; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Name:&#9;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">Title:&#9;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Global 2064 Note]</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[FORM OF CERTIFICATION OF AUTHENTICATION]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CERTIFICATE OF AUTHENTICATION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This is one of the Securities
of the series designated therein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">Date of authentication:</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: left"><B>COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION, </B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: left">as Trustee</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 3%; text-align: justify">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 47%; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">Authorized Signatory</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[FORM OF REVERSE OF 2064 NOTE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Indenture</I>. This Security
is one of a duly authorized issue of securities of the Company (herein called the &ldquo;<B>Securities</B>&rdquo;), issued and to be issued
in one or more series under an Indenture, dated as of March 30, 2011 (as heretofore supplemented, herein called the &ldquo;<B>Base Indenture</B>&rdquo;,
which term shall have the meaning assigned to it in such instrument), as supplemented by a Tenth Supplemental Indenture dated as of November
20, 2024 (herein called the &ldquo;<B>Tenth Supplemental Indenture</B>&rdquo;, and together with the Base Indenture, the &ldquo;<B>Indenture</B>&rdquo;),
between the Company and Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National Association, as
Trustee (herein called the &ldquo;<B>Trustee</B>&rdquo;, which term includes any successor trustee under the Indenture), and reference
is hereby made to the Indenture for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the
Company, the Trustee and the Holders of the Securities and of the terms upon which the Securities are, and are to be, authenticated and
delivered. This Security is one of the series designated on the face hereof, initially limited in aggregate principal amount to $750,000,000.
The Company may at any time issue additional securities under the Indenture in unlimited amounts having the same terms as the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Optional Redemption</I>.
The Securities of this series are subject to redemption at the Company&rsquo;s option, at any time and from time to time, in whole or
in part, prior to the Par Call Date (as defined below), upon not less than 10 nor more than 60 days&rsquo; notice mailed or electronically
delivered (or otherwise transmitted in accordance with the depositary&rsquo;s procedures) to each Holder of Securities to be redeemed
at his address as it appears in the records of the Registrar, on any date prior to their Stated Maturity at a Redemption Price (expressed
as a percentage of principal amount and rounded to three decimal places) equal to the greater of (i) (a) the sum of the present values
of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming the Securities matured
on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined
below) plus 15 basis points, less (b) interest accrued to the Redemption Date; and (ii) 100% of the principal amount of the Securities
to be redeemed; plus, in either case, accrued and unpaid interest thereon to the Redemption Date (the &ldquo;<B>Redemption Price</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any time on or after May
15, 2064 (the &ldquo;<B>Par Call Date</B>&rdquo;), the Company may redeem the Securities of this series at the Company&rsquo;s option,
in whole or in part, at any time and from time to time, at a Redemption Price equal to 100% of the principal amount of the Securities
to be redeemed, plus accrued and unpaid interest on the Securities being redeemed to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of determining
the Redemption Price, the following definition is applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Treasury Rate</B>&rdquo;
means, with respect to any Redemption Date, the yield determined by the Company in accordance with the following two paragraphs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Treasury Rate shall be
determined by the Company after 4:15 p.m., New York City time (or after such time as yields on U.S. government securities are posted daily
by the Board of Governors of the Federal Reserve System), on the third Business Day preceding the Redemption Date based upon the yield
or yields for the most recent day that appear after such time on such day in the most recent statistical release published by the Board
of Governors of the Federal Reserve System designated as &ldquo;Selected Interest Rates (Daily) - H.15&rdquo; (or any successor designation
or publication) (&ldquo;H.15&rdquo;) under the caption &ldquo;U.S. government securities&ndash;Treasury constant maturities&ndash;Nominal&rdquo;
(or any successor caption or heading). In determining the Treasury Rate, the Company shall select, as applicable: (1) the yield for the
Treasury constant maturity on H.15 exactly equal to the period from the Redemption Date to the Par Call Date (the &ldquo;Remaining Life&rdquo;);
or (2) if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields &ndash; one yield corresponding
to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15
immediately longer than the Remaining Life &ndash; and shall interpolate to the Par Call Date on a straight-line basis (using the actual
number of days) using such yields and rounding the result to three decimal places; or (3) if there is no such Treasury constant maturity
on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining
Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity
date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the Redemption Date.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If on the third Business Day
preceding the Redemption Date H.15 or any successor designation or publication is no longer published, the Company shall calculate the
Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on
the second Business Day preceding such Redemption Date of the United States Treasury security maturing on, or with a maturity that is
closest to, the Par Call Date, as applicable. If there is no United States Treasury security maturing on the Par Call Date but there are
two or more United States Treasury securities with a maturity date equally distant from the Par Call Date, one with a maturity date preceding
the Par Call Date and one with a maturity date following the Par Call Date, the Company shall select the United States Treasury security
with a maturity date preceding the Par Call Date. If there are two or more United States Treasury securities maturing on the Par Call
Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among
these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the
average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time. In determining the Treasury
Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security
shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New York City
time, of such United States Treasury security, and rounded to three decimal places.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s actions
and determinations in determining the Redemption Price shall be conclusive and binding for all purposes, absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the case of a partial redemption,
selection of the Securities for redemption will be made pro rata, by lot or by such other method as the Trustee deems appropriate and
fair. No Securities of a principal amount of $2,000 or less will be redeemed in part. If any Security is to be redeemed in part only,
the notice of redemption that relates to the Security will state the portion of the principal amount of the Security to be redeemed. A
new Security in a principal amount equal to the unredeemed portion of the Security will be issued in the name of the holder of the Security
upon surrender for cancellation of the original Security. For so long as the Securities are held by DTC (or another depositary), the redemption
of the Securities shall be done in accordance with the policies and procedures of the depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the Company defaults
in payment of the Redemption Price, on and after the Redemption Date interest will cease to accrue on the Securities or portions thereof
called for redemption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of redemption
of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed portion hereof will be
issued in the name of the Holder hereof upon the cancellation hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Change of Control</I>.
If a Change of Control Triggering Event occurs, unless the Company has exercised its right to redeem the Securities as described in &ldquo;Optional
Redemption&rdquo; above, the Company will be required to make an offer to repurchase all, or any part (equal to $2,000 or an integral
multiple of $1,000 in excess thereof), of each Holder&rsquo;s Securities pursuant to the offer described below (the &ldquo;<B>Change of
Control Offer</B>&rdquo;) on the terms set forth herein. In the Change of Control Offer, the Company will be required to offer payment
in cash equal to 101% of the aggregate principal amount of Securities repurchased plus accrued and unpaid interest, if any, on the Securities
repurchased, to the date of repurchase (the &ldquo;<B>Change of Control Payment</B>&rdquo;), subject to the rights of Holders of Securities
on the relevant record date to receive interest due on the relevant Interest Payment Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Within 30 days following any
Change of Control Triggering Event or, at the Company&rsquo;s option, prior to any Change of Control but after the public announcement
of the pending Change of Control, the Company will be required to send, or cause the Trustee to send on the Company&rsquo;s behalf and
at the Company&rsquo;s sole expense, by first class mail or in accordance with applicable depositary procedures, a notice to Holders of
Securities describing the transaction or transactions that constitute or may constitute the Change of Control Triggering Event and offering
to repurchase the Securities on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days
from the date such notice is sent (the &ldquo;<B>Change of Control Payment Date</B>&rdquo;), pursuant to the procedures required herein
and described in such notice. The Company must comply with the requirements of Rule 14e-1 under the Securities Exchange Act of 1934, as
amended (the &ldquo;<B>Exchange Act</B>&rdquo;), and any other securities laws and regulations thereunder to the extent those laws and
regulations are applicable in connection with the repurchase of the Securities as a result of a Change of Control Triggering Event. To
the extent that the provisions of any securities laws or regulations conflict with the Change of Control provisions herein, the Company
will be required to comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations
under the Change of Control provisions herein by virtue of such conflicts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On the Change of Control Payment
Date, the Company will be required, to the extent lawful, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) accept for payment all
Securities or portions of Securities properly tendered, and not validly withdrawn, pursuant to the Change of Control Offer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) no later than 11:00 a.m.
New York City time, deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all Securities or portions
of Securities properly tendered and not validly withdrawn; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) deliver or cause to be
delivered to the Trustee the Securities properly accepted together with an Officers&rsquo; Certificate stating the aggregate principal
amount of Securities or portions of Securities being purchased by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Paying Agent will be required
to send promptly to each Holder who properly tendered Securities the purchase price for such Securities and the Trustee will be required
to authenticate and send (or cause to be transferred by book entry) promptly to each such Holder a new Security equal in principal amount
to any unpurchased portion of the Securities surrendered, if any, <I>provided</I> that each new Security will be in a principal amount
of $2,000 or an integral multiple of $1,000 in excess thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing,
the Company will not be required to make a Change of Control Offer with respect to the Securities upon the occurrence of a Change of Control
Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for
such an offer made by the Company and the third party purchases all such Securities properly tendered and not validly withdrawn under
its offer. Further, the Company will not be required to repurchase any Securities if there has occurred and is continuing on the Change
of Control Payment Date an Event of Default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Holders of not less than
90% in aggregate principal amount of the outstanding Notes of any series validly tender and do not withdraw such notes in a Change of
Control Offer and the Company, or any third party making such an offer in lieu of the Company as described above, purchases all of such
notes validly tendered and not withdrawn by such Holders, the Company or such third party will have the right, upon not less than 30 days
nor more than 60 days&rsquo; prior notice, provided that such notice is given not more than 30 days following such repurchase pursuant
to the Change of Control Offer described above, to redeem all Notes of such series that remain outstanding following such purchase on
a date specified in such notice (the &ldquo;Second Change of Control Payment Date&rdquo;) and at a price in cash equal to 101% of the
aggregate principal amount of the notes repurchased plus any accrued and unpaid interest on the Notes repurchased to, but not including,
the Second Change of Control Payment Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of the foregoing
discussion of a repurchase at the option of Holders, the following definitions are applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Capital Stock</B>&rdquo;
means the capital stock of every class whether now or hereafter authorized, regardless of whether such capital stock shall be limited
to a fixed sum or percentage with respect to the rights of the holders thereof to participate in dividends and in the distribution of
assets upon the voluntary or involuntary liquidation, dissolution or winding up of such corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Change of Control</B>&rdquo;
means the occurrence of any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or more
series of related transactions, of all or substantially all of the Company&rsquo;s assets and the assets of its Subsidiaries, taken as
a whole, to any &ldquo;person&rdquo; (as that term is used in Section 13(d)(3) of the Exchange Act), other than the Company or one of
its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any &ldquo;person&rdquo;
(as that term is used in Section 13(d)(3) of the Exchange Act) other than the Company or one of its Subsidiaries, becomes the &ldquo;beneficial
owner&rdquo; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of more than 50% of the Company&rsquo;s then outstanding
Voting Stock or other Voting Stock into which the Company&rsquo;s Voting Stock is reclassified, consolidated, exchanged or changed, measured
by voting power rather than number of shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Company consolidates, or merges with or into any person, or any person consolidates with, or merges with or into, the Company, in any
such event pursuant to a transaction in which any of its Voting Stock or the Voting Stock of such other person is converted into or exchanged
for cash, securities or other property, other than any such transaction where the shares of the Company&rsquo;s Voting Stock outstanding
immediately prior to such transaction constitute, or are converted into or exchanged for, a majority of the Voting Stock of the surviving
person or any direct or indirect parent company of the surviving person immediately after giving effect to such transaction; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
adoption of a plan relating to the Company&rsquo;s liquidation or dissolution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding paragraphs
(a), (b) and (c) above, a transaction will not be considered to be a Change of Control if (a) the Company becomes a direct or indirect
wholly-owned subsidiary of a holding company and (b)(x) immediately following that transaction, the direct or indirect holders of the
Voting Stock of the holding company are substantially the same as the holders of the Company&rsquo;s Voting Stock immediately prior to
that transaction or (y) immediately following that transaction, no person is the beneficial owner, directly or indirectly, of more than
50% of the Voting Stock of such holding company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Change of Control
Triggering Event</B>&rdquo; means the occurrence of both a Change of Control and a Rating Event. Notwithstanding anything herein to the
contrary, no Change of Control Triggering Event will be deemed to have occurred in connection with (i) any particular Change of Control
unless and until such Change of Control has actually been consummated or (ii) any reduction in rating if the Rating Agencies making the
reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or inform the Trustee in writing
at its request that the reduction was the result of any event or circumstance comprised of or arising as a result of, or in respect of,
a Change of Control (whether or not the Change of Control shall have occurred at the time of the reduction in rating).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investment Grade</B>&rdquo;
means a rating of Baa3 or better by Moody&rsquo;s (or its equivalent under any successor rating categories of Moody&rsquo;s) and a rating
of BBB- or better by S&amp;P (or its equivalent under any successor rating categories of S&amp;P) or the equivalent investment grade credit
rating from any additional Rating Agency or Rating Agencies selected by the Company in accordance with the definition of &ldquo;Rating
Agencies.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Moody&rsquo;s</B>&rdquo;
means Moody&rsquo;s Investors Service, Inc., a subsidiary of Moody&rsquo;s Corporation, and its successors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Rating Agencies</B>&rdquo;
means (a) each of Moody&rsquo;s and S&amp;P; and (b) if any of Moody&rsquo;s or S&amp;P ceases to rate the Securities or fails to make
a rating of the Securities publicly available for reasons outside of the Company&rsquo;s control, a &ldquo;nationally recognized statistical
rating organization&rdquo; within the meaning of Section 3(a)(62) of the Exchange Act that is selected by the Company (as certified by
a resolution of the Company&rsquo;s board of directors) as a replacement agency for Moody&rsquo;s or S&amp;P, or both of them, as the
case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Rating Event</B>&rdquo;
means, with respect to the Securities, the rating on the Securities is lowered below Investment Grade by each of the Rating Agencies then
providing a rating for such Securities on any date beginning on the date of public notice of an arrangement that could result in a Change
of Control until the end of the 60-day period following public notice of the occurrence of the Change of Control (which 60-day period
shall be extended so long as the rating of such Securities is under publicly announced consideration for possible downgrade by any of
the Rating Agencies, such extension to last with respect to each such Rating Agency until the date on which such Rating Agency considering
such possible downgrade either (x) rates such Securities below Investment Grade or (y) publicly announces that it is no longer considering
such Securities for possible downgrade).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>S&amp;P</B>&rdquo;
means Standard &amp; Poor&rsquo;s Ratings Services, a division of The McGraw-Hill Companies, Inc., and its successors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Voting Stock</B>&rdquo;
means, with respect to any specified person as of any date, the Capital Stock of such person that is at the time entitled to vote generally
in the election of the board of directors of such person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture contains provisions
for defeasance at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect
to this Security, in each case upon compliance with certain conditions set forth in the Indenture, which provisions apply to this Security.
This Security is not subject to repayment at the Holder&rsquo;s option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No reference herein to the
Indenture and no provision of this Security or the Indenture shall affect or impair the obligation of the Company, which is absolute and
unconditional, to pay the principal of, premium, if any, and interest on this Security at the respective due dates, place and rate, and
in the Currency herein prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Default and Remedies</I>.
If an Event of Default with respect to Securities of this series shall occur and be continuing, the principal of the Securities of this
series may be declared due and payable in the manner and with the effect provided in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Amendment, Modification
and Waiver</I>. The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the
rights and obligations of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture
at any time by the Company and the Trustee with the consent of the Holders of a majority in principal amount of the Securities at the
time outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages
in principal amount of the Securities of each series at the time outstanding, on behalf of the Holders of all Securities of such series,
to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences.
Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders
of this Security and of any Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether
or not notation of such consent or waiver is made upon this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Denominations; Transfer
and Exchange</I>. As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security is
registrable in the records of the Registrar, upon surrender of this Security for registration of transfer at the office or agency of the
Company in any place where the principal of and any premium and interest on this Security are payable, duly endorsed by, or accompanied
by a written instrument of transfer in form satisfactory to the Company and the Registrar duly executed by, the Holder hereof or the Holder&rsquo;s
attorney duly authorized in writing, and thereupon one or more new Securities of this series and of like tenor, of authorized denominations
and for the same aggregate principal amount, will be issued to the designated transferee or transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
are issuable only in registered form in denominations of $2,000 and any integral multiple of $1,000 in excess thereof. As provided in
the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal
amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder surrendering
the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No service charge shall be
made to a Holder for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any
tax or other governmental charge payable in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Persons Deemed Owners</I>.
Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee
may treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security be overdue,
and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Miscellaneous</I>. <B>The
Indenture and the Securities, including this Security, shall be governed by and construed in accordance with the laws of the State of
New York.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All terms used in this Security
and not defined herein shall have the meanings assigned to them in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to a recommendation
promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused &ldquo;CUSIP&rdquo; numbers to be printed
on the Securities as a convenience to the Holders of the Securities. No representation is made as to the correctness or accuracy of such
CUSIP numbers as printed on the Securities, and reliance may be placed only on the other identification numbers printed hereon.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the certificate of
authentication hereon has been executed by or on behalf of the Trustee by manual signature, this Security shall not be entitled to any
benefit under the Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FOR VALUE RECEIVED, the undersigned hereby<BR>
sells, assigns and transfers unto</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING
NUMBER OF ASSIGNEE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">(Please Print or Typewrite Name and Address, including Zip Code, of Assignee)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">the within Security of Gilead Sciences, Inc. and________________ hereby does irrevocably constitute and appoint</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">Attorney to transfer said Security on the books of the within-named Company with full power of substitution in the premises</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">Dated:</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">Signature</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="4" STYLE="text-align: justify">NOTICE: The signature to this assignment must correspond with the name as it appears on the first page of the within Security in every particular, without alteration or enlargement or any change whatever.</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">Signature<BR>
Guaranteed:</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="4" STYLE="text-align: justify">NOTICE: Signature(s) must be guaranteed by an &ldquo;<I>eligible guarantor institution</I>&rdquo; that is a member or participant in a &ldquo;<I>signature guarantee program</I>&rdquo; (e.g., the Securities Transfer Agents Medallion Program, the Stock Exchange Medallion Program and the New York Stock Exchange Medallion Program).</TD></TR>
  <TR>
    <TD STYLE="width: 14%"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 13%"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 48%"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 25%"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE OF INCREASES OR DECREASES IN GLOBAL SECURITY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following increases or
decreases in this Global Security have been made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: justify">Date of Exchange</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center">Amount of <BR>
increase in<BR>
 Principal <BR>
Amount of this <BR>
Global Security</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center">Amount of <BR>
decrease in <BR>
Principal<BR>
 Amount of this <BR>
Global Security</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center">Principal <BR>
Amount of this <BR>
Global Security <BR>
following such<BR>
 decrease or <BR>
increase</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: center">Signature of<BR>
 authorized <BR>
signatory of<BR>
 Trustee</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 68; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>tm2426602d4_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 0.05in; width: 20%">&nbsp;<IMG SRC="tm2426602d4_ex4-2img001.jpg" ALT=""></TD>
    <TD STYLE="padding-bottom: 0.05in; width: 28%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Davis Polk &amp; Wardwell <FONT STYLE="font-variant: small-caps">llp</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">450 Lexington Avenue<BR>
    New York, NY 10017</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">davispolk.com</P></TD>
    <TD STYLE="padding-bottom: 0.05in; width: 22%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 0.05in; text-align: right; text-transform: uppercase; width: 30%">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 20, 2024</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="width: 96%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Davis Polk &amp; Wardwell LLP</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Gilead Sciences, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">333 Lakeside Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Foster City, CA 94404</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">Gilead Sciences, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;),
has filed with the Securities and Exchange Commission a Registration Statement on Form S-3 (File No. 333-273745) (the &ldquo;<B>Registration
Statement</B>&rdquo;) for the purpose of registering under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;),
certain securities, including $750,000,000 aggregate principal amount of the Company&rsquo;s 4.80% Senior Notes due 2029 (the &ldquo;<B>2029
Notes</B>&rdquo;), $1,000,000,000 aggregate principal amount of the Company&rsquo;s 5.10% Senior Notes due 2035 (the &ldquo;<B>2035 Notes</B>&rdquo;),
$1,000,000,000 aggregate principal amount of the Company&rsquo;s 5.50% Senior Notes due 2054 (the &ldquo;<B>2054 Notes</B>&rdquo;) and
$750,000,000 aggregate principal amount of the Company&rsquo;s 5.60% Senior Notes due 2064 (the &ldquo;<B>2064 Notes</B>&rdquo; and, together
with the 2029 Notes, the 2035 Notes and the 2054 Notes, the &ldquo;<B>Securities</B>&rdquo;). The Securities are to be issued pursuant
to the provisions of the Base Indenture dated as of March 30, 2011 (the &ldquo;<B>Base Indenture</B>&rdquo;) between the Company and Computershare
Trust Company, National Association, as successor to Wells Fargo Bank, National Association, as trustee (the &ldquo;<B>Trustee</B>&rdquo;),
as supplemented by the Tenth Supplemental Indenture dated as of November 20, 2024 between the Company and the Trustee (together with the
Base Indenture, the &ldquo;<B>Indenture</B>&rdquo;). The Securities are to be sold pursuant to the Underwriting Agreement dated November
13, 2024 (the &ldquo;<B>Underwriting Agreement</B>&rdquo;) among the Company and the several underwriters named therein (the &ldquo;<B>Underwriters</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">We, as your counsel, have examined originals or copies of such documents,
corporate records, certificates of public officials and other instruments as we have deemed necessary or advisable for the purpose of
rendering this opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">In rendering the opinion expressed herein, we have, without independent
inquiry or investigation, assumed that (i) all documents submitted to us as originals are authentic and complete, (ii) all documents submitted
to us as copies conform to authentic, complete originals, (iii) all signatures on all documents that we reviewed are genuine, (iv) all
natural persons executing documents had and have the legal capacity to do so, (v) all statements in certificates of public officials and
officers of the Company that we reviewed were and are accurate and (vi) all representations made by the Company as to matters of fact
in the documents that we reviewed were and are accurate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the foregoing, and subject to the additional assumptions and qualifications set forth below, we advise you that, in our opinion,
when the Securities have been duly executed and authenticated in accordance with the provisions of the Indenture and delivered to and
paid for by the Underwriters pursuant to the Underwriting Agreement, the Securities will constitute</FONT> valid and binding obligations
of the Company, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors&rsquo;
rights generally, concepts of reasonableness and equitable principles of general applicability, provided that we express no opinion as
to, (x) the enforceability of any waiver of rights under any usury or stay law, (y) the effect of fraudulent conveyance, fraudulent transfer
or similar provision of applicable law on the conclusions expressed above or (z) the validity, legally binding effect or enforceability
of any provision that permits holders to collect any portion of stated principal amount upon acceleration of the Securities to the extent
determined to constitute unearned interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 0.05in; width: 21%"><IMG SRC="tm2426602d4_ex4-2img001.jpg" ALT=""></TD>
    <TD STYLE="padding-bottom: 0.05in; width: 27%">Gilead Sciences, Inc.</TD>
    <TD STYLE="padding-bottom: 0.05in; width: 22%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 0.05in; text-align: right; text-transform: uppercase; width: 30%">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">In addition, we have assumed that the Indenture and the Securities
(collectively, the &ldquo;<B>Documents</B>&rdquo;) are valid, binding and enforceable agreements of each party thereto (other than as
expressly covered above in respect of the Company). We have also assumed that the execution, delivery and performance by each party to
each Document to which it is a party (a) are within its corporate powers, (b) do not contravene, or constitute a default under, the certificate
of incorporation or bylaws or other constitutive documents of such party, (c) require no action by or in respect of, or filing with, any
governmental body, agency or official and (d) do not contravene, or constitute a default under, any provision of applicable law or regulation
or any judgment, injunction, order or decree or any agreement or other instrument binding upon such party, provided that we make no such
assumption to the extent that we have specifically opined as to such matters with respect to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are members of the Bar of the State of New York and the foregoing opinion is limited to the laws of the State of New York and the General
Corporation Law of the State of Delaware, except that we express no opinion as to any law, rule or regulation that is applicable to the
Company</FONT>, the Documents or such transactions solely because such law, rule or regulation is part of a regulatory regime applicable
to any party to any of the Documents or any of its affiliates due to the specific assets or business of such party or such affiliate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the filing of this opinion as an exhibit to a report on Form 8-K to be filed by the Company on the date hereof and its
incorporation by reference into the Registration Statement and further consent to the reference to our name under the caption</FONT> &ldquo;Legal
Matters&rdquo; in the prospectus supplement which is a part of the Registration Statement. In giving this consent, we do not admit that
we are in the category of persons whose consent is required under Section 7 of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Davis Polk &amp; Wardwell LLP</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection Last; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify"><TD STYLE="width: 50%; text-align: left">November 20, 2024</TD><TD STYLE="text-align: right; width: 50%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>gild-20241120.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWa+NCbOdzZR+aYkxtmB5bdlKvy4j+7xRciVF9GeG8RwD -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:GILD="http://gilead.com/20241120" elementFormDefault="qualified" targetNamespace="http://gilead.com/20241120">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://gilead.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="gild-20241120_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="gild-20241120_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>gild-20241120_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>gild-20241120_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://gilead.com/role/Cover" xlink:href="gild-20241120.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://gilead.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2426602d4_ex1-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2426602d4_ex1-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !- .4# 2(  A$! Q$!_\0
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M"H7=BSM-*6).23N[U6^*VJ?8O"@M$(WWLHC//.U?F)_,*/QJQ\+O^1'M^O\
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/N.F??&:T:* "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm2426602d4_ex4-2img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2426602d4_ex4-2img001.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  C '\# 2(  A$! Q$!_\0
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MBU?>%KSQ!_PDFH^$_!GA>XLK2Y\(>'O#2G3)+/P9:RW"WVG!_.>8@2QF26<
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M]]\0OAM<:AXAURS\<:>T7B%?$5Y:^']&\&:7X9T32M/T:RL+73^#^'7_  ;
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L-S<21+&"AR =A1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45709397685616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 20, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 20,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-19731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GILEAD SCIENCES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000882095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3047598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">333 Lakeside Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Foster City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">574-3000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GILD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
M\8%T693,?C]'!   ?1   !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R=
MF']OXC88Q]^*E4W3)K7-#T*!#I XH#=T/8Z5;B=MVA\F,6 UL7.V ^V[W^-
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M J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ \8%T69>*NQS
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M4$L! A0#%     @ \8%T60=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #Q@719;E)ID>T    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" #Q@719F5R<(Q &  "<)P  $P              @ '+ 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( /&!=%F4S'X_1P0  'T0   8
M      " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" #Q@719GZ ;\+$"  #B#   #0              @ &)#   >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( /&!=%F7BKL<P    !,"   +              "
M 64/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( /&!=%FJQ"(6,P$  "("   /
M              "  4X0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #Q
M@719)!Z;HJT   #X 0  &@              @ &N$0  >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #Q@71999!YDAD!  #/ P  $P
M            @ &3$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 )
+ #X"  #=$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2426602d4_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://gilead.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>gild-20241120.xsd</File>
    <File>gild-20241120_lab.xml</File>
    <File>gild-20241120_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2426602d4_8k.htm">tm2426602d4_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2426602d4_8k.htm": {
   "nsprefix": "GILD",
   "nsuri": "http://gilead.com/20241120",
   "dts": {
    "schema": {
     "local": [
      "gild-20241120.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "gild-20241120_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gild-20241120_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2426602d4_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://gilead.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2426602d4_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2426602d4_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://gilead.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001104659-24-121025-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-121025-xbrl.zip
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MDP2(_\_7@O_(+5(+W%/%9&(OZ0K _D@,I'Z&2=WC$)7WC4B@M+=2</R##_O
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M-]0)AFK<+,G2[BH\O!&S"9.DL1+B##MD7P\O3^?#G?CQ\Z%YQZ8&'YCVF#K
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MHB^D71,L.U#<&'X$ZP,F2(^74$FZ^=%M'/[XUM\LZUM30B/5SF6<MBZ><Q!
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MFAEFS.80>W/'"U3PS?NJ..3'T39SS(Q7=4/L?%<S*[,A B)"[D\C5 A'4W]
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MD>UMV86@H+\60-Y*R0U'(][P!%22BHFC9@+274^]ON<1&CJC,$-JA*G@:49
MP*BPU,T=:UH6A3NO)'T9*:K,X8W\.J8%8#=3]X7OX7"B:90$V=Q[K\^L\L)N
M9QH&0'IA %J?.5DY'C9#02>;M.W:#LT'=3PD<?PH9Z(M4M0%423!5L)/ WC
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M"K%3Z05_P0GDPX@VUDW)8:&!SN0REGPI#)^G-XG:/"=/BEB4>CD96DKH( 7
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M+42-W<I5N?*<ZBS7 &J3-F+2-)37"_.MO$B?%;_&PJ'68 $X%GKQ!AQ&L4Q
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M+?.HFM-&<.Z-K,V$)NGSDOX2W/BDA_N6#NY+J(9+MU,$]YYA"UIN.E2RI83
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M]>9<M0&M]PEB?!IV2TM5\ZY'/;29/D@B\PVPO/J*/H!<BTC4FHS4&:&0)7(
M*>2@MQ/LBG+#1+(5^N1J_J#>P??E$.H=/'J$'I)Y,U\3;XF3G<J,5&AB?+G!
M5U6,4FFS.>4HZL;.G)R-UURXQE"_3>GZDDJB4[>UG''5"^Z]<A3L]4YVPMW&
M1N"[6C<"2Q@V@F4*V.!DQ].?+)NVDJEF<KHJ98/$$%$4BNT>,99[+O&_*?E"
MFKN_L*1#,#IJ;L91+?R12AT-"#J_7U1=89P%VN*U?K!69X/&AI^LOQ(*OQV*
M;=GJUGTBG<3>K"AW5!3V?6"W*NF$ZZH2:D[=#M!M(+G6#.M-:?WHTD*=/([3
M&UHHR.XAK#"7 .@XR%B754=DJ,:E.I2[@R#+J!TM2+$0%3LWZ]1!\=69;LO)
ML%I/9=&?UT![6R&_6AC&?]=C&&=69V'%,)J+6.IH'$7P"0$&<@&R1Z :82QH
MP6EF$BGCWJI)U.>8ER-6G$G#%1A*J]*4E?;,1.P$O@,T5<?<HUBJPMML@)4T
MM*WOH (C1-; 5W;@!GG1IGLEVUD;3+$*7+_3Y)U=BM(%6/NQ&\LJ&SI 8Q-G
ME6"F=A/XA!0^BNHYTHF<<I [Y[L$WYAS$Q==<LQS*<@(DE;@&]J7U[OBWE"[
MT#9#G :ELVOO -M5JAV=I-19QI*DJY #5D?9A1$):B!64R/Q2:R\XF\81B.I
M,\W%8KC@V59;6'NK=[!>5LK:[6PJU6D##:E9L.#YWUTK:KOYT:(,ZR\K7W<"
M^:8G*JB9'/FH- _2J] \1S&:;6;Y0;!N*8]PU):Z RMP5,FOH!)M%,1T!_C'
MC*0W,H(Q=^LTK [I$0OAA"FHI'926&*J=V2-*LH_*9I-Q,4R16["[1*)V1IQ
MP)$<U<>>2#G'M"_CKI[1'1]L-39,OW_[N ?MV:]I$LZ!OY$RS*SNQC(5N+-F
M ZIS<V5*(/AE!E1(PI8H&@H.+=).-*4ZV=%4BW:077T*PYD*#F>:*U>=ZC0]
M].>@^PT?_442+3_:4MMP=1-ZH=(H(#U5&T5>$-J9V.R,<M(K'Z2-\<4\JJ66
MRJJ<(D%&#:=8*4^M_C;X73L!E,%9#/M5N."^]H2K3JN"E#Q4R41-(#G+DN9:
M"<$.A?#M-. ^+0E-&#1B))]EV#V^U?)58'Q4]"K(^E%!P-F80);&UY44)YWP
MVHB\T^ S;5PAJT<J>6XM;*!MYBN#P1?RE2OXF8A80;8E]:ULAQ=:X1Q8P\-N
M6OAXBN8#YOXB66& 72*O*D,.)(]&!%T5VI)<PPDVZZ),%0G=8/X)[&I8Z'P(
MM=)%UY)C(.8"J)DXF"!+<X_I&_M7^]YKU.<*^T4?43:6F5%]?J,=P3\K+GA&
M.K:V[WQ[ N^$5>FP]#G(TD$D#UV46 $3)/@TSN-?$>8+_A7FA1E/3< WN1F8
M[GQ-#7K-%JG;#K:#RY#<WM?J"_6(=\+!"/L8,;&>^B:85N'DS<\)?(!#"626
M<!P1SB>+**BHD2F= QX9XJU7O^@*8+N3&X8]Y#>L&2JLPF1U/KK.N5[>K*4#
MP9-Y<8@ETSID8&!;J8QQ"O:. N/'P#%EKZBQQ/"Q6DMZ?Z41QLX$<P^I)N&P
M'A\1-U9D8BT(A'^$C5MH!248.IRL+N)8^"]93M*'DJ^ O,5<&"O.21 #FAEL
M \M<,6+0^\XB!KW'B,%#DN##X?IXJP@/GHE"BX@S-D"-Y),N O8V]]\DF_@M
MC-*W2R1JB,.8YU)'I8Z*"@*?#?E,A:RS8*ZJF"@0#:PTK_BYY4G@H^I)YH1V
MS0JN'3FKE2]I!-TM6V+2J.B'F5MU0L:8FA.&-^<=#J_%SYE66P5W._2:B@[#
MGZ&-,T+1II8UJGY;+Z&I%KPZ):4;T>*LGJ2I- \RW7VJK5V=ZK^[S6C4J3\R
M@_60O;^SGBUA>!N.8)W3!T+RT8Q I/Y$NO,1S@^G23%DU8J:-GV#(?Y8>S&:
M$<$2! BTU0HN3#[8(#>(,%QBKGYK:_U8]WPJ-%+=^;L=D&8KM)@6(AF-=KVU
MJ>2*'?X<%FB&,, [2;[Z=H% C) =^W:,,^7DHJ7 &8, =&_2H*V[C_1D3X[*
MSL%&F)6FP('5=3&6OI^3'H_78P=X>Y#C_MYR%>OY!1H""HXBA"E1=(5\6.P(
M(V%^$\;Q'IKY('+I;$-I,)Y5T,&MU +B!FREN'.H?J708?F&>'R%DRQ!8?^^
MB&,R6=/_,^^C9&7G 5$"&/AGN]['QAP#X]91H1W=Z3))37]SM H&$V83#$R,
M6J/=C)YCG6EFY098_@?T,(-J%.7<"(,X@UNG76G(8,LEU4+/CKD5X6"2I'$Z
MGJMLBEF)8DO@#!%HK[A)";UP$F3#FP"GDZ>C@G_"6"-K+/@39J7F3IU[16/$
M"5)XDB,B9AI-\#X#.,YT2JGCRO=%!;WX/OKT&G3A-,N5!QIO3Y0-19>F84QR
MNY7WPB5?:7,7XX9D .7@YK8K^-K65ZGA&88<P=\G03Q:)<ZPZY.Z/=,HXN9<
M%GF5+C]Z5P(\B6]]#;.K^9<THDJ5]ZR0(+Y*_NLJ:"O486%IK(7>%,%9DTH3
MN@%R%>\4S @Z&I,G(X5B:M<0AX"J],8E4&U>R3G@#)M"8<>C@3/.R%6$@T1)
M255Y*DZ$ 8PA\.= Q6#T;=94VW ,]IY:4;U*8!OS0:2S'Y=9)$.@^HQ$/(R(
M4^?9<MQ/IPUHD&=3_JZ_X4JLUJ"6A.$I>0(SI%H*/W"V;KN97-5,E@J B4-'
MC):QK.!#.=AT",4*BJ15<"134(<K-'&5*M.C4O.&TVDZ%TE!$8^FA=Y!]]M\
M@^F$OD+6J,.F"0"">;7O 3LVA-H !+054G5%%^'A=^8B/'QT$3X@)>]X?PT5
M[_>7OP +(M><;N!1S0GX^<??*Q: ZG8GG ^_*+R;9*ONA<Z%$L5/VW#WV[)S
MUE.H/^C64[\P9E[=K*90%(&YL=\C8>1DE4#6Y.-8GJNLLF:/#X]W^MRD '_O
M=HZ/#LY\#_Y]A1P;_GO>VO')MZ9&V,YL\OV"4%%_X&,@BZR)VL#C4JGMY9,P
M+'1:%Z&O *T!%9Z!A?:YVWF%M.9Q#EJU*7@M _CXZ*B].U6@&C[3=-%>F*&8
M1RFM4LB53DOF9Z30-#]S!H*MF%LYG95,=892K6C032=DUS^JZKS>$5"/C_\9
MX'^.\0!Z)SO#7>V,=1+847DAUJHS'X96[+N"ID8NMM2+4TK"Y*=5@T.J)9J9
MYZV.:"W6,MI9RES.6KQG+3'549DE43Y!;'J)+#;,EKC&,G)"  J+'%!E!_7M
M.@(]E7+6:77A4).-Q86(XO#N_PE6G'>.BI%NAM8[^.G@P#O;_W7?KSR"5\GW
MI!\B:%2IE876[0P#LH94>HQ['DX_))7U]C<2@$!?Y^+&% 642E_9TVZIS'@J
M85ZXO)=V%7%X.4'73L4<A>)<I0GH(VOF#@WWZ>04>,-.;Q<KY5LOUH[*8&C$
M_>;6E:G@=D?)KEBY=-&H=K&]#=U6J(AM"7WK-E;GNTH.CG.Z.BV"0NC>))8
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M7UCH)U%=PCO3W%P0J>B[KN19+&MTA)@U<BHQJ0B*%X*,C.]F85B79"[O;)Q
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MF.J,\.5Y[1S^Z(<FUN*+WF7EDG(IG)U,ZB]*MK52TFUUX=E9NRJIIZ'686H
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M8DA57@_4IFK3/)@B;(&VDF;!G/:E06QI-=;M$6#GV70[2_8"?326<VN69JK
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MU."K8&T!\%=D)@5C=<)$L<![$LKOH<K(62^IE.X1S62E!,YZ^FU,X#O$(BR
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MA <$LOK[/J/;'M(O5Y=W?49'SP[W%]VBBBMYX3:^\%8]E?M7E8S0<;38BE;
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M[,\K[_SL_>7'L[>BJ+:QVT:9TB*R[GTIO_URYEU=G/_^X?+CI=&YO\6E"*#
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MZ>YC%-]% CCBK@.? &QY%\)2>+G!#A4<#_8!L="$>1^4F"[-N,U;S4:(8Y^
MD)0)5.#Z.@FNT1$Q2\)H%,[023&-YU%&2^604HW?U3Y7/KQ.#MJCEJI2<K>5
M5GW*_O'[T3/WV3/Z=\]I(6[%9V.>[K2"9>1[U8T9_RG.5CN'+] \]>@N[*VV
M4'&$WRKW^FD0Q=.0#W.J3[-- G<A;[H0 8EML.WC.7KD@'[#E$&]*(>XVJEH
ML0#?[H*,T@4B,T1Z@.19/@W8*!(8RH;7"7P_G4^R<#8AB?(?^_02#"GX-!*%
M&M6<ZHG(V8.A#P,\N0HI9P.#;-3<NTD\A XM-B6 !&FE\"HLK0KD;N%J.EZ6
M>:,;;8QRV7M-O@'V48P\06(H0Q!Z+[P%W8PS]&\H)T9N3>,QO(E@0D)CJO"H
MU)L&M?NGMX$G?+77WP/1>P(*&%OW9]X"^0=?WGH+$%013,,Y;&U(%GY7W,NX
MZ6FF6Y]Z?E!L=I-8P0^JK@&]GGL9DO;"P2@TPP'Z&5&*_M4F"NV KSK$0$=P
MVP>*1\!I,B#__2.7WZFX@YL-;J@PGN^%.O^NY+2.*^GPE7,Q(][Q$KL7.?Z5
M\Y<WF7\[3U.5VF;W\:RB"R+R\G&QCX ]<37E5\Y@,8,G6HDW#$>OG"YP.UZ6
M;HR3/<CYE]1;%%0FQ+[I+K#ORR+]Q\XB2PZPCMQRS!75)\WA8O:56TQ0/W+)
MERGQL!QR8!B IKOK%KEGCNF!\.&";#(F0 ((",.).-!Z@1],Z<S;#:-BK=Q0
M19B<,ED\WSNH5NIW7<.Y2<80B6LT2E RPH 'B5T"WC^9HVV/QQ).IX$?PBA
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M?X%PYM,YCI#HV[I'[<--@$4^O/H"\\994%*EBLM:7D(D46N9L?7\?;.[AU9
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MF!'R(B[:T(,$S@ZGUE:IW?$P4*)>.55^XMU%94Y>(ZZ_VCP<RCH&T(-G&VT
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M1NO=.$-^@V!+#45$H> ZAD^%M.^V7E<VOM=)KZ5XR0(A:'<->1JXX$JU*HW
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M/<&AJBS VB40^JZ212DK(P?:\:6-ZU:W922QDFK$'4U=T;0QD4\:4!CY<-.
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M-,SRZ<C+8REDX2P/;7-56&'-%3=V'^U1R/CI"><RCDV>)-Y\+3Q1CA&$\BF
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MQ3R^]SC[2JO>+OD7\XC_O[UO[6DCR];^CL1_*.5,CVS)84((?4EZ(AGC!.N
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M"MDJY8C62FZ41BUFS#!<E,149 H:()\"OTOX.#;@76H0OX-A)#R#2S22Z]P
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MV,=CW\7,'.78 Q.F0\P%>N;0S!4CU2F['=G+7^9RT& !$J6:;))A!24( G1
ML# 6#"D2V@EVUKU::R9P1#.);F0]"K+= ;+:-S1<A,[5Z'"E%K JC+:=QI_0
MGD&\H/)<EER7P@4FMR1BC:NN20'VR0/:5G&N1/YCS9;UU][;CG!L7L(93!99
M.A4$*BIB0>&/H!3&5U<1N0^ZO!G&L)@Y\H\7#C,2.46?P;@C@OAXD3-J6T%6
MB\@E@L_EXRR^X'642(J"R2)5KMIV*C 67J0WGD_!*)="\$FF[B=46Y%4,LJX
M V!ZC*]1((3(%JR8W7#?-K2B9M36,"%A B8U=&,&(BJ>,\D]PZD)3_=Y+#.
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M+A%\+A]G\06OHT12%$P6&675ME.!L? BO?%\"D:Y%!Y,,G4_H=J*W(M1QAT
MTV-\C0(A1%)=18"&^[:A%36CMH8)"1,PJ:$;,Q!1\9RYX/^V2S]!/-WGL<P
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MVRIPAZ:K<G+G2-1M5C(1''GZ25O$O-K/T8$Y<9$\ETOT31*A&IF[%[R 0D?
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M[1\'IX<?<6__XVAT<@S_^/]02P,$%     @ \8%T62T ;EF\#   (S   !4
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M$4K(LW :R6!!Y>.SF!\^;S<;$YF($<AZR!?I1-"6:^5FL4YS>5W<NA,9C)4
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M@[]2)*K6!>N<S!5)/3 L21<1EWR0'FS.K&1B1=9!R2+E3#N5Z-1L/BFB84+
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M@]E1S0<69VI!LFZ7'YN9-Q6!1,I*L# YQK$4/DX1UM%(8GYFS'*9):6#FI)
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M,#(T,3$R,%]P<F4N>&UL4$L! A0#%     @ \8%T6;6D:+9?&   VH4  !(
M             ( !$A8  '1M,C0R-C8P,F0T7SAK+FAT;5!+ 0(4 Q0    (
M /&!=%EWQS@^%'8  &H! P 5              "  :$N  !T;3(T,C8V,#)D
M-%]E>#$M,2YH=&U02P$"% ,4    " #Q@719.26D.H7*  !!2 4 %0
M        @ 'HI   =&TR-#(V-C R9#1?97@T+3(N:'1M4$L! A0#%     @
M\8%T62T ;EF\#   (S   !4              ( !H&\! '1M,C0R-C8P,F0T
@7V5X-2TQ+FAT;5!+!08     !P ' ,X!  "/? $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>tm2426602d4_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gild-20241120.xsd" xlink:type="simple"/>
    <context id="AsOf2024-11-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882095</identifier>
        </entity>
        <period>
            <startDate>2024-11-20</startDate>
            <endDate>2024-11-20</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-11-20" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-11-20" id="Fact000004">0000882095</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-11-20" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-11-20" id="Fact000010">2024-11-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-11-20" id="Fact000011">GILEAD SCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-11-20" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-11-20" id="Fact000013">0-19731</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-11-20" id="Fact000014">94-3047598</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-11-20" id="Fact000015">333 Lakeside Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-11-20" id="Fact000016">Foster City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-11-20" id="Fact000017">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-11-20" id="Fact000018">94404</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-11-20" id="Fact000019">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-11-20" id="Fact000020">574-3000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-11-20" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-11-20" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-11-20" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-11-20" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-11-20" id="Fact000025">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-11-20" id="Fact000026">GILD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-11-20" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-11-20" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
